Form 10-Q for quarterly period ended February 29, 2012

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

0001193125-12-162577.txt : 20120413 0001193125-12-162577.hdr.sgml : 20120413 20120413160402 ACCESSION NUMBER: 0001193125-12-162577 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20120229 FILED AS OF DATE: 20120413 DATE AS OF CHANGE: 20120413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DYNACQ HEALTHCARE INC CENTRAL INDEX KEY: 0000890908 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760375477 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-21574 FILM NUMBER: 12758744 BUSINESS ADDRESS: STREET 1: 4301 VISTA ROAD CITY: PASADENA STATE: TX ZIP: 77504 BUSINESS PHONE: 713-378-2000 MAIL ADDRESS: STREET 1: 4301 VISTA ROAD CITY: PASADENA STATE: TX ZIP: 77504 FORMER COMPANY: FORMER CONFORMED NAME: DYNACQ INTERNATIONAL INC DATE OF NAME CHANGE: 19960126 10-Q 1 d331373d10q.htm FORM 10-Q FOR QUARTERLY PERIOD ENDED FEBRUARY 29, 2012 Form 10-Q for quarterly period ended February 29, 2012

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 29, 2012

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 000-21574

DYNACQ HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)


Nevada		76-0375477
(State or other jurisdiction of incorporation or organization)		( (I.R.S. Employer Identification No.)

4301 Vista Road Pasadena, Texas		77504
(Address of principal executive offices)		(Zip Code)

(713) 378-2000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. (Check One):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of April 13, 2012, the number of shares outstanding of the registrant’s common stock, par value $.001 per share, was 14,543,626.

Table of Contents


		Page

Report of Independent Registered Public Accounting Firm.			3

PART I—FINANCIAL INFORMATION			4

Item 1.	Financial Statements.		4

	Consolidated Balance Sheets as of February 29, 2012 and August 31, 2011.		4

	Consolidated Statements of Operations for the three and six months ended February 29, 2012 and February 28, 2011.		6

	Consolidated Statements of Cash Flows for the three and six months ended February 29, 2012 and February 28, 2011.		7

	Notes to Consolidated Financial Statements.		9

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.		24

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.		34

Item 4.	Controls and Procedures.		34

PART II–OTHER INFORMATION			35

Item 1.	Legal Proceedings.		35

Item 1A.	Risk Factors.		35

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.		35

Item 3.	Defaults Upon Senior Securities.		35

Item 4.	Mine Safety Disclosures.		35

Item 5.	Other Information.		35

Item 6.	Exhibits.		36

Signatures			37

Index of Exhibits			38

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To:	The Stockholders and Board of Directors

Dynacq Healthcare, Inc.

Houston, Texas

We have reviewed the accompanying consolidated balance sheet of Dynacq Healthcare, Inc. (the “Company”), as of February 29, 2012, and the related consolidated statements of operations and cash flows for the three-month and six-month periods ended February 29, 2012 and February 28, 2011. These interim financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the accompanying consolidated interim financial statements for them to be in conformity with United States of America generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of Dynacq Healthcare, Inc., as of August 31, 2011, and the related consolidated statements of operations, stockholders’ equity, and cash flows for the year then ended not presented herein, and in our report dated November 16, 2011, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of August 31, 2011, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

/s/ KWCO, P.C.

KWCO, P.C.

Houston, Texas

April 13, 2012

PART I—FINANCIAL INFORMATION

ITEM I—FINANCIAL STATEMENTS

Dynacq Healthcare, Inc.

Consolidated Balance Sheets


	February 29, 2012		August 31, 2011
	(Reviewed)		(Audited)
Assets
Current assets:
Cash and cash equivalents	$	15,842,467	$	24,315,160
Accounts receivable, net of contractual allowances of approximately $187,059,000 and $188,513,000 at February 29, 2012 and August 31, 2011, respectively		500,824		1,192,279
Inventories		474,109		550,441
Trading securities		1,424,399		1,471,644
Interest receivable		178,874		192,366
Prepaid expenses		198,121		272,414
Income tax receivable		2,363,724		2,363,724
Assets of discontinued operations		6,651,726		6,909,527

Total current assets		27,634,244		37,267,555
Investments available-for-sale		18,281,129		18,722,274
Investment in real estate, net		1,915,218		1,941,041
Property and equipment, net		7,038,699		7,168,864
Income tax receivable		868,249		868,249
Deferred tax asset		612,216		—
Other assets		249,695		255,517

Total assets	$	56,599,450	$	66,223,500

See accompanying notes.

Dynacq Healthcare, Inc.

Consolidated Balance Sheets (continued)


	February 29, 2012		August 31, 2011
	(Reviewed)		(Audited)
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	1,974,753	$	2,346,720
Accrued liabilities		13,691,664		18,430,553
Current portion of notes payable		121,543		97,918
Current portion of capital lease obligations		97,794		94,044
Liabilities of discontinued operations		615,598		604,302

Total current liabilities		16,501,352		21,573,537
Non-current liabilities:
Long-term portion of notes payable		1,125,903		1,093,961
Long-term portion of capital lease obligations		139,308		189,161

Total liabilities		17,766,563		22,856,659

Commitments and contingencies
Equity:
Dynacq stockholders’ equity:
Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding		—		—
Common stock, $.001 par value; 100,000,000 shares authorized, 14,543,626 and 14,426,960 shares issued at February 29, 2012 and August 31, 2011		14,544		14,427
Additional paid-in capital		10,047,320		9,780,837
Accumulated other comprehensive income		6,326,320		7,453,676
Retained earnings		22,314,605		26,054,284

Total Dynacq stockholders’ equity		38,702,789		43,303,224

Non-controlling interest		130,098		63,617

Total equity		38,832,887		43,366,841

Total liabilities and equity	$	56,599,450	$	66,223,500

See accompanying notes.

Dynacq Healthcare, Inc.

Consolidated Statements of Operations

(Reviewed)


	Three months ended						Six months ended
	February 29, 2012			February 28, 2011			February 29, 2012			February 28, 2011
Net patient service revenue	$	966,716		$	1,688,813		$	2,811,689		$	4,138,628

Costs and expenses:
Compensation and benefits		2,019,312			1,604,895			3,696,681			3,603,843
Medical services and supplies		343,508			365,464			566,626			784,020
Other operating expenses		1,349,336			1,550,251			2,672,125			3,354,188
Depreciation and amortization		160,287			44,109			310,098			90,954

Total costs and expenses		3,872,443			3,564,719			7,245,530			7,833,005

Operating loss		(2,905,727	)		(1,875,906	)		(4,433,841	)		(3,694,377	)

Other income (expense):
Rent and other income		1,257,844			196,608			1,260,442			977,266
Interest income		338,305			353,763			606,203			740,453
Interest expense		(143,265	)		(9,750	)		(294,589	)		(20,300	)

Total other income, net		1,452,884			540,621			1,572,056			1,697,419

Loss before income taxes from continuing operations		(1,452,843	)		(1,335,285	)		(2,861,785	)		(1,996,958	)
Benefit for income taxes		—			493,030			—			666,679

Loss from continuing operations		(1,452,843	)		(842,255	)		(2,861,785	)		(1,330,279	)
Discontinued operations, net of income taxes		(169,547	)		(715,258	)		(732,213	)		(1,384,909	)
Loss on disposal of discontinued operations, net of income taxes		(229,201	)		(121,577	)		(229,201	)		(121,577	)

Net loss		(1,851,591	)		(1,679,090	)		(3,823,199	)		(2,836,765	)
Less: Net loss attributable to noncontrolling interest		56,005			1,728			83,520			2,763

Net loss attributable to Dynacq Healthcare, Inc.	$	(1,795,586	)	$	(1,677,362	)	$	(3,739,679	)	$	(2,834,002	)

Basic and diluted loss per common share:
Loss from continuing operations attributable to Dynacq Healthcare, Inc.	$	(0.10	)	$	(0.06	)	$	(0.19	)	$	(0.09	)
Discontinued operations, net of income taxes		(0.01	)		(0.05	)		(0.05	)		(0.10	)
Loss on disposal of discontinued operations, net of income taxes		(0.02	)		(0.01	)		(0.02	)		(0.01	)

Net loss attributable to Dynacq Healthcare, Inc.	$	(0.13	)	$	(0.12	)	$	(0.26	)	$	(0.20	)

Basic and diluted average common shares outstanding		14,456,127			14,176,960			14,443,627			14,176,960

Amounts attributable to Dynacq Healthcare, Inc.:
Loss from continuing operations	$	(1,396,838	)	$	(840,527	)	$	(2,778,265	)	$	(1,327,516	)
Discontinued operations, net of income taxes		(169,547	)		(715,258	)		(732,213	)		(1,384,909	)
Loss on disposal of discontinued operations, net of income taxes		(229,201	)		(121,577	)		(229,201	)		(121,577	)

Net loss attributable to Dynacq Healthcare, Inc.	$	(1,795,586	)	$	(1,677,362	)	$	(3,739,679	)	$	(2,834,002	)

See accompanying notes.

Dynacq Healthcare, Inc.

Consolidated Statements of Cash Flows

(Reviewed)


	Six months ended
	February 29, 2012			February 28, 2011
Cash flows from operating activities
Net loss	$	(3,739,679	)	$	(2,834,002	)
Less loss from discontinued operations, net of income taxes		961,414			1,506,486

Net loss before discontinued operations		(2,778,265	)		(1,327,516	)
Adjustments to reconcile net loss before discontinued operations to net cash used in operating activities:
Depreciation and amortization		310,098			90,954
Loss on trading securities		57,101			14,995
Deferred income taxes		(1,655,662	)		272,534
Noncontrolling interest		(83,520	)		(2,763	)
Charge for stock options to employees		149,934			4,251
Charge for non-controlling interest sale and issuance of stock awards		166,666			—
Foreign currency exchange losses (gains)		152,435			(157,939	)
Changes in operating assets and liabilities:
Accounts receivable		691,455			1,112,382
Interest receivable		13,493			110,183
Inventories		76,332			55,313
Prepaid expenses		74,293			290,635
Income taxes receivable		—			(1,710,119	)
Other assets		5,316			29,979
Accounts payable		(371,967	)		291,070
Accrued liabilities		(4,766,187	)		(802,185	)

Cash used in continuing activities		(7,958,478	)		(1,728,226	)
Cash used in discontinued activities		(696,218	)		(1,239,848	)

Net cash used in operating activities		(8,654,696	)		(2,968,074	)

Cash flows from investing activities
Purchase of trading securities		—			(4,909,498	)
Sales proceeds of trading securities		—			3,494,738
Purchase of equipment		(157,753	)		(6,794	)

Cash used in continuing activities		(157,753	)		(1,421,554	)
Cash used in discontinued activities		—			(101,651	)

Net cash used in investing activities		(157,753	)		(1,523,205	)

Cash flows from financing activities
Proceeds from notes payable		116,339			65,000
Principal payments on notes payable		(60,773	)		(44,567	)
Payments on capital lease		(46,103	)		(42,635	)
Contributions from, and distributions to, noncontrolling interest, net		100,000			—

Cash provided by (used in) continuing activities		109,463			(22,202	)
Cash used in discontinued activities		—			(23,222	)

Net cash provided by (used in) financing activities		109,463			(45,424	)

Effect of exchange rate changes on cash		230,293			484,536

Net decrease in cash and cash equivalents		(8,472,693	)		(4,052,167	)
Cash at beginning of period		24,315,160			27,665,945

Cash at end of period	$	15,842,467		$	23,613,778

Continued.

Dynacq Healthcare, Inc.

Consolidated Statements of Cash Flows (continued)

(Reviewed)


	Six months ended
	February 29, 2012			February 28, 2011
Supplemental cash flow disclosures
Cash paid during the period for:
Interest	$	728,788		$	22,804

Income taxes	$	0		$	0

Non cash investing and financing activities:
Investments available-for-sale	$	(278,855	)	$	1,024,427
Accumulated other comprehensive income		181,256			(665,877	)
Deferred tax liabilities		97,599			(358,550	)
Equipment from capital lease (discontinued operations)		—			34,592
Capital lease obligation (discontinued operations)		—			(34,592	)

See accompanying notes.

Dynacq Healthcare, Inc.

Notes to Consolidated Financial Statements

February 29, 2012

(reviewed)

General

Dynacq Healthcare, Inc., a Nevada corporation (the “Company”), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its subsidiaries in China and Hong Kong also (1) provided healthcare management services to a hospital in China until February 28, 2011; and (2) invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings. The Company through its United States subsidiaries (1) owns and operates one general acute care hospital in Pasadena, Texas, and (2) owns one general acute care hospital in Garland, Texas, which was closed on September 30, 2011, and accordingly this business is classified as “Discontinued Operations” for the six months ended February 29, 2012 and February 28, 2011 (see Note below on Discontinued Operations). The Company is currently composed of two divisions: U.S. and Corporate.

Basis of Presentation

The accompanying reviewed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company’s expenses are “cost of revenue” items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $1.5 million and $1.3 million for the three months ended February 29, 2012 and February 28, 2011, respectively, and $2.8 million and $3.2 million for the six months ended February 29, 2012 and February 28, 2011, respectively. These reviewed financial statements should be read in conjunction with the audited financial statements at August 31, 2011. Operating results for the three and six months ended February 29, 2012 are not necessarily indicative of the results that may be expected for the year ending August 31, 2012.

Reorganization of Segments and Reclassification

The Industry Segment “U.S. Division” comprises of the Company’s Pasadena facility. In the prior year it was classified as discontinued operations in the consolidated financial statements. The Company at the present time has the U.S. Division and the Corporate Division. Certain previously reported financial information has been reclassified to conform to the current year’s presentation. The impact of such reclassification was not significant to the prior year’s overall presentation, except for (1) presenting the Pasadena facility as continuing operations under U.S. Division, which was presented in the prior year as discontinued operations, and (2) the presentation of the various subsidiaries (except for Dynacq Huai Bei Healthcare, Inc. (“Dynacq-Huai Bei”) and Sino Bond Inc. Limited (“Sino Bond”), which are now shown as part of the Corporate Division) in China as discontinued operations under the Corporate Division, which in the previous year was shown as part of continuing operations under the China Division.

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.

Investments in Available-for-Sale and Trading Securities

12 months. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss.

The Company also invests in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and are carried at fair value as of February 29, 2012. These investments are subject to fluctuations in the market price. During the six months ended February 29, 2012 and February 28, 2011, the Company had a net loss of $57,101 and $14,995 in trading of these securities, respectively.

Investment in Real Estate and Notes Payable

In March 2010, the Company purchased an apartment in Hong Kong as an investment for $2,014,207. This apartment was used as a security to obtain an 18-year mortgage loan of $1,245,775 from a financial institution, with a variable interest rate at the lower of 3-month Hang Seng Interbank Offered Rates plus 0.7% or 2.9% below the Hong Kong Dollar best lending rate quoted by the financial institution. The effective interest rate at February 29, 2012 was 1.1%. The Company has paid down $32,090 and $31,651 during the six months ended February 29, 2012 and February 28, 2011, respectively, and the current and long-term portions of the note payable as of February 29, 2012 are $64,319 and $1,059,320, respectively. Depreciation expense associated with the apartment was $12,912 in each year for the three months ended February 29, 2012 and February 28, 2011, and $25,824 in each year for the six months ended February 29, 2012 and February 28, 2011.

In November 2011 and September 2010, the Company borrowed $116,339 and $65,000 as notes payable from a financial institution at an interest rate of 4.5% and 6%, which notes are to be repaid in 36 and 24 monthly installments, respectively, and are secured by specific equipments purchased at our Pasadena facility. The Company has paid down $28,683 during the six months ended February 29, 2012, and the current and long-term portions of the notes payable as of February 29, 2012 are $57,224 and $66,583, respectively.

Inventories

Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company’s estimates is the determination of revenue to recognize for the services the Company provides and the determination of the contractual allowance. See “Revenue Recognition” below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.

Discontinued Operations

Under ASC Topic 360-10-35, Property, Plant, and Equipment – Subsequent Measurement (formerly referred to as SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets), we classify assets to be disposed of as held for sale or, if appropriate, discontinued operations when they have received appropriate approvals to be disposed of by our management or Board of Directors. Cash flows from our discontinued businesses are reflected as discontinued operating, investing, and financing activities in our statement of cash flows. We had $6,651,726 of assets of discontinued operations and $615,598 of liabilities of discontinued operations as of February 29, 2012.

U.S. Division

period following the decision to sell, the operations of the Pasadena facility have been reclassified as continuing operations for the fiscal years 2011 and 2012. The Company is continuing to revamp its operations at the Pasadena facility by modifying the business model and controlling expenses. However, there can be no assurance that we will be successful in turning the facility around.

The Company had an independent appraisal done for both the hospitals in October 2011, and based on each hospital’s valuation, expected sale proceeds, and expected cash flows has determined that there is no impairment charge required in connection with the foregoing disposal activities. Because we do not intend to sell the accounts receivable of hospitals in discontinued operations, the receivables are included in our accounts receivable in the accompanying Consolidated Balance Sheets.

Corporate Division

The Company’s operations at Second People’s Hospital and its various proposed businesses in China, including but not limited to sandstone mining, mined coal trading, natural gas stations and sale of artifacts have been classified as discontinued operations. The Company’s two foreign subsidiaries, Dynacq-Huai Bei and Sino Bond, are the only two companies that continue to be classified as continuing operations, and its other foreign subsidiaries have been reclassified as discontinued operations.

The following is a summary of financial information related to our discontinued operations for the three and six months ended February 29, 2012 and February 28, 2011. We have reclassified prior period financial statements to exclude these businesses from continuing operations.

Discontinued Operations


	Three months ended February 29, 2012									Three months ended February 28, 2011
	U.S. Division			Corporate Division			Total			U.S. Division			Corporate Division			Total
Net patient service revenue	$	93,711		$	—		$	93,711		$	734,538		$	339,910		$	1,074,448

Costs and expenses:
Compensation and benefits		11,196			—			11,196			657,684			285,781			943,465
Medical services and supplies		46,580			—			46,580			250,524			130,807			381,331
Other operating expenses		195,171			—			195,171			660,700			232,608			893,308
Depreciation and amortization		—			—			—			—			10,754			10,754

Total costs and expenses		252,947			—			252,947			1,568,908			659,950			2,228,858

Operating loss		(159,236	)		—			(159,236	)		(834,370	)		(320,040	)		(1,154,410	)
Other income (expense), net		(10,311	)		—			(10,311	)		2,762			56,790			59,552

Loss before income taxes		(169,547	)		—			(169,547	)		(831,608	)		(263,250	)		(1,094,858	)
Benefit for income taxes		—			—			—			267,827			111,773			379,600

Loss on discontinued operations, net of income taxes		(169,547	)		—			(169,547	)		(563,781	)		(151,477	)		(715,258	)

Loss on disposal of discontinued assets		—			(229,201	)		(229,201	)		—			(187,041	)		(187,041	)
Benefit for income taxes		—			—			—			—			65,464			65,464

Loss on disposal of discontinued assets, net of income taxes		—			(229,201	)		(229,201	)		—			(121,577	)		(121,577	)

Total loss on discontinued operations, net of taxes	$	(169,547	)	$	(229,201	)	$	(398,748	)	$	(563,781	)	$	(273,054	)	$	(836,835	)


	Six months ended February 29, 2012									Six months ended February 28, 2011
	U.S. Division			Corporate Division			Total			U.S. Division			Corporate Division			Total
Net patient service revenue	$	318,587		$	—		$	318,587		$	1,288,049		$	831,232		$	2,119,281

Costs and expenses:
Compensation and benefits		166,803			22,511			189,314			1,334,918			556,100			1,891,018
Medical services and supplies		267,551			—			267,551			476,252			406,452			882,704
Other operating expenses		533,115			98,493			631,608			1,282,304			358,232			1,640,536
Depreciation and amortization		—			5,175			5,175			—			21,180			21,180

Total costs and expenses		967,469			126,179			1,093,648			3,093,474			1,341,964			4,435,438

Operating loss		(648,882	)		(126,179	)		(775,061	)		(1,805,425	)		(510,732	)		(2,316,157	)
Other income (expense), net		(21,056	)		63,904			42,848			2,813			191,474			194,287

Loss before income taxes		(669,938	)		(62,275	)		(732,213	)		(1,802,612	)		(319,258	)		(2,121,870	)
Benefit for income taxes		—			—			—			585,218			151,743			736,961

Loss on discontinued operations, net of income taxes		(669,938	)		(62,275	)		(732,213	)		(1,217,394	)		(167,515	)		(1,384,909	)

Loss on disposal of discontinued assets		—			(229,201	)		(229,201	)		—			(187,041	)		(187,041	)
Benefit for income taxes		—			—			—			—			65,464			65,464

Loss on disposal of discontinued assets, net of income taxes		—			(229,201	)		(229,201	)		—			(121,577	)		(121,577	)

Total loss on discontinued operations, net of taxes	$	(669,938	)	$	(291,476	)	$	(961,414	)	$	(1,217,394	)	$	(289,092	)	$	(1,506,486	)


	February 29, 2012						August 31, 2011
	U.S. Division		Corporate Division		Total		U.S. Division		Corporate Division		Total
Current assets	$	—	$	120,954	$	120,954	$	260,020	$	118,734	$	378,754
Property and equipment, net		6,530,772		—		6,530,772		6,530,773		—		6,530,773

Total assets	$	6,530,772	$	120,954	$	6,651,726	$	6,790,793	$	118,734	$	6,909,527

Current liabilities:
Accounts payable and accrued liabilities	$	—	$	615,598	$	615,598	$	—	$	604,302	$	604,302

Total liabilities	$	—	$	615,598	$	615,598	$	—	$	604,302	$	604,302

Net Loss per Share

The following table presents the computation of basic and diluted loss per common share attributable to the Company:


	Three months ended						Six months ended
	February 29, 2012			February 28, 2011			February 29, 2012			February 28, 2011
Basic and diluted loss per common share:
Numerator:
Loss from continuing operations	$	(1,452,843	)	$	(842,255	)	$	(2,861,785	)	$	(1,330,279	)
Less: Net loss attributable to noncontrolling interest		56,005			1,728			83,520			2,763

Loss from continuing operations attributable to Dynacq Healthcare, Inc.		(1,396,838	)		(840,527	)		(2,778,265	)		(1,327,516	)
Discontinued operations, net of income taxes		(169,547	)		(715,258	)		(732,213	)		(1,384,909	)
Loss on disposal of discontinued operations, net of income taxes		(229,201	)		(121,577	)		(229,201	)		(121,577	)

Net loss attributable to Dynacq Healthcare, Inc.	$	(1,795,586	)	$	(1,677,362	)	$	(3,739,679	)	$	(2,834,002	)

Denominator:
Basic and diluted average common shares outstanding		14,456,127			14,176,960			14,443,627			14,176,960

Basic and diluted loss per common share:
Loss from continuing operations attributable to Dynacq Healthcare, Inc.	$	(0.10	)	$	(0.06	)	$	(0.19	)	$	(0.09	)
Discontinued operations, net of income taxes		(0.01	)		(0.05	)		(0.05	)		(0.10	)
Loss on disposal of discontinued operations, net of income taxes		(0.02	)		(0.01	)		(0.02	)		(0.01	)

Net loss attributable to Dynacq Healthcare, Inc.	$	(0.13	)	$	(0.12	)	$	(0.26	)	$	(0.20	)

Basic net income (loss) per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted net income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the calculation of diluted net income (loss) per share, the basic weighted average number of shares is increased by the dilutive effect of stock options determined using the treasury stock method. However, if it is anti-dilutive, the dilutive effect of the stock options is not included in the calculation of diluted net income (loss) per share. Stock options with exercise prices exceeding current market prices that were excluded from the computation of net income (loss) per share amounted to approximately 2,367,000 shares and 1,139,000 shares for the six months ended February 29, 2012 and February 28, 2011, respectively.

Stock Based Compensation

Year 2011 Stock Incentive Plan

In August 2011, we mailed an Information Statement to all of our stockholders of record as of July 29, 2011. The Information Statement disclosed that our Board of Directors had approved, and the holders of a majority of the outstanding shares of our common stock had executed an Action by Written Consent of Stockholders in Lieu of a Special Meeting (the “Written Consent”), approving the adoption of the Year 2011 Stock Incentive Plan (“2011 Plan”).

The purpose of the 2011 Plan is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and thereby encouraging them to devote their abilities and industry to the success of the Company’s business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved 15,000,000 shares of common stock for future issuance under the 2011 Plan.

On November 14, 2011, the Compensation Committee granted stock options to purchase an aggregate of 200,000 shares under the 2011 Plan, with a weighted average exercise price of $1.07 to two employees. These stock options will vest based on certain operating performance criteria, and expire after five years. The shares underlying these stock options are registered under the Securities Act of 1933 (the “Securities Act”).

On January 12, 2012, the Compensation Committee granted stock options to purchase 250,000 shares under the 2011 Plan, with an exercise price of $1.10 to the Company’s chief executive officer, Eric K. Chan. These stock options will vest in annual installments of 25 percent beginning on the first anniversary date, and expire after ten years. The shares underlying these stock options are registered under the Securities Act.

On February 6, 2012, the Compensation Committee granted stock options to purchase an aggregate of one million shares under the 2011 Plan, with a weighted average exercise price of $1.00 to various employees. These stock options will vest based on certain operating performance criteria, and expire after five years. The shares underlying these stock options are registered under the Securities Act.

As of February 29, 2012, there remain 13,650,000 shares which can be issued under the 2011 Plan after giving effect to shares issued.

2000 Incentive Plan

The Company’s 2000 Incentive Plan (“2000 Plan”) provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of February 29, 2012, there remain 2,023,066 shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.

The 2011 Plan and the 2000 Plan (the “Plans”) are administered by the Compensation Committee of the Board of Directors (the “Committee”). The Committee has the power to determine which eligible employees will receive awards, the timing and manner of the grant of such awards, the exercise price of stock options (which may not be less than market value on the date of grant), the number of shares, and all of the terms of the awards. The Company may at any time amend or terminate the 2011 Plan. However, no amendment that would impair the rights of any participant with respect to outstanding grants can be made without the participant’s prior consent. Stockholder approval of an amendment to the Plans is necessary only when required by applicable law or stock exchange rules.

Generally, options granted become exercisable in annual installments of 25 percent beginning on the first anniversary date, and expire after five to ten years.

The following table summarizes the stock option activities for the six months ended February 29, 2012 (share amounts in thousands):


	Shares			Weighted Average Option Exercise Price Per Share		Weighted Average Grant Date Fair Value Per Share		Aggregate Intrinsic Value⁽¹⁾
Outstanding, August 31, 2011		2,206		$	2.41	$	—	$	—
Granted		1,450			1.03		0.52		—
Exercised		—			—		—		—
Expired or canceled		(283	)		1.79		—		—

Outstanding, February 29, 2012		3,373		$	1.87	$	—	$	—

⁽¹⁾

These amounts represent the difference between the exercise price and the closing price of Dynacq common stock on February 29, 2012 and August 31, 2011, as reported on the NASDAQ stock market, for all in-the-money options outstanding. For exercised options, intrinsic value represents the difference between the exercise price and the closing price of Dynacq common stock on the date of exercise.

For the six months ended February 29, 2012 and February 28, 2011, there were no stock options exercised.

The following summarizes information related to stock options outstanding as of February 29, 2012, and related weighted average price and life information:


	Options Outstanding						Options Exercisable
Range of Exercise Prices	Shares		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Shares		Weighted Average Exercise Price
	(Share Amounts In Thousands)
$ 1.00 – 1.10		1,350		6.0	$	1.03		—	$	—
$ 1.86 – 2.05		1,200		9.4		1.89		—		—
$ 2.50 – 2.75		587		1.3		2.54		587		2.54
$ 4.90 – 4.96		236		2.6		4.90		236		4.90

Total		3,373		6.1	$	1.87		823	$	3.22

For the three months ended February 29, 2012 and February 28, 2011, stock-based compensation expense associated with the Company’s stock options was $82,244 and $(102,963), respectively. For the six months ended February 29, 2012 and February 28, 2011, stock-based compensation expense associated with the Company’s stock options was $149,934 and $4,251, respectively. The total unrecognized compensation expense for outstanding stock options as of February 29, 2012 was $1,464,000, and will be recognized, in general, over 3.8 years. The weighted average time to recognize the compensation expense is 1.9 years.

Fair Value of Financial Instruments

On September 1, 2008, the Company adopted ASC Topic 825-10-25, “Financial Instruments” (formerly referred to as SFAS No. 159, The Fair Value Option for Financial Assets and Liabilities (“SFAS 159”)), which permits entities to choose to measure certain financial assets and liabilities at fair value. The adoption of ASC Topic 825-10-25 had no impact on the consolidated financial statements because the Company did not elect the fair value option for any financial assets or financial liabilities that were not already recorded at fair value.

On September 1, 2008, the Company adopted ASC Topic 820, “Fair Value Measurements and Disclosures” (formerly referred to as SFAS 157) for our financial assets and liabilities. Management uses the fair value hierarchy of ASC Topic 820, which gives the highest priority to quoted prices in active markets. The fair value of financial instruments is estimated based on market trading information, where available. Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value. Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. ASC Topic 820 defines fair value as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, ASC Topic 820 establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:

Level 1

Quoted prices in active markets for identical assets or liabilities.

Level 2

Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.

Level 3

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

In January 2010, the Financial Accounting Standards Board (“FASB”) issued guidance related to fair value disclosure requirements. The new guidance resulted in a change in the Company’s accounting policy effective March 1, 2010. Under this guidance, companies will be required to make additional disclosures concerning significant transfers of amounts between the Level 1 and Level 2 fair value disclosures, as well as further disaggregation of the types of activity that were previously disclosed in the rollforward of Level 3 fair value disclosures. Further, the guidance clarifies the level of aggregation of assets and liabilities within the fair value hierarchy that may be presented. The adoption of this guidance did not have an impact on the Company’s consolidated financial statements.

The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of February 29, 2012, segregated among the appropriate levels within the fair value hierarchy:


	Quoted prices in active markets for identical		Significant other observable inputs		Significant unobservable
	(Level 1)		(Level 2)		(Level 3)
Assets
Investments available-for-sale	$	—	$	18,281,129	$	—
Trading securities		1,424,399		—		—

The Company’s investments in Level 1 are in equity stocks at a cost of $1,967,570. The Company’s investments in Level 2 are in perpetual bonds traded on the European markets, at a cost of $8,435,146.

Foreign Currency Translation

The functional currency of the Company as a whole is the U.S. Dollar. The Company has designated the Chinese Yuan Renminbi as the functional currency for its subsidiaries in mainland China, and the U.S. Dollar for Sino Bond in Hong Kong. Assets and liabilities are translated into U.S. dollars using current exchange rates as of the balance sheet date. Income and expense are translated at average exchange rates prevailing during the period. The effects of foreign currency translation adjustments are included as a component of Accumulated Other Comprehensive Income within Stockholders’ Equity.

Revenue Recognition

Background

The Company’s revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company’s services is subject to significant judgments and estimates, which are discussed below.

Revenue Recognition Policy

The Company has established billing rates for its medical services which it bills as gross revenue as services are delivered. Gross billed revenues are then reduced by the Company’s estimate of the discount (contractual allowance) to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for actual differences in estimated revenue recorded in prior periods and actual cash collections.

Contractual Allowance

The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to 30 days after the end of the

period, for the services performed and also estimating amounts collectible for the services performed within the last six months. The following table shows gross revenues and contractual allowances for the three and six months ended February 29, 2012 and February 28, 2011:


	Three months ended						Six months ended
	February 29, 2012			February 28, 2011			February 29, 2012			February 28, 2011
Gross billed charges	$	3,692,503		$	4,954,275		$	8,746,618		$	10,924,743
Contractual allowance		2,725,787			3,265,462			5,934,929			6,786,115

Net revenue	$	966,716		$	1,688,813		$	2,811,689		$	4,138,628

Contractual allowance percentage		74	%		66	%		68	%		62	%

A significant amount of our net revenue results from Texas workers’ compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.

For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a “fair and reasonable” rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.

Based on these Guidelines, the reimbursement due the Company for workers’ compensation cases is lower than we previously experienced. The Company has continued accepting Texas workers’ compensation cases, and has not made any substantial changes in its focus towards such cases. Our net patient service revenue for Texas workers’ compensation cases as a percentage of gross billings has decreased primarily as a result of lower reimbursement rates for workers’ compensation procedures still being performed.

Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the MDR process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over 90% of its claims presented for administrative determination. The 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards, once the definitions of those standards are determined. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC, pending a final, non-appealable decision.

A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court’s decision has further delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases is not anticipated during the 2012 fiscal year.

Through February 2012, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims. In most of these cases, the carriers have requested refunds of the payments made in the event that the SOAH decisions and orders are reversed on appeal. Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases. Motions filed seeking a refund in some cases in which the awards were voluntarily paid have been granted and the Company has been ordered to refund approximately $3.7 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. In September and October 2011, the Company deposited these amounts as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. We anticipate that similar motions requesting remand and a refund for awards voluntarily paid will be filed and will likely be granted by the 345th Judicial District Court of Travis County, Texas. If and when these additional motions are granted, the Company will be ordered to refund an additional $7.7 million, not including prejudgment interest. The Company has appealed the judgments requiring a refund to the carriers. The appeal of the refund judgments will progress simultaneously to the adjudication of those cases remanded for determinations of whether the services provided were unusually costly and unusually extensive. Voluntary payments made pursuant to the Decisions and Orders are premature payments by the carriers and will likely be ordered to be refunded. Once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in the underlying stop-loss fee disputes and that voluntary payments refunded to the carriers will be recaptured.

Due to the uncertainties associated with these stop-loss fee dispute cases, in fiscal year 2011, the Company recognized an increase of $10,254,990 in the contractual allowance at our Pasadena facility (and an additional loss of $779,583 in the contractual allowance at our Garland facility, which is classified as discontinued operations), and $1,751,478 in interest expense at our Pasadena facility (and an additional interest expense of $132,339 at our Garland facility).

Claims regarding payment for hospital outpatient services remain pending at the TDWC. It is expected that these claims will be adjudicated at SOAH and ultimately in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the determination of “fair and reasonable” charges. In 2007, we received unfavorable rulings from SOAH in all of our appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Court of Appeal in our lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 cases. Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living. This ruling will impact cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided in 2001 and 2002 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company anticipates that it will be given the opportunity to establish the criteria in several hundred cases currently pending at SOAH during the 2012 fiscal year.

We are currently pursuing claims against two healthcare agents relating to contracts with certain of our facilities which set out reimbursement guidelines by several workers’ compensation carriers at a minimum of 70% of the facility’s charges. Discovery is continuing on these claims to determine which carriers are involved, the amount of reimbursement due to us, and the data used to determine “usual and customary” market rates for medical services in specific geographic regions.

Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. Any monies collected for these MDR accounts receivable will be recorded as current period’s net patient service revenues.

Accounts Receivable

Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility.

The contractual allowance stated as a percentage of gross receivables at the balance sheet dates is larger than the contractual allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the contractual allowance. The contractual allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.

Discontinued Operations

Revenue Recognition Policy

In China, the local government Department of Health establishes billing rates for a hospital’s sale of prescription medication and medical services. A majority of the services provided by Second People’s Hospital is to cash pay patients, who pay for the services in advance. For services provided under the local government’s social healthcare insurance program, we are generally paid at approximately 95% of billed charges two to three months after the date of service. The remaining 5% of billed charges is evaluated by the local government Department of Health on a semi-annual basis and may be paid to the hospital after that evaluation is complete. As of February 28, 2011, the Company made the decision to terminate the management agreement with the Rui An City Department of Health, and is currently in negotiation with them to finalize the terms, including the effective date of termination. The Company had bad debt expenses of $-0- and $21,991 for the three months ended February 29, 2012 and February 28, 2011, respectively, and $-0- and $24,755 for the six months ended February 29, 2012 and February 28, 2011, respectively, related to denials under the social healthcare insurance program. Since the amount of bad debt expense is minimal, it has been included with Other Operating Expenses in the income statement.

Noncontrolling Interest

The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company’s facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest ranged from 1.75% to 3.00% at February 29, 2012).

Comprehensive Loss and Accumulated Other Comprehensive Income

Comprehensive loss consists of net loss and other comprehensive income (loss). Other comprehensive income (loss) represents certain components of revenues, expenses, gains and losses that are included in comprehensive loss, but are excluded from net loss. Other comprehensive income (loss) amounts are recorded directly as an adjustment to stockholders’ equity, net of tax, and for the three and six months ended February 29, 2012 and February 28, 2011 were as follows:


	Three months ended						Six months ended
	February 29, 2012			February 28, 2011			February 29, 2012			February 28, 2011
Net loss	$	(1,795,586	)	$	(1,677,362	)	$	(3,739,679	)	$	(2,834,002	)
Other comprehensive income (loss), net of taxes:
Foreign currency translation adjustment, net of taxes of $(10,246), $68,535, $(13,344) and $166,069, respectively		(19,029	)		117,242			(24,782	)		308,413
Reclassification adjustment for foreign currency gains included in net income, net of taxes of $(384,283), $-0-, $(501,273) and $-0-, respectively		(704,051	)		—			(921,318	)		—
Change in valuation of investment available-for-sale, net of taxes of $1,293,508, $369,802, $(97,599) and $358,550, respectively		2,402,230			686,773			(181,256	)		665,877

Total other comprehensive loss, net of taxes		(116,436	)		(873,347	)		(4,867,035	)		(1,859,712	)
Comprehensive loss attributable to the noncontrolling interest		—			—			—			—

Comprehensive loss attributable to Dynacq Healthcare, Inc.	$	(116,436	)	$	(873,347	)	$	(4,867,035	)	$	(1,859,712	)

The components of accumulated other comprehensive income were as follows:


	February 29, 2012		August 31, 2011
Foreign currency translation adjustment, net of taxes of $3,600 and $518,217, respectively	$	6,682	$	952,782
Change in valuation of investment available-for-sale, net of taxes of $3,402,882 and $3,500,481, respectively		6,319,638		6,500,894

Total accumulated other comprehensive income, net of taxes of $3,406,482 and $4,018,698, respectively	$	6,326,320	$	7,453,676

Contingencies

Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has recognized, in fiscal year 2011, an increase of $12.9 million in the contractual allowance and related interest expense at our Pasadena and Garland facilities. For a detailed discussion of this, see Revenue Recognition Policy under Notes to Consolidated Financial Statements. Motions filed seeking a refund in some cases in which the awards were voluntarily paid have been granted and the Company has been ordered to refund approximately $3.7 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. In September and October 2011, the Company deposited these amounts as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. We anticipate that similar motions requesting remand and a refund for awards voluntarily paid will be filed and will likely be granted by the 345th Judicial District Court of Travis County, Texas. If and when these additional motions are granted, the Company will be ordered to refund an additional $7.7 million, not including prejudgment interest. The Company has appealed the judgments requiring a refund to the carriers. The appeal of the refund judgments will progress simultaneously to the adjudication of those cases remanded for determinations of whether the services provided were unusually costly and unusually extensive. Voluntary payments made pursuant to the Decisions and Orders are premature payments by the carriers and will likely be ordered to be refunded. Once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in the underlying stop-loss fee disputes and that voluntary payments refunded to the carriers will be recaptured.

The Company maintains various insurance policies that cover each of its U.S. facilities; including occurrence medical malpractice coverage. In addition, all physicians granted privileges at the Company’s U.S. facilities are required to maintain medical malpractice insurance coverage. The Company also maintains general liability and property insurance coverage for each U.S. facility, including flood coverage. The Company does not currently maintain workers’ compensation coverage in Texas. In regard to the Employee Health Insurance Plan, the Company is self-insured with specific and aggregate re-insurance with stop-loss levels appropriate for the Company’s group size. Coverage is maintained in amounts management deems adequate.

The management agreement for the Second People’s Hospital required that 1% of the drug income, and drug income in excess of 40% of total sales, of the hospital be paid to the government. This requirement was designed to control the cost of drugs by discouraging the sale by the hospital of drugs purchased from other than approved drug vendors. However, the local government has not published a list of approved drug vendors and therefore has not enforced the payment provision since the inception of the original management agreement. The Company has been advised by a local attorney that enforcement of that provision is remote, so it has not accrued the amount that would be payable to the local government if this provision were enforced. If the government were to enforce this provision, Dynacq-Huai-Bei could potentially owe approximately $1.6 million to the government for the period of time since inception of the original management contract on the hospital to February 29, 2012.

Industry Segments and Geographic Information

Certain previously reported financial information has been reclassified to conform to the current year’s presentation. The impact of such reclassification was not significant to the prior year’s overall presentation, except for (1) presenting the Pasadena facility as continuing operations under U.S. Division, which was presented in the prior year as discontinued operations, and (2) the presentation of the various subsidiaries (except for Dynacq-Huai Bei and Sino Bond, which are now shown as part of the Corporate Division) in China as discontinued operations under the Corporate Division, which in the previous year was shown as part of continuing operations under the China Division.

The Company had made the decision to sell its Garland facility as of August 31, 2010, and its operation was classified as discontinued operations for the year ended August 31, 2010. However, the Company closed the Garland facility on September 30, 2011, and accordingly its operations for the fiscal years 2011 and 2012 continue to be classified as “Discontinued Operations” (see Discontinued Operations below). The Company plans to either sell the Garland facility or pursue converting it into an ambulatory surgical center, if and when the Company can identify and generate a steady referral source for outpatient cases. The Company intended to sell its Pasadena facility also, and had it classified as discontinued operations, as of August 31, 2010. However, since a sale was not consummated during the 12-month period following the decision to sell, the operations of the Pasadena facility have been reclassified as continuing operations for the fiscal years 2011 and 2012. The Company is continuing to revamp its operations at the Pasadena facility by modifying the business model and controlling expenses. However, there can be no assurance that we will be successful in turning the facility around.

From March 1, 2009 to February 28, 2011, Dynacq Huai Bei Healthcare, Inc. (“Dynacq-Huai Bei”), a wholly owned subsidiary of the Company provided healthcare management services to the Second People’s Hospital in Rui An, China. The Company organized Dynacq-Huai Bei in April 2008 under the laws of the People’s Republic of China. Dynacq-Huai Bei was responsible for funding any operating deficits, and was entitled to any operating profits, of that hospital during the management period. Due to continued losses at the Second People’s Hospital,

the Company made the decision to terminate the management agreement with the Rui An City Department of Health, and is currently in negotiation with them to finalize the terms, including the effective date of termination. The Company ceased providing healthcare management services to the Second People’s Hospital as of February 28, 2011. The Company has written off the fixed assets and inventory balances as of February 28, 2011, and does not expect any further losses due to the termination of this management agreement related to the Second People’s Hospital. We have accounted for the operations of the Second People’s Hospital in Rui An, China as discontinued operations, and have reclassified prior period financial statements to exclude them from continuing operations.

Dynacq-Huai Bei and the Rui An City Department of Health had also previously entered into an agreement assigning to Dynacq-Huai Bei the right to manage the Third People’s Hospital in Rui An, which hospital is currently under construction. Dynacq-Huai Bei and the Rui An City Department of Health, in November 2010, mutually agreed to terminate this agreement, due to continued delays in the construction of the Third People’s Hospital. Accordingly, Dynacq-Huai Bei will not be managing the Third People’s Hospital.

The Company has also organized Sino Bond Inc. Limited, a Hong Kong corporation (“Sino Bond”) to hold and manage investments in Hong Kong. Sino Bond invests in debt and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings.

At the present time, the Company’s subsidiaries in China and Hong Kong are not pursuing any new line of business and/or projects.

The Company has invested in various bonds. These investments are classified as available-for-sale securities, and are carried at fair value as of February 29, 2012, based on the quoted market prices as of that date. As of February 29, 2012, these securities are valued at approximately $18.3 million. The Company intends to hold these for a minimum period of an additional 12 months. During the three months ended February 29, 2012 and February 28, 2011, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had gains of $108,491 and $69,584, respectively. During the six months ended February 29, 2012 and February 28, 2011, the trading in initial public offerings of equity securities on the Hong Kong Stock Exchange generated losses of $57,101 and $14,995, respectively. The Company, through a subsidiary in Hong Kong, has expanded its investments in debt and equity securities in Europe and Asia and has engaged the services of an investment banker to recommend such investment opportunities. The Company’s primary investment focus will be on growth companies from mainland China. The Company anticipates making short-term investments in these entities through initial public offerings (held mostly through the Hong Kong Stock Exchange) and pre-initial public offerings.

Discontinued Operations

On September 29, 2011, the Board of Directors of the Company approved the closure of the Garland facility, included in our U.S. division, effective September 30, 2011. Prior to that, in August 2010, the Board of Directors of the Company had approved a plan to dispose of the Garland facility due to continued operating losses. The Garland facility had experienced decreases in net patient revenues and number of cases, generally attributable to the loss of physicians from our medical staff. The opening of a new hospital near our Garland facility has had a direct adverse impact on our ability to retain members of the medical staff at that facility and consequently on our patient volume. The Garland facility was operating at a loss, and the Board of Directors believes that ceasing operations of the facility at this time is in the Company’s best interest. The Company has estimated a closing cost of $625,000. However, the ongoing losses incurred will be reduced due to the closing of the facility.

The Company had an independent appraisal done in October 2011 for both the hospitals, and based on each hospital’s valuation, expected sale proceeds, and expected cash flows has determined that there is no impairment charge required in connection with the foregoing disposal activities.

The Company has discontinued operations of all its foreign subsidiaries, except for Dynacq-HuaiBei and Sino Bond, and has either closed or is in the process of closing them.

The Corporate Division includes interest and other income related to the investments in available-for-sale and trading securities, corporate personnel compensation expenses, and general and administrative expenses. Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.

We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. There are no transfers between segments.

Summarized financial information concerning the business segments from continuing operations is as follows:


	Three months ended						Six months ended
	February 29, 2012			February 28, 2011			February 29, 2012			February 28, 2011
Revenues from external customers
Net patient service revenues
U.S. Division	$	966,716		$	1,688,813		$	2,811,689		$	4,138,628
Corporate		—			—			—			—

Consolidated	$	966,716		$	1,688,813		$	2,811,689		$	4,138,628

Income (loss) before taxes and discontinued operations
U.S. Division	$	(1,584,878	)	$	(593,099	)	$	(1,989,527	)	$	(513,394	)
Corporate		132,035			(742,186	)		(872,258	)		(1,483,564	)

Consolidated	$	(1,452,843	)	$	(1,335,285	)	$	(2,861,785	)	$	(1,996,958	)


	February 29, 2012		August 31, 2011
Total Assets

U.S. Division	$	8,416,886	$	8,763,015
Corporate		41,530,838		50,550,958

Assets of continuing operations		49,947,724		59,313,973
Assets of discontinued operations		6,651,726		6,909,527

Consolidated	$	56,599,450	$	66,223,500

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This quarterly report on Form 10-Q contains forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or the negative of these terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Such forward-looking statements relate to future events or future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our Company’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including the risks and uncertainties described in “Risk Factors” in our annual report on Form 10-K for the fiscal year ended August 31, 2011. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. You must read the following discussion of the results of our business and our operations and financial condition in conjunction with our reviewed consolidated financial statements, including the notes, included in this quarterly report on Form 10-Q and our audited consolidated financial statements, including the notes, included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2011.

Update on Critical Accounting Policies and Estimates

There have been no changes to the critical accounting policies used in our reporting of results of operations and financial position for the three months ended February 29, 2012. For a discussion of our critical accounting policies see Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Form 10-K for the fiscal year ended August 31, 2011.

Results of Operations


	Thee Months Ended February 29, 2012									Three Months Ended February 28, 2011
	U.S. Division			Corporate			Total			U.S. Division			Corporate			Total
Net patient service revenue	$	966,716		$	—		$	966,716		$	1,688,813		$	—		$	1,688,813

Costs and expenses:
Compensation and benefits		964,412			1,054,900			2,019,312			1,049,769			555,126			1,604,895
Medical services and supplies		343,508			—			343,508			365,464			—			365,464
Other operating expenses		990,283			359,053			1,349,336			887,927			662,324			1,550,251
Depreciation and amortization		115,206			45,081			160,287			—			44,109			44,109

Total costs and expenses		2,413,409			1,459,034			3,872,443			2,303,160			1,261,559			3,564,719

Operating loss		(1,446,693	)		(1,459,034	)		(2,905,727	)		(614,347	)		(1,261,559	)		(1,875,906	)

Other income (expense):
Rent and other income		2,110			1,255,734			1,257,844			28,013			168,595			196,608
Interest income		—			338,305			338,305			—			353,763			353,763
Interest expense		(140,295	)		(2,970	)		(143,265	)		(6,765	)		(2,985	)		(9,750	)

Total other income (expense), net		(138,185	)		1,591,069			1,452,884			21,248			519,373			540,621

Income (loss) before income taxes from continuing operations	$	(1,584,878	)	$	132,035			(1,452,843	)	$	(593,099	)	$	(742,186	)		(1,335,285	)

Benefit for income taxes								—									493,030

Loss from continuing operations								(1,452,843	)								(842,255	)
Discontinued operations, net of income taxes								(169,547	)								(715,258	)
Loss on disposal of discontinued operations, net of income taxes								(229,201	)								(121,577	)

Net loss								(1,851,591	)								(1,679,090	)
Less: Net loss attributable to noncontrolling interest								56,005									1,728

Net loss attributable to Dynacq Healthcare, Inc.							$	(1,795,586	)							$	(1,677,362	)

Operational statistics (Number of medical procedures) for Pasadena facility:
Inpatient:
Bariatric		13									17
Orthopedic		—									7
Other		14									4

Total inpatient procedures		27									28

Outpatient:
Orthopedic		28									19
Other		93									117

Total outpatient procedures		121									136

Total procedures		148									164

Results of Operations (continued)


	Six Months Ended February 29, 2012									Six Months Ended February 28, 2011
	U.S. Division			Corporate			Total			U.S. Division			Corporate			Total
Net patient service revenue	$	2,811,689		$	—		$	2,811,689		$	4,138,628		$	—		$	4,138,628

Costs and expenses:
Compensation and benefits		1,929,426			1,767,255			3,696,681			2,206,090			1,397,753			3,603,843
Medical services and supplies		566,626			—			566,626			784,020			—			784,020
Other operating expenses		1,803,519			868,606			2,672,125			1,686,965			1,667,223			3,354,188
Depreciation and amortization		224,638			85,460			310,098			—			90,954			90,954

Total costs and expenses		4,524,209			2,721,321			7,245,530			4,677,075			3,155,930			7,833,005

Operating loss		(1,712,520	)		(2,721,321	)		(4,433,841	)		(538,447	)		(3,155,930	)		(3,694,377	)

Other income (expense):
Rent and other income		11,811			1,248,631			1,260,442			38,999			938,267			977,266
Interest income		—			606,203			606,203			—			740,453			740,453
Interest expense		(288,818	)		(5,771	)		(294,589	)		(13,946	)		(6,354	)		(20,300	)

Total other income (expense), net		(277,007	)		1,849,063			1,572,056			25,053			1,672,366			1,697,419

Loss before income taxes from continuing operations	$	(1,989,527	)	$	(872,258	)		(2,861,785	)	$	(513,394	)	$	(1,483,564	)		(1,996,958	)

Benefit for income taxes								—									666,679

Loss from continuing operations								(2,861,785	)								(1,330,279	)
Discontinued operations, net of income taxes								(732,213	)								(1,384,909	)
Loss on disposal of discontinued operations, net of income taxes								(229,201	)								(121,577	)

Net loss								(3,823,199	)								(2,836,765	)
Less: Net loss attributable to noncontrolling interest								83,520									2,763

Net loss attributable to Dynacq Healthcare, Inc.							$	(3,739,679	)							$	(2,834,002	)

Operational statistics (Number of medical procedures) for Pasadena facility:
Inpatient:
Bariatric		30									36
Orthopedic		1									14
Other		45									8

Total inpatient procedures		76									58

Outpatient:
Orthopedic		53									43
Other		173									262

Total outpatient procedures		226									305

Total procedures		302									363

Three Months Ended February 29, 2012 Compared to the Three Months Ended February 28, 2011

U.S. Division

Through February 29, 2012, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims. In most of these cases, the carriers have requested refunds of the payments made in the event that the SOAH decisions and orders are reversed on appeal. Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases. Motions filed seeking a refund in some cases in which the awards were voluntarily paid have been granted and the Company has been ordered to refund approximately $3.7 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. In September and October 2011, the Company deposited these amounts as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. We anticipate that similar motions requesting remand and a refund for awards voluntarily paid will be filed and will likely be granted by the 345th Judicial District Court of Travis County, Texas. If and when these additional motions are granted, the Company will be ordered to refund an additional $7.7 million, not including prejudgment interest. The Company has appealed the judgments requiring a refund to the carriers. The appeal of the refund judgments will progress simultaneously to the adjudication of those cases remanded for determinations of whether the services provided were unusually costly and unusually extensive. Voluntary payments made pursuant to the Decisions and Orders are premature payments by the carriers and will likely be ordered to be refunded. Once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in the underlying stop-loss fee disputes and that voluntary payments refunded to the carriers will be recaptured.

Net patient service revenue decreased by $722,097, or 43%, from $1,688,813 to $966,716, and total surgical cases decreased by 10% from 164 cases for the three months ended February 28, 2011 to 148 cases for the three months ended February 29, 2012. While the number of cases decreased by 10%, net patient service revenue decreased by 43%. The change in percentage decrease in net patient service revenue compared to the decrease in the number of cases is primarily due to a change in the surgical mix of cases. Decreases in net patient revenues and number of cases are generally attributable to the loss of physicians from our medical staff.

Total costs and expenses increased by $110,249, or 5%, from $2,303,160 for the three months ended February 28, 2011 to $2,413,409 for the three months ended February 29, 2012. The following discusses the various changes in costs and expenses:

•

Compensation and benefits decreased by $85,357, or 8%, primarily associated with reduction in workforce due to lower net patient service revenues.

•

Medical services and supplies expenses decreased by $21,956, or 6%, while the number of surgery cases decreased 10%. The percentage decrease in medical services and supplies was marginally lower than the percentage decrease in the number of surgery cases due to a change in the surgical mix of cases.

•

Other operating expenses increased by $102,356, or 12%. The Company is trying to revamp its Pasadena facility operations and thus has a marginal increase in its other operating expenses, including marketing and legal fees.

•

Depreciation and amortization expenses increased by $115,206 in 2012 compared to 2011. The Company had ceased depreciating property and equipment for its Pasadena facility in the prior year since it was

classified as discontinued operations, and was being measured at the lower of its carrying amount or fair value less cost to sell. However, in the current year, the Pasadena facility’s operations are classified as continuing operations, and thus its property and equipment are being depreciated.

Other income (expense) for the three months ended February 29, 2012 of $(138,185) includes interest expense of $140,295 primarily associated with the stop-loss cases discussed above.

Corporate Division

Compensation and benefits includes all corporate personnel compensation and benefits, and it increased by $499,774, or 90%, in 2012, compared to 2011. The increase in compensation and benefits was due to the following reasons: (1) for the three months ended February 29, 2012, there was a non-cash compensation expense of $82,244, related to employees’ incentive stock options granted in fiscal years 2007, 2011 and 2012. However, for the three months ended February 28, 2011, due to the non-cash compensation expense true-up in 2011 based on forfeiture of incentive stock options, the expense was $(102,963), (2) during the current fiscal year, the Company issued 50,000 shares of its common stock to Dr. Kelly Larkin as consideration for Dr. Larkin’s employment as the Company’s marketing director, and took a compensation charge of $50,000 related to the issuance, (3) the Company has retained the services of Dr. Eric Chan, as its chief executive officer starting January 10, 2012, (4) the chief financial officer of the Company had a reduction in his compensation for part of the three months in 2011, whereas for the three months in 2012, the Compensation Committee reinstated his compensation to $200,000, effective February 1, 2012, and paid him a sum of $77,000, which equates to the prior reductions in his compensation from January 1, 2010 to January 31, 2012. The Committee recognized that he has been working above and beyond the norm to revive the Company’s business including actively working on several special projects and that he has further been instrumental in providing the continuity in management during the transition of the Company’s new chief executive officer, and (5) the Company continues to make efforts to increase its net patient service revenues and has hired various marketing personnel during the three months ended February 29, 2012.

Other operating expenses includes primarily administrative expenses for managing the various projects the Company was undertaking in China and Hong Kong, related marketing expenses and rent for an apartment for our chief executive officer in Hong Kong. The Company has made the decision to not pursue any new line of business and/or projects, and has also terminated the apartment lease. Other operating expenses also includes all the corporate general and administrative expenses in the U.S., including other professional fees such as legal expenses and audit expenses. Other operating expenses decreased by $303,271, from $662,324 for the three months ended February 28, 2011 to $359,053 for the three months ended February 29, 2012. For the three months ended February 28, 2011, the Company’s subsidiary in Hong Kong incurred the following costs: (1) marketing fees of $150,000, (2) rent of $33,242 for an apartment for the Company’s chief executive officer in Hong Kong, and (3) other administrative support services fees. These expenses were not incurred for the three months ended February 29, 2012. The Company also incurred lower professional fees and other miscellaneous expenses primarily associated with lower net revenues.

Rent and other income increased by $1,087,139, from $168,595 for the three months ended February 28, 2011 to $1,255,734 for the three months ended February 29, 2012. Rent and other income for the three months ended February 29, 2012 includes (1) a foreign currency gain of $1,088,333 realized due to the monies invested in China coming back to the U.S. The Company had invested in its foreign subsidiaries in China during the last few years, and due to a favorable change in exchange rates between the U.S. Dollar and the Chinese Yuan Renminbi, the Company had accumulated other comprehensive income of $1,088,333. This amount was realized as a gain during the three months ended February 29, 2012 upon the return of investments from the Company’s foreign subsidiaries in China, (2) a gain of $108,491 due to fair valuation of trading securities as of February 29, 2012, and (3) foreign currency exchange gains of $63,072. Rent and other income for the three months ended February 28, 2011 includes (1) foreign currency exchange gains of $77,362, primarily on investments in Euro bonds, and (3) a gain of $69,584 on short-term investments in trading securities in Hong Kong.

Interest income of $338,305 and $353,763 for the three months ended February 29, 2012 and February 28, 2011, respectively, are primarily related to the Company’s investments in bonds.

Investments in securities

The Company has invested in various bonds. These investments are classified as available-for-sale securities, and are carried at fair value as of February 29, 2012, based on the quoted market prices as of that date. As of February 29, 2012, these securities are valued at approximately $18.3 million. Unrealized gains in these investments of $6.3 million are included in accumulated other comprehensive income in the Consolidated Balance Sheet as at February 29, 2012, net of taxes of $3.4 million. The Company intends to hold these for a minimum period of an additional 12 months. During the three months ended February 29, 2012 and February 28, 2011, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had gains of $108,491 and $69,584, respectively. The Company, through a subsidiary in Hong Kong, has expanded its investments in debt and equity securities in Europe and Asia and has engaged the services of an investment banker to recommend such investment opportunities. The Company’s primary investment focus will be on growth companies from mainland China. The Company anticipates making short-term investments in these entities through initial public offerings (held mostly through the Hong Kong Stock Exchange) and pre-initial public offerings.

For the three months ended February 29, 2012, the Company did not recognize any tax benefits applicable to the operating loss. The balance sheet reflects an increase in the deferred tax asset of $612,216 due to a reduction in deferred tax liability related to the foreign currency exchange gain realized.

Discontinued Operations

Garland Facility (discontinued operations)

Due to the uncertainties associated with the stop-loss fee dispute cases discussed above, in fiscal year 2011, the Company recognized an increase of $779,583 in the contractual allowance, and an additional interest expense of $132,339, at our Garland facility.

The Company closed the Garland facility on September 30, 2011, and accordingly its operations for the fiscal years 2011 and 2012 continue to be classified as discontinued operations. The Company plans to either sell the Garland facility or pursue converting it into an ambulatory surgical center, if and when the Company can identify and generate a steady referral source for outpatient cases. Net patient service revenue decreased by $640,827, from $734,538 to $93,711, due to the closure of the facility on September 30, 2011.

Total costs and expenses decreased by $1,315,961, from $1,568,908 for the three months ended February 28, 2011 to $252,947 for the three months ended February 29, 2012, due to the closure of the facility on September 30, 2011.

Corporate (discontinued operations)

The Corporate Division revenue includes net patient service revenues from Second People’s Hospital in Rui An, China. Due to continued losses at the Second People’s Hospital, the Company made the decision to terminate the management agreement as of February 28, 2011 with the Rui An City Department of Health, and is currently in negotiation with them to finalize the terms, including the effective date of termination. The loss before income taxes at the Second People’s Hospital for the three months ended February 28, 2011 was $343,612, which includes a loss before income taxes of $187,041 for disposal of the hospital.

The Corporate Division also includes other operating expenses the Company incurred at certain of its subsidiaries in China while pursuing various projects. All of the Company’s foreign subsidiaries, except for Dynacq-Huai Bei and Sino Bond, have been reclassified as discontinued operations. The Company incurred $-0- and $161,738 in total costs and expenses at these subsidiaries during the three months ended February 29, 2012 and February 28, 2011, respectively. Loss before income taxes in these subsidiaries was $-0- and $106,679 for the three months ended February 29, 2012 and February 28, 2011, respectively. In addition, loss on disposal of discontinued operations in China was $229,201 for the three months ended February 29, 2012.

Six Months Ended February 29, 2012 Compared to the Six Months Ended February 28, 2011

U.S. Division

Net patient service revenue decreased by $1,326,939, or 32%, from $4,138,628 to $2,811,689, and total surgical cases decreased by 17% from 363 cases for the six months ended February 28, 2011 to 302 cases for the six months ended February 29, 2012. While the number of cases decreased by 17%, net patient service revenue decreased by 32%. The change in percentage decrease in net patient service revenue compared to the decrease in the number of cases is primarily due to a change in the surgical mix of cases. Decreases in net patient revenues and number of cases are generally attributable to the loss of physicians from our medical staff.

Total costs and expenses decreased by $152,866, or 3%, from $4,677,075 for the six months ended February 28, 2011 to $4,524,209 for the six months ended February 29, 2012. The following discusses the various changes in costs and expenses:

•

Compensation and benefits decreased by $276,664, or 13%, primarily associated with reduction in workforce due to lower net patient service revenues.

•

Medical services and supplies expenses decreased by $217,394, or 28%, while the number of surgery cases decreased 17%. The percentage decrease in medical services and supplies was higher than the percentage decrease in the number of surgery cases due to a change in the surgical mix of cases.

•

Other operating expenses increased by $116,554, or 7%. The Company is trying to revamp its Pasadena facility operations and thus has a marginal increase in its other operating expenses, including marketing and legal fees.

•

Depreciation and amortization expenses increased by $224,638 in 2012 compared to 2011. The Company had ceased depreciating property and equipment for its Pasadena facility in the prior year since it was classified as discontinued operations, and was being measured at the lower of its carrying amount or fair value less cost to sell. However, in the current year, the Pasadena facility’s operations are classified as continuing operations, and thus its property and equipment are being depreciated.

Other income (expense) for the six months ended February 29, 2012 of $(277,007) includes interest expense of $288,818 primarily associated with the stop-loss cases discussed above.

Corporate Division

Compensation and benefits includes all corporate personnel compensation and benefits, and it increased by $369,502, or 26%, in 2012, compared to 2011. The increase in compensation and benefits was due to the following reasons: (1) for the six months ended February 29, 2012, there was a non-cash compensation expense of $149,934, related to employees’ incentive stock options granted in fiscal years 2007, 2011 and 2012. However, for the six months ended February 28, 2011, due to the non-cash compensation expense true-up in 2011 based on forfeiture of incentive stock options, the expense was $4,251, (2) during the current fiscal year, the Company issued 50,000 shares of its common stock to Dr. Kelly Larkin as consideration for Dr. Larkin’s employment as the Company’s marketing director, and took a compensation charge of $50,000 related to the issuance, (3) the Company has retained the services of Dr. Eric Chan, as its chief executive officer starting January 10, 2012, (4) the chief financial officer of the Company had a reduction in his compensation for part of the six months in 2011, whereas for the six months in 2012, the Compensation Committee reinstated his compensation to $200,000, effective February 1, 2012, and paid him a sum of $77,000, which equates to the prior reductions in his compensation from January 1, 2010 to January 31, 2012. The Committee recognized that he has been working above and beyond the norm to revive the Company’s business including actively working on several special projects and that he has further been instrumental in providing the continuity in management during the transition of the Company’s new chief executive officer, and (5) the Company continues to make efforts to increase its net patient service revenues and has hired various marketing personnel during the six months ended February 29, 2012.

Other operating expenses includes primarily administrative expenses for managing the various projects the Company was undertaking in China and Hong Kong, related marketing expenses and rent for an apartment for our chief executive officer in Hong Kong. The Company has made the decision to not pursue any new line of business and/or projects, and has also terminated the apartment lease. Other operating expenses also includes all the corporate general and administrative expenses in the U.S., including other professional fees such as legal expenses and audit expenses. Other operating expenses decreased by $798,617, from $1,667,223 for the six months ended February 28, 2011 to $868,606 for the six months ended February 29, 2012. For the six months ended February 28, 2011, the Company’s subsidiary in Hong Kong incurred the following costs: (1) marketing fees of $300,000, (2) rent of $99,726 for an apartment for the Company’s chief executive officer in Hong Kong, and (3) other administrative support services fees. These expenses were not incurred for the six months ended February 29, 2012. The Company also incurred lower professional fees and other miscellaneous expenses primarily associated with lower net revenues.

Rent and other income increased by $310,364, from $938,267 for the six months ended February 28, 2011 to $1,248,631 for the six months ended February 29, 2012. Rent and other income for the six months ended February 29, 2012 includes (1) a foreign currency gain of $1,422,590 realized due to the monies invested in China coming back to the U.S. The Company had invested in its foreign subsidiaries in China during the last few years, and due to a favorable change in exchange rates between the U.S. Dollar and the Chinese Yuan Renminbi, the Company had accumulated other comprehensive income of $1,422,590. This amount was realized as a gain during the six months ended February 29, 2012 upon the return of investments from the Company’s foreign subsidiaries in China, (2) a loss of $57,101 due to fair valuation of trading securities as of February 29, 2012, and (3) foreign currency exchange losses of $144,078, primarily on investments in Euro bonds. Rent and other income for the six months ended February 28, 2011 includes (1) a $720,696 refund received from the Rui An City Department of Health as part of the negotiation of termination of the assignment agreement to manage the Third People’s Hospital, and write-off of associated liabilities of $43,840 (the decision to terminate the agreement was based on the continued delays in the construction of the hospital), (2) foreign currency exchange gains of $178,877, primarily on investments in Euro bonds, and (3) a loss of $14,995 on short-term investments in trading securities in Hong Kong.

Interest income of $606,203 and $740,453 for the six months ended February 29, 2012 and February 28, 2011, respectively, are primarily related to the Company’s investments in bonds.

Investments in securities

The Company has invested in various bonds. These investments are classified as available-for-sale securities, and are carried at fair value as of February 29, 2012, based on the quoted market prices as of that date. As of February 29, 2012, these securities are valued at approximately $18.3 million. Unrealized gains in these investments of $6.3 million are included in accumulated other comprehensive income in the Consolidated Balance Sheet as at February 29, 2012, net of taxes of $3.4 million. The Company intends to hold these for a minimum period of an additional 12 months. During the six months ended February 29, 2012 and February 28, 2011, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had losses of $57,101 and $14,995, respectively. The Company, through a subsidiary in Hong Kong, has expanded its investments in debt and equity securities in Europe and Asia and has engaged the services of an investment banker to recommend such investment opportunities. The Company’s primary investment focus will be on growth companies from mainland China. The Company anticipates making short-term investments in these entities through initial public offerings (held mostly through the Hong Kong Stock Exchange) and pre-initial public offerings.

For the six months ended February 29, 2012, the Company did not recognize any tax benefits applicable to the operating loss. The balance sheet reflects an increase in the deferred tax asset of $612,216 due to a reduction in deferred tax liability related to the foreign currency exchange gain realized and a decline in value of the available-for-sale securities.

Discontinued Operations

Garland Facility (discontinued operations)

The Company closed the Garland facility on September 30, 2011, and accordingly its operations for the fiscal years 2011 and 2012 continue to be classified as discontinued operations. The Company plans to either sell the Garland facility or pursue converting it into an ambulatory surgical center, if and when the Company can identify and generate a steady referral source for outpatient cases. Net patient service revenue decreased by $969,462, from $1,288,049 to $318,587, due to the closure of the facility on September 30, 2011.

Total costs and expenses decreased by $2,126,005, from $3,093,474 for the six months ended February 28, 2011 to $967,469 for the six months ended February 29, 2012, due to the closure of the facility on September 30, 2011.

Corporate (discontinued operations)

The Corporate Division also includes other operating expenses the Company incurred at certain of its subsidiaries in China while pursuing various projects. All of the Company’s foreign subsidiaries, except for Dynacq-Huai Bei and Sino Bond, have been reclassified as discontinued operations. The Company incurred $126,179 and $233,131 in total costs and expenses at these subsidiaries during the six months ended February 29, 2012 and February 28, 2011, respectively. Loss before income taxes in these subsidiaries was $62,275 and $137,746 for the six months ended February 29, 2012 and February 28, 2011, respectively. In addition, loss on disposal of discontinued operations in China was $229,201 for the six months ended February 29, 2012.

Liquidity and Capital Resources

Our 2011 Annual Report on Form 10-K includes a detailed discussion of our liquidity, contractual obligations and commitments. The information presented below updates and should be read in conjunction with the information disclosed in that Form 10-K.

Cash flows from operating activities

Cash flow used in operating activities for continuing activities was $7,958,478 during the six months ended February 29, 2012, primarily due to a net loss before discontinued operations of $2,778,265, net changes in income tax related accounts of $1,655,662 and decreases in accounts payable and accrued liabilities of $5,138,154, of which a decrease of $3,703,252 was due to cash deposits made by the Company into the registry of the court in order to stay execution of the judgments ordering refunds in the stop-loss fee dispute cases. These decreases were partially offset by reduction in accounts receivable of $691,455, and depreciation and amortization of $310,098.

In addition, cash flow used in operating activities for discontinued operations was $696,218 during the six months ended February 29, 2012, primarily due to a net loss from discontinued operations of $961,414, partially offset by a reduction in inventories of $260,020.

Total cash flow used in operating activities for continuing and discontinued operations combined was $8,654,696 during the six months ended February 29, 2012.

Cash flows from investing activities

Cash flow used in investing activities for continuing activities was $157,753 for purchase of equipment at the Pasadena facility.

Cash flows from financing activities

Cash flow provided by financing activities for continuing activities was $109,463. In November 2011, the Company borrowed $116,339 as note payable from a financial institution at an interest rate of 4.5%. This note payable is to be repaid in 36 monthly installments and is secured by specific equipment purchased at our Pasadena facility. The Company has paid $28,683 during the six months ended February 29, 2012 towards notes payable for equipment purchased. In addition, the Company paid $32,090 towards a mortgage loan for the purchase of an apartment in Hong Kong. During the six months ended February 29, 2012, the Company received contributions of $100,000 for sale of non-controlling interests in our Pasadena facility’s operations.

The Company had working capital of $11,132,892 as of February 29, 2012 and maintained a liquid position by a current ratio of approximately 1.7 to 1.

We believe we will be able to meet our ongoing liquidity and cash needs for fiscal year 2012 through the combination of available cash and cash flow from operations.

Recent Accounting Pronouncements

Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities: In July 2011, the FASB issued Accounting Standards Update (ASU) No. 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which requires health care entities to change the presentation in their statement of operations by reclassifying the provision for bad debts associated with patient service revenue from an operating expense to a deduction from patient service revenue (net of contractual allowances and discounts). The guidance provided in this ASU is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2011, with early adoption permitted. The Implementation of this standard has had no impact on our consolidated financial position or results of operations.

Presentation of Insurance Claims and Related Insurance Recoveries: In August 2010, the FASB issued ASU 2010-24, “Health Care Entities (Topic 954): Presentation of Insurance Claims and Related Insurance Recoveries,” which clarifies that a health care entity should not net insurance recoveries against a related claim liability. The guidance provided in this ASU is effective for the fiscal years, and interim periods within those years, beginning after December 15, 2010. The adoption of this standard has had no impact on our consolidated financial position or results of operations.

Fair Value Measurements and Disclosures: The Financial Accounting Standards Board (“FASB”) has issued ASU No. 2010-06, Fair Value Measurements and Disclosures about Fair Value Measurements. ASU 2010-06 affects all entities that are required to make disclosures about recurring and nonrecurring fair value measurements under FASB ASC Topic 820, originally issued as FASB Statement No. 157, Fair Value Measurements. This ASU requires certain new disclosures and clarifies two existing disclosure requirements. The new disclosures and clarifications of existing disclosures are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances, and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years. ASU No. 2010-06 did not have a significant impact on our disclosures, and the disclosures related to the roll forward of activity in Level 3 fair value measurements did not have an impact on our disclosures.

Presentation of Comprehensive Income: In June 2011, the FASB amended its guidance governing the presentation of comprehensive income. The amended guidance eliminates the option to report other comprehensive income and its components in the statement of changes in equity. Under the new guidance, an entity can elect to present items of net income and other comprehensive income in one continuous statement referred to as the statement of comprehensive income or in two separate, but consecutive, statements. While the options for presenting other comprehensive income change under the guidance, other portions of the current guidance will not change. For public entities, these changes are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this standard is not expected to have a material impact on our consolidated financial position or results of operation.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not required.

Item 4. Controls and Procedures.

Under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we conducted an evaluation to assess the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, pursuant to Exchange Act Rule 13a-15(e). Based on that evaluation, our chief executive officer and chief financial officer concluded that, as of February 29, 2012, our disclosure controls and procedures were effective.

There have been no significant changes in our internal control over financial reporting during the most recently completed fiscal quarter or in other factors that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls or internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. In addition, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of error or fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management’s override of the control. The design of any systems of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

Because of these inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

The Company is routinely involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our Texas facilities’ fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure. Please refer to Revenue Recognition, as well as Business – Government Regulation – Texas Workers’ Compensation Systems in our Form 10-K for the fiscal year ended August 31, 2011, for a detailed description of the MDR process and our accounts receivable. The Company cannot predict whether any litigation or administrative proceeding to which it is currently a party will have a material adverse effect on the Company’s results of operations, cash flows or financial condition.

Item 1A. Risk Factors.

The Company’s Risk Factors as disclosed in its Form 10-K for the year ended August 31, 2011 have not materially changed.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On January 26, 2012, the Company issued 50,000 shares of its common stock to Dr. Kelly Larkin as consideration for Dr. Larkin’s employment as the Company’s marketing director.

On February 6, 2012, the Company entered into an Incentive Stock Grant Agreement (“Incentive Agreement”) with Eric G. Carter, whereby he is to be issued an aggregate of 300,000 shares of the Company’s common stock as consideration for securing organized, nationally recognized labor unions (“Union Partners”) as non-controlling interest partners in the Company’s Pasadena facility (“Partnership”). These shares are to be issued to Mr. Carter at the rate of 33,333 shares for every one of the first nine Union Partners that join the Partnership. As of February 29, 2012, since two Union Partners have joined the Partnership, Mr. Carter was issued an aggregate of 66,666 shares of the Company’s common stock. As an additional consideration, upon the execution of the Incentive Agreement, a Company affiliated with Mr. Carter was granted 1% non-controlling interest in the Pasadena facility.

The Company issued these shares to Dr. Larkin and Mr. Carter under the exemption from registration provided by Section 4(2) of the Securities Act of 1933 and the rules and regulations promulgated thereunder. The issuance did not involve a “public offering” based upon the following factors: (i) the issuance of the securities were isolated private transactions; (ii) a limited number of securities were issued to two offerees; (iii) there was no public solicitation; (iv) the investment intent of the offerees; (v) the offerees represented that they were an “accredited investor” and (vi) the restriction on transferability of the securities issued.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mining Safety Disclosures.

None.

Item 5. Other Information.

None.

Item 6. Exhibits.


EXHIBIT NO.		IDENTIFICATION OF EXHIBIT
Exhibit 15.1		Awareness Letter of KWCO, P.C.

Exhibit 23.1		Consent of KWCO, P.C.

Exhibit 31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Exhibit 32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

**101.INS		XBRL Instance Document.

**101.SCH		XBRL Taxonomy Schema Document.

**101.CAL		XBRL Calculation Linkbase Document.

**101.LAB		XBRL Label Linkbase Document.

**101.PRE		XBRL Presentation Linkbase Document

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	DYNACQ HEALTHCARE, INC.

Date: April 13, 2012	By:	/s/ Eric K. Chan
		Eric K. Chan Chief Executive Officer (duly authorized officer)

Date: April 13, 2012	By:	/s/ Philip S. Chan
		Philip S. Chan Chief Financial Officer (principal financial and accounting officer)

INDEX OF EXHIBITS


EXHIBIT NO.		IDENTIFICATION OF EXHIBIT
Exhibit 15.1		Awareness Letter of KWCO, P.C.

Exhibit 23.1		Consent of KWCO, P.C.

Exhibit 31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Exhibit 32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

**101.INS		XBRL Instance Document.

**101.SCH		XBRL Taxonomy Schema Document.

**101.CAL		XBRL Calculation Linkbase Document.

**101.LAB		XBRL Label Linkbase Document.

**101.PRE		XBRL Presentation Linkbase Document

EX-15.1 2 d331373dex151.htm AWARENESS LETTER OF KWCO, P.C. Awareness Letter of KWCO, P.C.

EXHIBIT 15.1

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

AWARENESS LETTER

Securities and Exchange Commission

Washington, D.C. 20549

We are aware that our report dated April 13, 2012 on our review of the interim consolidated financial statements of Dynacq Healthcare, Inc. as of and for the three and six month periods ended February 29, 2012 and February 28, 2011 and included in this Form 10-Q for the quarter ended February 29, 2012 is incorporated by reference in the Company’s Registration Statements No. 333-72756 and 333-176740. Pursuant to Rule 436(c) under the Securities Act of 1933, this report should not be considered as part of the Registration Statements prepared or certified by us within the meaning of Sections 7 and 11 of that Act.

/s/ KWCO, P.C.

KWCO, P.C.

Houston, Texas

April 13, 2012

EX-23.1 3 d331373dex231.htm CONSENT OF KWCO, P.C. Consent of KWCO, P.C.

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation of our review report dated April 13, 2012 with respect to the consolidated financial statements of Dynacq Healthcare, Inc. included in the Quarterly Report (Form 10-Q) for the quarter ended February 29, 2012.

/s/ KWCO, P.C.

KWCO, P.C.

Houston, Texas

April 13, 2012

EX-31.1 4 d331373dex311.htm SECTION 302 CERTIFICATION OF CEO Section 302 Certification of CEO

EXHIBIT 31.1

CERTIFICATION

I, Eric K. Chan, Chief Executive Officer of Dynacq Healthcare, Inc., certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Dynacq Healthcare, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Eric K. Chan

Eric K. Chan

Chief Executive Officer

(principal executive officer)

Date: April 13, 2012

EX-31.2 5 d331373dex312.htm SECTION 302 CERTIFICATION OF CFO Section 302 Certification of CFO

EXHIBIT 31.2

CERTIFICATION

I, Philip S. Chan, Chief Financial Officer of Dynacq Healthcare, Inc., certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Dynacq Healthcare, Inc.;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Philip S. Chan

Philip S. Chan

Chief Financial Officer

(principal financial and accounting officer)

Date: April 13, 2012

EX-32.1 6 d331373dex321.htm SECTION 906 CERTIFICATION OF CEO Section 906 Certification of CEO

EXHIBIT 32.1

CERTIFICATION OF PERIODIC REPORT

In connection with the Quarterly Report of Dynacq Healthcare, Inc. (the “Company”) on Form 10-Q for the quarterly period ended February 29, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Eric K. Chan, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Eric K. Chan

Eric K. Chan

Chief Executive Officer

April 13, 2012

EX-32.2 7 d331373dex322.htm SECTION 906 CERTIFICATION OF CFO Section 906 Certification of CFO

EXHIBIT 32.2

CERTIFICATION OF PERIODIC REPORT

In connection with the Quarterly Report of Dynacq Healthcare, Inc. (the “Company”) on Form 10-Q for the quarterly period ended February 29, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Philip S. Chan, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Philip S. Chan

Philip S. Chan

Chief Financial Officer

April 13, 2012

EX-101.INS 8 dyii-20120229.xml XBRL INSTANCE DOCUMENT 0000890908 2011-02-28 0000890908 2010-08-31 0000890908 2012-02-29 0000890908 2011-08-31 0000890908 2011-12-01 2012-02-29 0000890908 2010-12-01 2011-02-28 0000890908 2010-09-01 2011-02-28 0000890908 2012-04-13 0000890908 2011-09-01 2012-02-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares false --08-31 Q2 2012 2012-02-29 10-Q 0000890908 14543626 Smaller Reporting Company DYNACQ HEALTHCARE INC -665877 181256 166666 -358550 97599 34592 -0.01 -0.01 -0.02 -0.02 <div> <div> Investment in Real Estate and Notes Payable In March 2010, the Company purchased an apartment in Hong Kong as an investment for $2,014,207. This apartment was used as a security to obtain an 18-year mortgage loan of $1,245,775 from a financial institution, with a variable interest rate at the lower of 3-month Hang Seng Interbank Offered Rates plus 0.7% or 2.9% below the Hong Kong Dollar best lending rate quoted by the financial institution. The effective interest rate at February 29, 2012 was 1.1%. The Company has paid down $32,090 and $31,651 during the six months ended February 29, 2012 and February 28, 2011, respectively, and the current and long-term portions of the note payable as of February 29, 2012 are $64,319 and $1,059,320, respectively. Depreciation expense associated with the apartment was $12,912 in each year for the three months ended February 29, 2012 and February 28, 2011, and $25,824 in each year for the six months ended February 29, 2012 and February 28, 2011. In November 2011 and September 2010, the Company borrowed $116,339 and $65,000 as notes payable from a financial institution at an interest rate of 4.5% and 6%, which notes are to be repaid in 36 and 24 monthly installments, respectively, and are secured by specific equipments purchased at our Pasadena facility. The Company has paid down $28,683 during the six months ended February 29, 2012, and the current and long-term portions of the notes payable as of February 29, 2012 are $57,224 and $66,583, respectively. </div> </div> 1024427 -278855 <div> <div> Noncontrolling Interest The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company's facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest ranged from 1.75% to 3.00% at February 29, 2012).</div> </div> -977266 -196608 -1260442 -1257844 <div> <div> Reorganization of Segments and Reclassification The Industry Segment "U.S. Division" comprises of the Company's Pasadena facility. In the prior year it was classified as discontinued operations in the consolidated financial statements. The Company at the present time has the U.S. Division and the Corporate Division. Certain previously reported financial information has been reclassified to conform to the current year's presentation. The impact of such reclassification was not significant to the prior year's overall presentation, except for (1) presenting the Pasadena facility as continuing operations under U.S. Division, which was presented in the prior year as discontinued operations, and (2) the presentation of the various subsidiaries (except for Dynacq Huai Bei Healthcare, Inc. ("Dynacq-Huai Bei") and Sino Bond Inc. Limited ("Sino Bond"), which are now shown as part of the Corporate Division) in China as discontinued operations under the Corporate Division, which in the previous year was shown as part of continuing operations under the China Division. </div> </div> <div> <div> Revenue Recognition Background The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below. Revenue Recognition Policy The Company has established billing rates for its medical services which it bills as gross revenue as services are delivered. Gross billed revenues are then reduced by the Company's estimate of the discount (contractual allowance) to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for actual differences in estimated revenue recorded in prior periods and actual cash collections. Contractual Allowance The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. The following table shows gross revenues and contractual allowances for the three and six months ended February 29, 2012 and February 28, 2011:   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr><td width="55%"> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="6" align="center">Three months ended</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="6" align="center">Six months ended</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 28, 2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 28, 2011</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Gross billed charges</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,692,503</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,954,275</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,746,618</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,924,743</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Contractual allowance</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,725,787</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,265,462</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,934,929</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,786,115</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Net revenue</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">966,716</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,688,813</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,811,689</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,138,628</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Contractual allowance percentage</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">74</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">66</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">68</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">62</td> <td valign="bottom" nowrap="nowrap">% </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table> A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers' Compensation ("TDWC") and the workers' compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers' compensation claims will be governed by the network contract. For claims arising prior to the implementation of workers' compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers' Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the "Guidelines") became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis. Based on these Guidelines, the reimbursement due the Company for workers' compensation cases is lower than we previously experienced. The Company has continued accepting Texas workers' compensation cases, and has not made any substantial changes in its focus towards such cases. Our net patient service revenue for Texas workers' compensation cases as a percentage of gross billings has decreased primarily as a result of lower reimbursement rates for workers' compensation procedures still being performed. Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the MDR process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings ("SOAH"), receiving positive rulings in over 90% of its claims presented for administrative determination. The 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards, once the definitions of those standards are determined. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC, pending a final, non-appealable decision. A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court's decision has further delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases is not anticipated during the 2012 fiscal year.   Through February 2012, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims. In most of these cases, the carriers have requested refunds of the payments made in the event that the SOAH decisions and orders are reversed on appeal. Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases. Motions filed seeking a refund in some cases in which the awards were voluntarily paid have been granted and the Company has been ordered to refund approximately $3.7 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. In September and October 2011, the Company deposited these amounts as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. We anticipate that similar motions requesting remand and a refund for awards voluntarily paid will be filed and will likely be granted by the 345th Judicial District Court of Travis County, Texas. If and when these additional motions are granted, the Company will be ordered to refund an additional $7.7 million, not including prejudgment interest. The Company has appealed the judgments requiring a refund to the carriers. The appeal of the refund judgments will progress simultaneously to the adjudication of those cases remanded for determinations of whether the services provided were unusually costly and unusually extensive. Voluntary payments made pursuant to the Decisions and Orders are premature payments by the carriers and will likely be ordered to be refunded. Once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in the underlying stop-loss fee disputes and that voluntary payments refunded to the carriers will be recaptured. Due to the uncertainties associated with these stop-loss fee dispute cases, in fiscal year 2011, the Company recognized an increase of $10,254,990 in the contractual allowance at our Pasadena facility (and an additional loss of $779,583 in the contractual allowance at our Garland facility, which is classified as discontinued operations), and $1,751,478 in interest expense at our Pasadena facility (and an additional interest expense of $132,339 at our Garland facility). Claims regarding payment for hospital outpatient services remain pending at the TDWC. It is expected that these claims will be adjudicated at SOAH and ultimately in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the determination of "fair and reasonable" charges. In 2007, we received unfavorable rulings from SOAH in all of our appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Court of Appeal in our lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 cases. Consequently, the Company is bound by the Third Court of Appeals' ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a "fair and reasonable rate" but also must "ensure the quality of medical care" and "achieve effective cost control" and be the same or less than that charged to others with an equivalent standard of living. This ruling will impact cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided in 2001 and 2002 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals' unfavorable ruling, collection, if any, in these cases depends on the Company's ability to establish the criteria in this ruling. The Company anticipates that it will be given the opportunity to establish the criteria in several hundred cases currently pending at SOAH during the 2012 fiscal year. We are currently pursuing claims against two healthcare agents relating to contracts with certain of our facilities which set out reimbursement guidelines by several workers' compensation carriers at a minimum of 70% of the facility's charges. Discovery is continuing on these claims to determine which carriers are involved, the amount of reimbursement due to us, and the data used to determine "usual and customary" market rates for medical services in specific geographic regions. Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals' opinions and our legal counsel's advice that settlements with insurance carriers have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. Any monies collected for these MDR accounts receivable will be recorded as current period's net patient service revenues.   Accounts Receivable Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility. The contractual allowance stated as a percentage of gross receivables at the balance sheet dates is larger than the contractual allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the contractual allowance. The contractual allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized. Discontinued Operations Revenue Recognition Policy In China, the local government Department of Health establishes billing rates for a hospital's sale of prescription medication and medical services. A majority of the services provided by Second People's Hospital is to cash pay patients, who pay for the services in advance. For services provided under the local government's social healthcare insurance program, we are generally paid at approximately 95% of billed charges two to three months after the date of service. The remaining 5% of billed charges is evaluated by the local government Department of Health on a semi-annual basis and may be paid to the hospital after that evaluation is complete. As of February 28, 2011, the Company made the decision to terminate the management agreement with the Rui An City Department of Health, and is currently in negotiation with them to finalize the terms, including the effective date of termination. The Company had bad debt expenses of $-0- and $21,991 for the three months ended February 29, 2012 and February 28, 2011, respectively, and $-0- and $24,755 for the six months ended February 29, 2012 and February 28, 2011, respectively, related to denials under the social healthcare insurance program. Since the amount of bad debt expense is minimal, it has been included with Other Operating Expenses in the income statement.</div> </div> <div> <div> <div> Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company's estimates is the determination of revenue to recognize for the services the Company provides and the determination of the contractual allowance. See "Revenue Recognition" below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements. </div></div> </div> 14176960 14176960 14443627 14456127

2346720

1974753

1192279

500824

18430553

13691664

7453676

6326320

9780837

10047320

188513000

187059000

66223500

56599450

37267555

27634244

6909527

6651726

18722274

18281129

<div> <div> <div> <div> General Dynacq Healthcare, Inc., a Nevada corporation (the "Company"), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its subsidiaries in China and Hong Kong also (1) provided healthcare management services to a hospital in China until February 28, 2011; and (2) invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings. The Company through its United States subsidiaries (1) owns and operates one general acute care hospital in Pasadena, Texas, and (2) owns one general acute care hospital in Garland, Texas, which was closed on September 30, 2011, and accordingly this business is classified as "Discontinued Operations" for the six months ended February 29, 2012 and February 28, 2011 (see Note below on Discontinued Operations). The Company is currently composed of two divisions: U.S. and Corporate.</div></div></div> </div>

94044

97794

-34592

189161

139308

27665945

23613778

24315160

15842467

-4052167

-8472693

-23222

-101651

-1239848

-696218

0.001

100000000

14426960

14543626

14427

14544

<div> <div> Comprehensive Loss and Accumulated Other Comprehensive Income Comprehensive loss consists of net loss and other comprehensive income (loss). Other comprehensive income (loss) represents certain components of revenues, expenses, gains and losses that are included in comprehensive loss, but are excluded from net loss. Other comprehensive income (loss) amounts are recorded directly as an adjustment to stockholders' equity, net of tax, and for the three and six months ended February 29, 2012 and February 28, 2011 were as follows:   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr><td width="56%"> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="6" align="center">Three months ended</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="6" align="center">Six months ended</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 28, 2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 28, 2011</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Net loss</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,795,586</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,677,362</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,739,679</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,834,002</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr><td valign="top"> Other comprehensive income (loss), net of taxes:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Foreign currency translation adjustment, net of taxes of $(10,246), $68,535, $(13,344) and $166,069, respectively</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(19,029</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">117,242</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(24,782</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">308,413</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Reclassification adjustment for foreign currency gains included in net income, net of taxes of $(384,283), $-0-, $(501,273) and $-0-, respectively</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(704,051</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(921,318</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Change in valuation of investment available-for-sale, net of taxes of $1,293,508, $369,802, $(97,599) and $358,550, respectively</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,402,230</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">686,773</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(181,256</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">665,877</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Total other comprehensive loss, net of taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(116,436</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(873,347</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,867,035</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,859,712</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Comprehensive loss attributable to the noncontrolling interest</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Comprehensive loss attributable to Dynacq Healthcare, Inc.</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(116,436</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(873,347</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,867,035</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,859,712</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table> The components of accumulated other comprehensive income were as follows:   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr><td width="74%"> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">August 31, 2011</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Foreign currency translation adjustment, net of taxes of $3,600 and $518,217, respectively</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,682</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">952,782</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Change in valuation of investment available-for-sale, net of taxes of $3,402,882 and $3,500,481, respectively</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,319,638</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,500,894</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Total accumulated other comprehensive income, net of taxes of $3,406,482 and $4,018,698, respectively</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,326,320</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,453,676</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table></div> </div>

7833005

3564719

7245530

3872443

272534

-1655662

612216

90954

44109

310098

160287

<div> <div> Stock Based Compensation Year 2011 Stock Incentive Plan In August 2011, we mailed an Information Statement to all of our stockholders of record as of July 29, 2011. The Information Statement disclosed that our Board of Directors had approved, and the holders of a majority of the outstanding shares of our common stock had executed an Action by Written Consent of Stockholders in Lieu of a Special Meeting (the "Written Consent"), approving the adoption of the Year 2011 Stock Incentive Plan ("2011 Plan").   The purpose of the 2011 Plan is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and thereby encouraging them to devote their abilities and industry to the success of the Company's business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved 15,000,000 shares of common stock for future issuance under the 2011 Plan. On November 14, 2011, the Compensation Committee granted stock options to purchase an aggregate of 200,000 shares under the 2011 Plan, with a weighted average exercise price of $1.07 to two employees. These stock options will vest based on certain operating performance criteria, and expire after five years. The shares underlying these stock options are registered under the Securities Act of 1933 (the "Securities Act"). On January 12, 2012, the Compensation Committee granted stock options to purchase 250,000 shares under the 2011 Plan, with an exercise price of $1.10 to the Company's chief executive officer, Eric K. Chan. These stock options will vest in annual installments of 25 percent beginning on the first anniversary date, and expire after ten years. The shares underlying these stock options are registered under the Securities Act. On February 6, 2012, the Compensation Committee granted stock options to purchase an aggregate of one million shares under the 2011 Plan, with a weighted average exercise price of $1.00 to various employees. These stock options will vest based on certain operating performance criteria, and expire after five years. The shares underlying these stock options are registered under the Securities Act. As of February 29, 2012, there remain 13,650,000 shares which can be issued under the 2011 Plan after giving effect to shares issued. 2000 Incentive Plan The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of February 29, 2012, there remain 2,023,066 shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan. The 2011 Plan and the 2000 Plan (the "Plans") are administered by the Compensation Committee of the Board of Directors (the "Committee"). The Committee has the power to determine which eligible employees will receive awards, the timing and manner of the grant of such awards, the exercise price of stock options (which may not be less than market value on the date of grant), the number of shares, and all of the terms of the awards. The Company may at any time amend or terminate the 2011 Plan. However, no amendment that would impair the rights of any participant with respect to outstanding grants can be made without the participant's prior consent. Stockholder approval of an amendment to the Plans is necessary only when required by applicable law or stock exchange rules. Generally, options granted become exercisable in annual installments of 25 percent beginning on the first anniversary date, and expire after five to ten years. The following table summarizes the stock option activities for the six months ended February 29, 2012 (share amounts in thousands):   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr><td width="59%"> </td> <td valign="bottom" width="7%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="7%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="7%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="7%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Shares</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Weighted Average Option Exercise Price Per Share</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Weighted Average Grant Date Fair Value Per Share</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Aggregate Intrinsic Value(1)</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Outstanding, August 31, 2011</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,206</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2.41</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Granted</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,450</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.03</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.52</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Exercised</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Expired or canceled</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(283</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.79</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Outstanding, February 29, 2012</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,373</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.87</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr></table> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="4%" align="left"> (1)  </td> <td valign="top" align="left"> These amounts represent the difference between the exercise price and the closing price of Dynacq common stock on February 29, 2012 and August 31, 2011, as reported on the NASDAQ stock market, for all in-the-money options outstanding. For exercised options, intrinsic value represents the difference between the exercise price and the closing price of Dynacq common stock on the date of exercise. </td></tr></table> For the six months ended February 29, 2012 and February 28, 2011, there were no stock options exercised. The following summarizes information related to stock options outstanding as of February 29, 2012, and related weighted average price and life information:   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td width="71%"> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="10" align="center">Options Outstanding</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="6" align="center">Options Exercisable</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom" nowrap="nowrap"> Range of Exercise Prices</td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Shares</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Weighted Average Remaining Contractual Life (Years)</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Weighted Average Exercise Price</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Shares</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Weighted Average Exercise Price</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="18" align="center">(Share Amounts In Thousands)</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> $ 1.00 – 1.10</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,350</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6.0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.03</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> $ 1.86 – 2.05</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,200</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9.4</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.89</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> $ 2.50 – 2.75</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">587</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.54</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">587</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.54</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> $ 4.90 – 4.96</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">236</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4.90</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">236</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4.90</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Total</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,373</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6.1</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.87</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">823</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.22</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table> For the three months ended February 29, 2012 and February 28, 2011, stock-based compensation expense associated with the Company's stock options was $82,244 and $(102,963), respectively. For the six months ended February 29, 2012 and February 28, 2011, stock-based compensation expense associated with the Company's stock options was $149,934 and $4,251, respectively. The total unrecognized compensation expense for outstanding stock options as of February 29, 2012 was $1,464,000, and will be recognized, in general, over 3.8 years. The weighted average time to recognize the compensation expense is 1.9 years.</div> </div>

-121577

-229201

<div> <div> Discontinued Operations Under ASC Topic 360-10-35, Property, Plant, and Equipment – Subsequent Measurement (formerly referred to as SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets), we classify assets to be disposed of as held for sale or, if appropriate, discontinued operations when they have received appropriate approvals to be disposed of by our management or Board of Directors. Cash flows from our discontinued businesses are reflected as discontinued operating, investing, and financing activities in our statement of cash flows. We had $6,651,726 of assets of discontinued operations and $615,598 of liabilities of discontinued operations as of February 29, 2012. U.S. Division The Company had made the decision to sell its Garland facility as of August 31, 2010, and its operation was classified as discontinued operations for the year ended August 31, 2010. However, the Company closed the Garland facility on September 30, 2011, and accordingly its operations for the fiscal years 2011 and 2012 continue to be classified as discontinued operations. The Company plans to either sell the Garland facility or pursue converting it into an ambulatory surgical center, if and when the Company can identify and generate a steady referral source for outpatient cases. The Company intended to sell its Pasadena facility also, and had it classified as discontinued operations, as of August 31, 2010. However, since a sale was not consummated during the 12-month period following the decision to sell, the operations of the Pasadena facility have been reclassified as continuing operations for the fiscal years 2011 and 2012. The Company is continuing to revamp its operations at the Pasadena facility by modifying the business model and controlling expenses. However, there can be no assurance that we will be successful in turning the facility around. The Company had an independent appraisal done for both the hospitals in October 2011, and based on each hospital's valuation, expected sale proceeds, and expected cash flows has determined that there is no impairment charge required in connection with the foregoing disposal activities. Because we do not intend to sell the accounts receivable of hospitals in discontinued operations, the receivables are included in our accounts receivable in the accompanying Consolidated Balance Sheets. Corporate Division The Company's operations at Second People's Hospital and its various proposed businesses in China, including but not limited to sandstone mining, mined coal trading, natural gas stations and sale of artifacts have been classified as discontinued operations. The Company's two foreign subsidiaries, Dynacq-Huai Bei and Sino Bond, are the only two companies that continue to be classified as continuing operations, and its other foreign subsidiaries have been reclassified as discontinued operations. The following is a summary of financial information related to our discontinued operations for the three and six months ended February 29, 2012 and February 28, 2011. We have reclassified prior period financial statements to exclude these businesses from continuing operations.   Discontinued Operations   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td width="48%"> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="10" align="center">Three months ended February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="10" align="center">Three months ended February 28, 2011</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">U.S. Division</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Corporate Division</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">U.S. Division</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Corporate Division</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Net patient service revenue</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">93,711</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">93,711</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">734,538</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">339,910</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,074,448</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Costs and expenses:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Compensation and benefits</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,196</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,196</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">657,684</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">285,781</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">943,465</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Medical services and supplies</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46,580</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46,580</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">250,524</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">130,807</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">381,331</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Other operating expenses</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">195,171</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">195,171</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">660,700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">232,608</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">893,308</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Depreciation and amortization</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,754</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,754</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Total costs and expenses</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">252,947</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">252,947</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,568,908</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">659,950</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,228,858</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Operating loss</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(159,236</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(159,236</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(834,370</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(320,040</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,154,410</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Other income (expense), net</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(10,311</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(10,311</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,762</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">56,790</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">59,552</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Loss before income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(169,547</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(169,547</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(831,608</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(263,250</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,094,858</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Benefit for income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">267,827</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">111,773</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">379,600</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Loss on discontinued operations, net of income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(169,547</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(169,547</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(563,781</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(151,477</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(715,258</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Loss on disposal of discontinued assets</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(187,041</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(187,041</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr><td valign="top"> Benefit for income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">65,464</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">65,464</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Loss on disposal of discontinued assets, net of income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(121,577</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(121,577</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Total loss on discontinued operations, net of taxes</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(169,547</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(398,748</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(563,781</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(273,054</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(836,835</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td height="16"> </td> <td height="16" colspan="12"> </td> <td height="16" colspan="12"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="10" align="center">Six months ended February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="10" align="center">Six months ended February 28, 2011</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">U.S. Division</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Corporate Division</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">U.S. Division</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Corporate Division</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Net patient service revenue</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">318,587</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">318,587</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,288,049</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">831,232</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,119,281</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Costs and expenses:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Compensation and benefits</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">166,803</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">22,511</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">189,314</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,334,918</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">556,100</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,891,018</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Medical services and supplies</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">267,551</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">267,551</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">476,252</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">406,452</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">882,704</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Other operating expenses</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">533,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">98,493</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">631,608</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,282,304</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">358,232</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,640,536</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Depreciation and amortization</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,175</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,175</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21,180</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21,180</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Total costs and expenses</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">967,469</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">126,179</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,093,648</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,093,474</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,341,964</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,435,438</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Operating loss</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(648,882</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(126,179</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(775,061</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,805,425</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(510,732</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,316,157</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Other income (expense), net</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(21,056</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">63,904</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">42,848</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,813</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">191,474</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">194,287</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Loss before income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(669,938</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(62,275</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(732,213</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,802,612</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(319,258</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,121,870</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Benefit for income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">585,218</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">151,743</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">736,961</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Loss on discontinued operations, net of income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(669,938</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(62,275</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(732,213</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,217,394</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(167,515</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,384,909</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Loss on disposal of discontinued assets</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(187,041</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(187,041</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr><td valign="top"> Benefit for income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">65,464</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">65,464</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Loss on disposal of discontinued assets, net of income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(121,577</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(121,577</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Total loss on discontinued operations, net of taxes</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(669,938</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(291,476</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(961,414</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,217,394</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(289,092</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,506,486</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table>   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td width="48%"> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="10" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="10" align="center">August 31, 2011</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">U.S. Division</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Corporate Division</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">U.S. Division</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Corporate Division</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Current assets</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">120,954</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">120,954</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">260,020</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">118,734</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">378,754</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Property and equipment, net</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,530,772</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,530,772</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,530,773</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,530,773</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Total assets</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,530,772</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">120,954</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,651,726</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,790,793</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">118,734</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,909,527</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Current liabilities:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Accounts payable and accrued liabilities</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">615,598</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">615,598</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">604,302</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">604,302</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Total liabilities</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">615,598</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">615,598</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">604,302</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">604,302</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table>  </div> </div>

-0.20

-0.12

-0.26

-0.13

<div> <div> Net Loss per Share The following table presents the computation of basic and diluted loss per common share attributable to the Company:   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr><td width="52%"> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="6" align="center">Three months ended</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="6" align="center">Six months ended</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 28, 2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 28, 2011</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Basic and diluted loss per common share:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr><td valign="top"> Numerator:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Loss from continuing operations</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,452,843</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(842,255</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,861,785</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,330,279</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr><td valign="top"> Less: Net loss attributable to noncontrolling interest</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">56,005</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,728</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">83,520</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,763</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Loss from continuing operations attributable to Dynacq Healthcare, Inc.</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,396,838</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(840,527</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,778,265</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,327,516</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr><td valign="top"> Discontinued operations, net of income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(169,547</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(715,258</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(732,213</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,384,909</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Loss on disposal of discontinued operations, net of income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(121,577</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(229,201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(121,577</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Net loss attributable to Dynacq Healthcare, Inc.</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,795,586</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,677,362</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,739,679</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,834,002</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Denominator:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr><td valign="top"> Basic and diluted average common shares outstanding</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,456,127</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,176,960</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,443,627</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,176,960</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Basic and diluted loss per common share:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr><td valign="top"> Loss from continuing operations attributable to Dynacq Healthcare, Inc.</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.10</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.06</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.19</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.09</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Discontinued operations, net of income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(0.01</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(0.05</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(0.05</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(0.10</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr><td valign="top"> Loss on disposal of discontinued operations, net of income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(0.02</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(0.01</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(0.02</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(0.01</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Net loss attributable to Dynacq Healthcare, Inc.</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.13</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.12</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.26</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.20</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table> Basic net income (loss) per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted net income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the calculation of diluted net income (loss) per share, the basic weighted average number of shares is increased by the dilutive effect of stock options determined using the treasury stock method. However, if it is anti-dilutive, the dilutive effect of the stock options is not included in the calculation of diluted net income (loss) per share. Stock options with exercise prices exceeding current market prices that were excluded from the computation of net income (loss) per share amounted to approximately 2,367,000 shares and 1,139,000 shares for the six months ended February 29, 2012 and February 28, 2011, respectively. </div> </div>

484536

230293

157939

-152435

784020

365464

566626

343508

4138628

1688813

2811689

966716

-1327516

-840527

-2778265

-1396838

-1996958

-1335285

-2861785

-1452843

-1330279

-842255

-2861785

-1452843

-0.09

-0.06

-0.19

-0.10

1506486

961414

-1384909

-715258

-732213

-169547

-0.10

-0.05

-0.01

2363724

868249

-666679

-493030

291070

-371967

-1112382

-691455

-802185

-4766187

1710119

-110183

-13493

-55313

-76332

-29979

-5316

-290635

-74293

20300

9750

294589

143265

740453

353763

606203

338305

22804

728788

192366

178874

<div> Inventories <div> Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method. </div> </div>

550441

474109

<div> <div> Investments in Available-for-Sale and Trading Securities The Company has invested in various bonds. These investments are classified as available-for-sale securities, and are carried at fair value as of February 29, 2012, based on the quoted market prices as of that date. These investments are subject to default risk. The Company intends to hold these for a minimum period of an additional 12 months. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The Company also invests in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and are carried at fair value as of February 29, 2012. These investments are subject to fluctuations in the market price. During the six months ended February 29, 2012 and February 28, 2011, the Company had a net loss of $57,101 and $14,995 in trading of these securities, respectively. </div> </div>

3603843

1604895

3696681

2019312

22856659

17766563

66223500

56599450

21573537

16501352

604302

615598

1093961

1125903

63617

130098

-45424

109463

-22202

109463

-1523205

-157753

-1421554

-157753

-2968074

-8654696

-1728226

-7958478

-2834002

-1677362

-3739679

-1795586

-2763

-1728

-83520

-56005

97918

121543

-3694377

-1875906

-4433841

-2905727

255517

249695

3354188

1550251

2672125

1349336

1697419

540621

1572056

1452884

6794

157753

4909498

0.01

5000000

272414

198121

65000

116339

100000

3494738

-2836765

-1679090

-3823199

-1851591

7168864

7038699

1941041

1915218

42635

46103

44567

60773

26054284

22314605

<div> <div> Industry Segments and Geographic Information The Industry Segment "U.S. Division" comprises of the Company's Pasadena facility. In the prior year it was classified as discontinued operations in the consolidated financial statements. The Company at the present time has the U.S. Division and the Corporate Division. Certain previously reported financial information has been reclassified to conform to the current year's presentation. The impact of such reclassification was not significant to the prior year's overall presentation, except for (1) presenting the Pasadena facility as continuing operations under U.S. Division, which was presented in the prior year as discontinued operations, and (2) the presentation of the various subsidiaries (except for Dynacq-Huai Bei and Sino Bond, which are now shown as part of the Corporate Division) in China as discontinued operations under the Corporate Division, which in the previous year was shown as part of continuing operations under the China Division. The Company had made the decision to sell its Garland facility as of August 31, 2010, and its operation was classified as discontinued operations for the year ended August 31, 2010. However, the Company closed the Garland facility on September 30, 2011, and accordingly its operations for the fiscal years 2011 and 2012 continue to be classified as "Discontinued Operations" (see Discontinued Operations below). The Company plans to either sell the Garland facility or pursue converting it into an ambulatory surgical center, if and when the Company can identify and generate a steady referral source for outpatient cases. The Company intended to sell its Pasadena facility also, and had it classified as discontinued operations, as of August 31, 2010. However, since a sale was not consummated during the 12-month period following the decision to sell, the operations of the Pasadena facility have been reclassified as continuing operations for the fiscal years 2011 and 2012. The Company is continuing to revamp its operations at the Pasadena facility by modifying the business model and controlling expenses. However, there can be no assurance that we will be successful in turning the facility around. From March 1, 2009 to February 28, 2011, Dynacq Huai Bei Healthcare, Inc. ("Dynacq-Huai Bei"), a wholly owned subsidiary of the Company provided healthcare management services to the Second People's Hospital in Rui An, China. The Company organized Dynacq-Huai Bei in April 2008 under the laws of the People's Republic of China. Dynacq-Huai Bei was responsible for funding any operating deficits, and was entitled to any operating profits, of that hospital during the management period. Due to continued losses at the Second People's Hospital, the Company made the decision to terminate the management agreement with the Rui An City Department of Health, and is currently in negotiation with them to finalize the terms, including the effective date of termination. The Company ceased providing healthcare management services to the Second People's Hospital as of February 28, 2011. The Company has written off the fixed assets and inventory balances as of February 28, 2011, and does not expect any further losses due to the termination of this management agreement related to the Second People's Hospital. We have accounted for the operations of the Second People's Hospital in Rui An, China as discontinued operations, and have reclassified prior period financial statements to exclude them from continuing operations. Dynacq-Huai Bei and the Rui An City Department of Health had also previously entered into an agreement assigning to Dynacq-Huai Bei the right to manage the Third People's Hospital in Rui An, which hospital is currently under construction. Dynacq-Huai Bei and the Rui An City Department of Health, in November 2010, mutually agreed to terminate this agreement, due to continued delays in the construction of the Third People's Hospital. Accordingly, Dynacq-Huai Bei will not be managing the Third People's Hospital. The Company has also organized Sino Bond Inc. Limited, a Hong Kong corporation ("Sino Bond") to hold and manage investments in Hong Kong. Sino Bond invests in debt and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings. At the present time, the Company's subsidiaries in China and Hong Kong are not pursuing any new line of business and/or projects. The Company has invested in various bonds. These investments are classified as available-for-sale securities, and are carried at fair value as of February 29, 2012, based on the quoted market prices as of that date. As of February 29, 2012, these securities are valued at approximately $18.3 million. The Company intends to hold these for a minimum period of an additional 12 months. During the three months ended February 29, 2012 and February 28, 2011, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had gains of $108,491 and $69,584, respectively. During the six months ended February 29, 2012 and February 28, 2011, the trading in initial public offerings of equity securities on the Hong Kong Stock Exchange generated losses of $57,101 and $14,995, respectively. The Company, through a subsidiary in Hong Kong, has expanded its investments in debt and equity securities in Europe and Asia and has engaged the services of an investment banker to recommend such investment opportunities. The Company's primary investment focus will be on growth companies from mainland China. The Company anticipates making short-term investments in these entities through initial public offerings (held mostly through the Hong Kong Stock Exchange) and pre-initial public offerings. Discontinued Operations On September 29, 2011, the Board of Directors of the Company approved the closure of the Garland facility, included in our U.S. division, effective September 30, 2011. Prior to that, in August 2010, the Board of Directors of the Company had approved a plan to dispose of the Garland facility due to continued operating losses. The Garland facility had experienced decreases in net patient revenues and number of cases, generally attributable to the loss of physicians from our medical staff. The opening of a new hospital near our Garland facility has had a direct adverse impact on our ability to retain members of the medical staff at that facility and consequently on our patient volume. The Garland facility was operating at a loss, and the Board of Directors believes that ceasing operations of the facility at this time is in the Company's best interest. The Company has estimated a closing cost of $625,000. However, the ongoing losses incurred will be reduced due to the closing of the facility. The Company had an independent appraisal done in October 2011 for both the hospitals, and based on each hospital's valuation, expected sale proceeds, and expected cash flows has determined that there is no impairment charge required in connection with the foregoing disposal activities. The Company has discontinued operations of all its foreign subsidiaries, except for Dynacq-HuaiBei and Sino Bond, and has either closed or is in the process of closing them. The Corporate Division includes interest and other income related to the investments in available-for-sale and trading securities, corporate personnel compensation expenses, and general and administrative expenses. Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.   We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. There are no transfers between segments. Summarized financial information concerning the business segments from continuing operations is as follows:   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr><td width="56%"> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="6" align="center">Three months ended</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="6" align="center">Six months ended</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 28, 2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 28, 2011</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Revenues from external customers</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr><td valign="top"> Net patient service revenues</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> U.S. Division</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">966,716</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,688,813</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,811,689</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,138,628</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Corporate</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Consolidated</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">966,716</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,688,813</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,811,689</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,138,628</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Income (loss) before taxes and discontinued operations</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> U.S. Division</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,584,878</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(593,099</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,989,527</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(513,394</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr><td valign="top"> Corporate</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">132,035</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(742,186</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(872,258</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,483,564</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Consolidated</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,452,843</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,335,285</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,861,785</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,996,958</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table>   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr><td width="72%"> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">February 29, 2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">August 31, 2011</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Total Assets</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> U.S. Division</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,416,886</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,763,015</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Corporate</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">41,530,838</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">50,550,958</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Assets of continuing operations</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">49,947,724</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">59,313,973</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Assets of discontinued operations</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,651,726</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,909,527</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Consolidated</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">56,599,450</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">66,223,500</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table></div> </div>

4251

149934

43303224

38702789

43366841

38832887

1471644

1424399

-14995

-57101

EX-101.SCH 9 dyii-20120229.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statements Of Operations link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Basis Of Presentation link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Reorganization Of Segments And Reclassification link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Cash And Cash Equivalents link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Investments In Available-For-Sale And Trading Securities link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Investment In Real Estate And Notes Payable link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Use Of Estimates link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Stock Based Compensation link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Fair Value Of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Foreign Currency Translation link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 11501 - Disclosure - Noncontrolling Interest link:presentationLink link:calculationLink link:definitionLink 11601 - Disclosure - Comprehensive Loss And Accumulated Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 11701 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 11801 - Disclosure - Industry Segments And Geographic Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 dyii-20120229_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.LAB 11 dyii-20120229_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and entity information [abstract]. Document And Entity Information [Abstract] Statement [Table] Statement [Line Items] Document Type Amendment Flag Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Consolidated Balance Sheets [Abstract] Assets [Abstract] Assets Cash and Cash Equivalents, at Carrying Value Cash at end of period Cash at beginning of period Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Accounts Receivable, Net, Current Accounts receivable, net of contractual allowances of approximately $187,059,000 and $188,513,000 at February 29, 2012 and August 31, 2011, respectively Accounts Receivable, Net, Current, Total Inventory, Net Inventories Inventory, Net, Total Trading Securities, Current Trading securities Trading Securities, Current, Total Interest Receivable, Current Interest receivable Prepaid Expense, Current Prepaid expenses Prepaid Expense, Current, Total Income Taxes Receivable, Current Income tax receivable Assets of Disposal Group, Including Discontinued Operation, Current Assets of discontinued operations Assets of Disposal Group, Including Discontinued Operation, Current, Total Assets, Current Total current assets Available-for-sale Securities, Noncurrent Investments available-for-sale Available-for-sale Securities, Noncurrent, Total Real Estate Investment Property, Net Investment in real estate, net Real Estate Investment Property, Net, Total Property, Plant and Equipment, Net Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property and equipment, net Property, Plant and Equipment, Net, Total Income Taxes Receivable, Noncurrent Income tax receivable Deferred Tax Assets, Net, Noncurrent Deferred tax asset Deferred Tax Assets, Net, Noncurrent, Total Other Assets, Noncurrent Other assets Other Assets, Noncurrent, Total Assets Total assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Accrued Liabilities, Current Accrued liabilities Accrued Liabilities, Current, Total Notes Payable, Current Current portion of notes payable Notes Payable, Current, Total Capital Lease Obligations, Current Current portion of capital lease obligations Liabilities of Disposal Group, Including Discontinued Operation, Current Liabilities of discontinued operations Liabilities of Disposal Group, Including Discontinued Operation, Current, Total Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Non-current liabilities: Notes Payable, Noncurrent Long-term portion of notes payable Notes Payable, Noncurrent, Total Capital Lease Obligations, Noncurrent Long-term portion of capital lease obligations Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Equity: Preferred Stock, Value, Issued Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding Preferred Stock, Value, Issued, Total Common Stock, Value, Issued Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common stock, $.001 par value; 100,000,000 shares authorized, 14,543,626 and 14,426,960 shares issued at February 29, 2012 and August 31, 2011 Common Stock, Value, Issued, Total Additional Paid in Capital Additional Paid in Capital, Ending Balance Additional Paid in Capital, Beginning Balance Additional paid-in capital Additional Paid in Capital, Total Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained earnings Retained Earnings (Accumulated Deficit), Total Stockholders' Equity Attributable to Parent Stockholders' Equity Attributable to Parent, Ending Balance Stockholders' Equity Attributable to Parent, Beginning Balance Total Dynacq stockholders' equity Total Dynacq stockholders' equity Stockholders' Equity Attributable to Noncontrolling Interest Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance Non-controlling interest Stockholders' Equity Attributable to Noncontrolling Interest, Total Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance Total equity Liabilities and Equity Total liabilities and equity Allowance for Doubtful Accounts Receivable, Current Allowance for Doubtful Accounts Receivable, Current, Ending Balance Allowance for Doubtful Accounts Receivable, Current, Beginning Balance Contractual allowances for accounts receivable Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Issued, Total Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, issued Common Stock, Shares, Issued, Total Consolidated Statements Of Operations [Abstract] Net patient service revenue Costs and Expenses [Abstract] Costs and expenses: Compensation and Benefits Compensation and benefits Labor and Related Expense, Total Health Care Organization, Medical Supplies and Drugs Expense Medical services and supplies Other Cost and Expense, Operating Other operating expenses Other Cost and Expense, Operating, Total Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction, Total Depreciation and amortization Operating Costs and Expenses Total costs and expenses Total costs and expenses Operating Income (Loss) Operating loss Operating loss Nonoperating Income (Expense) [Abstract] Other income (expense): Rent and other income (expense). Rent And Other Income Expense Rent and other income Interest Income (Expense), Net Interest income Interest Income (Expense), Net, Total Interest Expense Interest expense Interest expense Interest Expense, Total Other Nonoperating Income (Expense) Total other income, net Total other income, net Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Loss before income taxes from continuing operations Loss before income taxes from continuing operations Income Tax Expense (Benefit) Benefit for income taxes Benefit for income taxes Income Tax Expense (Benefit), Total Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest Loss from continuing operations Loss from continuing operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Discontinued operations, net of income taxes Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax 0 Loss on disposal of discontinued operations, net of income taxes Loss on disposal of discontinued operations, net of income taxes Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax, Total Loss on disposal of discontinued operations, net of income taxes Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Net Income (Loss) Attributable to Noncontrolling Interest Less: Net loss attributable to noncontrolling interest Noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest, Total Net Income (Loss) Attributable to Parent Net loss Net loss Net loss attributable to Dynacq Healthcare, Inc. Net loss attributable to Dynacq Healthcare, Inc. Net Loss Per Share [Abstract] Basic and diluted loss per common share: Income (Loss) from Continuing Operations, Per Basic and Diluted Share Loss from continuing operations attributable to Dynacq Healthcare, Inc. Income (Loss) from Discontinued Operations, Net of Tax, Per Basic and Diluted Share Discontinued operations, net of income taxes Discontinued operations, net of income taxes Gain loss on disposal of discontinued operation net of tax per basic and diluted share. Gain Loss on Disposal of Discontinued Operation Net of Tax Per Basic and Diluted Share Loss on disposal of discontinued operations, net of income taxes Earnings Per Share, Basic and Diluted Net loss attributable to Dynacq Healthcare, Inc. Weighted average number of share outstanding basic and diluted. Weighted Average Number of Share Outstanding Basic and Diluted Basic and diluted average common shares outstanding Income Amounts Attributable to Parent, Disclosures [Abstract] Amounts attributable to Dynacq Healthcare, Inc.: Income (Loss) from Continuing Operations Attributable to Parent Income Net loss before discontinued operations Loss from continuing operations Net loss before discontinued operations Net loss before discontinued operations Consolidated Statements Of Cash Flows [Abstract] Cash flows from operating activities Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Less loss from discontinued operations, net of income taxes Less loss from discontinued operations, net of income taxes Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total Adjustments to reconcile net loss before discontinued operations to net cash used in operating activities: Adjustments to reconcile net loss before discontinued operations to net cash used in operating activities: Trading Securities, Realized Gain (Loss) Loss on trading securities Gain on sale of trading securities Trading Securities, Realized Gain (Loss), Total Deferred Income Tax Expense (Benefit) Deferred income taxes Deferred Income Tax Expense (Benefit), Total Charge for Stock Options to Employees Charge for stock options to employees Charge for stock options to employees Share-based Compensation, Total Charge for stock options to employees Charge for non-controlling interest sale and issuance of stock awards. Charge for Non-Controlling Interest Sale and Issuance of Stock Awards Charge for non-controlling interest sale and issuance of stock awards Foreign Currency Transaction Gain (Loss), Unrealized Foreign currency exchange losses (gains) Foreign currency exchange (gains) losses Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Accounts receivable Increase (Decrease) in Interest and Dividends Receivable Interest receivable Interest receivable Increase (Decrease) in Interest and Dividends Receivable, Total Increase (Decrease) in Inventories Inventories Inventories Increase (Decrease) in Inventories, Total Increase (Decrease) in Prepaid Expense Prepaid expenses Prepaid expenses Increase (Decrease) in Income Taxes Receivable Income taxes receivable Income taxes receivable Increase (Decrease) in Other Operating Assets Other assets Other assets Increase (Decrease) in Other Operating Assets, Total Increase (Decrease) in Accounts Payable Accounts payable Accounts payable Increase (Decrease) in Accounts Payable, Total Increase (Decrease) in Accrued Liabilities Accrued liabilities Accrued liabilities Increase (Decrease) in Accrued Liabilities, Total Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash provided by (used in) continuing activities Cash used in continuing activities Cash Provided by (Used in) Operating Activities, Discontinued Operations Cash used in discontinued activities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Cash flows from investing activities Payments to Acquire Marketable Securities Purchase of trading securities Purchase of trading securities Payments to Acquire Marketable Securities, Total Proceeds from Sale and Maturity of Marketable Securities Sales proceeds of trading securities Proceeds from Sale and Maturity of Marketable Securities, Total Payments to Acquire Machinery and Equipment Purchase of equipment Purchase of equipment Net Cash Provided by (Used in) Investing Activities, Continuing Operations Cash used in continuing activities Cash used in continuing activities Cash Provided by (Used in) Investing Activities, Discontinued Operations Cash used in discontinued activities Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities Proceeds from Notes Payable Proceeds from notes payable Proceeds from Notes Payable, Total Repayments of Notes Payable Principal payments on notes payable Principal payments on notes payable Principal payments on notes payable Repayments of Long-term Capital Lease Obligations Payments on capital lease Payments on capital lease Proceeds from (Payments to) Noncontrolling Interests, Total Contributions from, and distributions to, noncontrolling interest, net Proceeds from (Payments to) Noncontrolling Interests, Total Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash provided by continuing activities Cash provided by (used in) continuing activities Cash Provided by (Used in) Financing Activities, Discontinued Operations Cash used in discontinued activities Net Cash Provided by (Used in) Financing Activities Net cash provided by (used in) financing activities Effect of Exchange Rate on Cash and Cash Equivalents Effect of exchange rate changes on cash Effect of Exchange Rate on Cash and Cash Equivalents, Total Cash and Cash Equivalents, Period Increase (Decrease) Net decrease in cash and cash equivalents Net decrease in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental cash flow disclosures Interest Paid Interest Interest Paid, Total Income Taxes Paid, Net Income taxes Income Taxes Paid, Net, Total Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Non cash investing and financing activities: Investments available-for-sale, non cash. Investments Available-For-Sale, Non Cash Investments available-for-sale Accumulated other comprehensive income, non cash. Accumulated Other Comprehensive Income, Non Cash Accumulated other comprehensive income Deferred tax liabilities, non cash. Deferred Tax Liabilities, Non Cash Deferred tax liabilities Equipment from capital lease (discontinued operations), non cash. Equipment from Capital Lease (Discontinued Operations), Non Cash Equipment from capital lease (discontinued operations) Capital Lease Obligations Incurred Capital lease obligation (discontinued operations) General [Abstract] Business Description and Basis of Presentation [Text Block] General Basis Of Presentation [Abstract] Basis of Presentation and Significant Accounting Policies [Text Block] Basis Of Presentation Reorganization of Segments and Reclassification. Reorganization Of Segments And Reclassification [Abstract] Reorganization of segments and reclassification. Reorganization of Segments and Reclassification [Text Block] Reorganization Of Segments And Reclassification Cash And Cash Equivalents [Abstract] Cash and Cash Equivalents Disclosure [Text Block] Cash And Cash Equivalents Investments In Available-For-Sale And Trading Securities [Abstract] Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Investments In Available-For-Sale And Trading Securities Investment in real estate and notes payable. Investment In Real Estate And Notes Payable [Abstract] Investment in real estates and notes payable. Investment in Real Estates and Notes Payable [Text Block] Investment In Real Estate And Notes Payable Inventories [Abstract] Inventory Disclosure [Text Block] Inventories Use of estimates. Use Of Estimates [Abstract] Usage of estimates. Usage of Estimates [Text Block] Use Of Estimates Discontinued Operations [Abstract] Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Discontinued Operations Earnings Per Share [Text Block] Net Loss Per Share Stock Based Compensation [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock Based Compensation Fair Value Of Financial Instruments [Abstract] Fair Value Disclosures [Text Block] Fair Value Of Financial Instruments Foreign Currency Translation [Abstract] Foreign Currency Disclosure [Text Block] Foreign Currency Translation Revenue Recognition [Abstract] Revenue recognition. Revenue Recognition [TextBlock] Revenue Recognition Noncontrolling Interest [Abstract] Noncontrolling interest. Noncontrolling Interest [Text Block] Noncontrolling Interest Comprehensive Loss And Accumulated Other Comprehensive Income [Abstract] Comprehensive Income (Loss) Note [Text Block] Comprehensive Loss And Accumulated Other Comprehensive Income Contingencies [Abstract] Commitments and Contingencies Disclosure [Text Block] Contingencies Industry Segments And Geographic Information [Abstract] Segment Reporting Disclosure [Text Block] Industry Segments And Geographic Information EX-101.PRE 12 dyii-20120229_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R9.htm IDEA: XBRL DOCUMENT

Cash And Cash Equivalents	6 Months Ended
Cash And Cash Equivalents	Feb. 29, 2012
Cash And Cash Equivalents [Abstract]
Cash And Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.

- Definition

The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9, 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 6.H.3)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13728-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section H

-Subsection 3

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

EXCEL 15 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Q-C`X,S-D-E\W-3-F7S1E.35?868P,%\V9&1A M9F,R8S`S.6,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E;W)G86YI>F%T:6]N7T]F7U-E9VUE;G1S7T%N9#PO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-A#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E5S95]/9E]%#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K7T)A#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D9A:7)?5F%L=65?3V9?1FEN86YC M:6%L7TEN#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D9O#I7;W)K#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H M965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^9F%L'0^1F5B M(#(Y+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!#;VUM;VX@ M4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T* M("`@("`@("`\=&0@8VQA"!R96-E:79A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XX-C@L,C0Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYB3H\+W-TF5D M+"!N;VYE(&ES'0^)FYB'0^)FYB6YA8W$@3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Q-C`X,S-D-E\W-3-F7S1E.35?868P,%\V9&1A9F,R8S`S M.6,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,38P.#,S9#9?-S4S M9E\T93DU7V%F,#!?-F1D869C,F,P,SEC+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\Q-C`X,S-D-E\W-3-F7S1E.35?868P,%\V9&1A9F,R8S`S.6,-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,38P.#,S9#9?-S4S9E\T93DU M7V%F,#!?-F1D869C,F,P,SEC+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S&5S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M/B0@*#`N,#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,3`L M,#DX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S6UE;G1S(&]N M(&-A<&ET86P@;&5A'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2`H=7-E9"!I;BD@8V]N=&EN=6EN9R!A8W1I=FET:65S/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#DL-#8S/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S"!L:6%B:6QI=&EE M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\Q-C`X,S-D-E\W-3-F7S1E.35?868P,%\V9&1A9F,R8S`S.6,-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,38P.#,S9#9?-S4S9E\T93DU M7V%F,#!?-F1D869C,F,P,SEC+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/&1I=CX@/&9O;G0@F4],T0R/@T*/"]F;VYT M/@T*/&1I=CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W M(%)O;6%N.R<@8VQA6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)VUA#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE'0M M:6YD96YT.B`S,G!X.R!M87)G:6XM8F]T=&]M.B`P<'@[)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA2!T:')O=6=H(&ET2`R."P@,C`Q,3L@86YD M("@R*2!I;G9E2!S96-U2`R."P@,C`Q,2`H2!I7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)VUA#LG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)VUA#L@=&5X="UI M;F1E;G0Z(#,R<'@[(&UA#LG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE2!A8V-E<'1E9"!A8V-O=6YT M:6YG('!R:6YC:7!L97,@9F]R(&EN=&5R:6T@9FEN86YC:6%L(&EN9F]R;6%T M:6]N(&%N9"!W:71H('1H92!I;G-T2P@ M=&AE>2!D;R!N;W0@:6YC;'5D92!A;&P@;V8@=&AE(&EN9F]R;6%T:6]N(&%N M9"!F;V]T;F]T97,@2!O9B!T:&4@0V]M<&%N>2=S(&5X M<&5N&EM871E;'D@ M)#$N-2!M:6QL:6]N(&%N9"`D,2XS(&UI;&QI;VX@9F]R('1H92!T:')E92!M M;VYT:',@96YD960@1F5B"!M;VYT:',@96YD960@1F5B2!B92!E>'!E8W1E9"!F;W(@=&AE M('EE87(@96YD:6YG($%U9W5S="`S,2P@,C`Q,BX@/"]F;VYT/CPO<#X\+V1I M=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\Q-C`X,S-D-E\W-3-F7S1E.35?868P,%\V9&1A9F,R8S`S.6,-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,38P.#,S9#9?-S4S9E\T93DU M7V%F,#!?-F1D869C,F,P,SEC+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%RF%T M:6]N($]F(%-E9VUE;G1S($%N9"!296-L87-S:69I8V%T:6]N/&)R/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/&1I=CX@ M/&9O;G0@F4],T0R/@T*/"]F;VYT/@T*/&1I=CX-"@T*/'`@ M#L@;6%R9VEN+6)O='1O;3H@,'!X M.R<^/&9O;G0@F4],T0R/CQB/E)E;W)G86YI>F%T:6]N(&]F M(%-E9VUE;G1S(&%N9"!296-L87-S:69I8V%T:6]N(#PO8CX\+V9O;G0^/"]P M/@T*#0H\<"!S='EL93TS1"=M87)G:6XM=&]P.B`V<'@[('1E>'0M:6YD96YT M.B`S,G!X.R!M87)G:6XM8F]T=&]M.B`P<'@[)SX\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA65A2!A="!T:&4@<')E&-E<'0@9F]R($1Y M;F%C<2!(=6%I($)E:2!(96%L=&AC87)E+"!);F,N("@B1'EN86-Q+4AU86D@ M0F5I(BD@86YD(%-I;F\@0F]N9"!);F,N($QI;6ET960@*")3:6YO($)O;F0B M*2P@=VAI8V@@87)E(&YO=R!S:&]W;B!A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)VUA M#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE'0M:6YD96YT.B`S,G!X.R!M87)G:6XM8F]T=&]M.B`P<'@[)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA M&EM871E'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA3H@5&EM97,@3F5W(%)O;6%N.R<@ M8VQA3H@5&EM97,@3F5W(%)O;6%N M.R<@8VQA6QE/3-$)VUA#L@=&5X M="UI;F1E;G0Z(#,R<'@[(&UA#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE2!D M96-L:6YE(&EN(&9A:7(@=F%L=64@=&AA="!I2!A;F0@#L@=&5X="UI;F1E;G0Z(#,R<'@[(&UA#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE2!S96-U"!M;VYT:',@96YD960@1F5B2!H860@82!N M970@;&]S'1087)T7S$V,#@S,V0V7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%B;&4@6T%B'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA#L@;6%R9VEN M+6)O='1O;3H@,'!X.R<^/&9O;G0@F4],T0R/DEN($UA2!H87,@<&%I9"!D;W=N("0S,BPP.3`@86YD("0S,2PV M-3$@9'5R:6YG('1H92!S:7@@;6]N=&AS(&5N9&5D($9E8G)U87)Y(#(Y+"`R M,#$R(&%N9"!&96)R=6%R>2`R."P@,C`Q,2P@'!E;G-E(&%S65A2`R.2P@,C`Q,B!A;F0@1F5B65A"!M;VYT:',@96YD960@ M1F5B2!B;W)R;W=E9"`D,3$V+#,S.2!A;F0@)#8U+#`P M,"!A2!I M;G-T86QL;65N=',L(')E2P@86YD(&%R92!S96-U2X@5&AE($-O;7!A;GD@:&%S('!A:60@9&]W;B`D,C@L-C@S M(&1U2`R.2P@,C`Q M,BP@86YD('1H92!C=7)R96YT(&%N9"!L;VYG+71E6%B;&4@87,@;V8@1F5B2X@/"]F;VYT/CPO M<#X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Q-C`X,S-D-E\W-3-F7S1E.35?868P,%\V9&1A9F,R8S`S M.6,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,38P.#,S9#9?-S4S M9E\T93DU7V%F,#!?-F1D869C,F,P,SEC+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=CX@/'`@#L@;6%R9VEN+6)O='1O;3H@,'!X.R<^/&9O;G0@ MF4],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE6QE/3-$)VUA#L@=&5X="UI;F1E;G0Z(#,R<'@[ M(&UA#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q-C`X,S-D M-E\W-3-F7S1E.35?868P,%\V9&1A9F,R8S`S.6,-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,38P.#,S9#9?-S4S9E\T93DU7V%F,#!?-F1D869C M,F,P,SEC+U=O'0O:'1M;#L@8VAA'0^/&1I=CX@/&9O;G0@3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA#L@ M;6%R9VEN+6)O='1O;3H@,'!X.R<^/&9O;G0@F4],T0R/E1H M92!P2!A M8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA6QE/3-$)VUA#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE#L@;6%R9VEN+6)O='1O;3H@ M,'!X.R<^/&9O;G0@F4],T0R/E5N9&5R($%30R!4;W!I8R`S M-C`M,3`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`R.2P@,C`Q,B!A;F0@1F5B&-L=61E('1H97-E(&)U6QE M/3-$)VUA#L@9F]N M="US:7IE.B`Q<'@[)SXF;F)S<#L\+W`^#0H-"CQP('-T>6QE/3-$)VUA#L@;6%R9VEN+6)O='1O;3H@,'!X.R<^/&9O;G0@#L@9F]N="US:7IE.B`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`C,#`P,#`P(#%P>"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;3X-"@T*/'`@3H@5&EM97,@3F5W(%)O;6%N.R<@ M8VQAF4],T0Q/B9N8G-P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X@/"]T9#X-"CQT9"!V M86QI9VX],T1B;W1T;VT^(#PO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B`\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!C;&%SF4],T0Q/B9N8G-P M.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X@/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT^(#PO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M/B`\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!C;&%S6QE/3-$)W1E>'0M M:6YD96YT.B`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`@3H@5&EM97,@3F5W(%)O;6%N.R<@ M8VQAF4],T0Q/B9N8G-P.R9N8G-P.SPO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R<@8VQAF4],T0R/C0V+#4X,#PO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@F4],T0R/B9N8G-P.R9N8G-P.SPO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!C;&%S3H@5&EM97,@3F5W(%)O;6%N.R<@8VQAF4],T0Q/B9N8G-P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R<@8VQAF4],T0R/C0V+#4X M,#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`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`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`C,#`P,#`P(#%P>"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;3X-"@T*/'`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`C,#`P,#`P(#%P>"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;3X-"@T*/'`@6QE/3-$)V)O6QE/3-$)V)O"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D/B9N8G-P.SPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B9N8G-P.SPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*#0H\<"!S='EL93TS1"=B;W)D97(M=&]P.B`C,#`P,#`P M(#%P>"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;3X-"@T*/'`@6QE/3-$)V)O6QE/3-$)W1E>'0M:6YD96YT M.B`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`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`C,#`P,#`P(#%P>"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;3X-"@T*/'`@6QE/3-$)V)O6QE/3-$)V)O"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D/B9N8G-P.SPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M/B9N8G-P.SPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*#0H\<"!S='EL93TS1"=B;W)D97(M=&]P.B`C,#`P,#`P(#%P M>"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;3X-"@T*/'`@6QE/3-$)V)O6QE/3-$)W1E>'0M:6YD96YT.B`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htm IDEA: XBRL DOCUMENT v2.4.0.6

Reorganization Of Segments And Reclassification
6 Months Ended

Feb. 29, 2012

Reorganization Of Segments And Reclassification [Abstract]

Reorganization Of Segments And Reclassification

Reorganization of Segments and Reclassification

The Industry Segment "U.S. Division" comprises of the Company's Pasadena facility. In the prior year it was classified as discontinued operations in the consolidated financial statements. The Company at the present time has the U.S. Division and the Corporate Division. Certain previously reported financial information has been reclassified to conform to the current year's presentation. The impact of such reclassification was not significant to the prior year's overall presentation, except for (1) presenting the Pasadena facility as continuing operations under U.S. Division, which was presented in the prior year as discontinued operations, and (2) the presentation of the various subsidiaries (except for Dynacq Huai Bei Healthcare, Inc. ("Dynacq-Huai Bei") and Sino Bond Inc. Limited ("Sino Bond"), which are now shown as part of the Corporate Division) in China as discontinued operations under the Corporate Division, which in the previous year was shown as part of continuing operations under the China Division.

X

- Details

Name: dyii_ReorganizationOfSegmentsAndReclassificationAbstract

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Reorganization of segments and reclassification.

+ References

No definition available.

+ Details

Name: dyii_ReorganizationOfSegmentsAndReclassificationTextBlock

Namespace Prefix: dyii_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 17 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6

Consolidated Balance Sheets (USD $)

Feb. 29, 2012

Aug. 31, 2011

Assets

Cash and cash equivalents $ 15,842,467 $ 24,315,160

Accounts receivable, net of contractual allowances of approximately $187,059,000 and $188,513,000 at February 29, 2012 and August 31, 2011, respectively 500,824 1,192,279

Inventories 474,109 550,441

Trading securities 1,424,399 1,471,644

Interest receivable 178,874 192,366

Prepaid expenses 198,121 272,414

Income tax receivable 2,363,724 2,363,724

Assets of discontinued operations 6,651,726 6,909,527

Total current assets 27,634,244 37,267,555

Investments available-for-sale 18,281,129 18,722,274

Investment in real estate, net 1,915,218 1,941,041

Property and equipment, net 7,038,699 7,168,864

Income tax receivable 868,249 868,249

Deferred tax asset 612,216

Other assets 249,695 255,517

Total assets 56,599,450 66,223,500

Liabilities and stockholders' equity

Accounts payable 1,974,753 2,346,720

Accrued liabilities 13,691,664 18,430,553

Current portion of notes payable 121,543 97,918

Current portion of capital lease obligations 97,794 94,044

Liabilities of discontinued operations 615,598 604,302

Total current liabilities 16,501,352 21,573,537

Non-current liabilities:

Long-term portion of notes payable 1,125,903 1,093,961

Long-term portion of capital lease obligations 139,308 189,161

Total liabilities 17,766,563 22,856,659

Commitments and contingencies

Equity:

Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding

Common stock, $.001 par value; 100,000,000 shares authorized, 14,543,626 and 14,426,960 shares issued at February 29, 2012 and August 31, 2011 14,544 14,427

Additional paid-in capital 10,047,320 9,780,837

Accumulated other comprehensive income 6,326,320 7,453,676

Retained earnings 22,314,605 26,054,284

Total Dynacq stockholders' equity 38,702,789 43,303,224

Non-controlling interest 130,098 63,617

Total equity 38,832,887 43,366,841

Total liabilities and equity $ 56,599,450 $ 66,223,500

X

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 14, 17, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS115-1/124-1

-Paragraph 15D

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e681-108580

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 12

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Topic 210

-SubTopic 10

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

-Section S99

-Name Accounting Standards Codification

-Publisher FASB

-Paragraph 1

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Concepts (CON)

-Number 6

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6801-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Section 45

-SubTopic 10

-Topic 210

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

-Publisher FASB

-Name Accounting Standards Codification

-Paragraph 1

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The aggregate value (measured at the lower of net carrying value or fair value less cost of disposal) for current assets (assets with expected useful life shorter than one year or one operating cycle, whichever is longer) of a disposal group, including a component of the entity (discontinued operation), to be sold or that has subsequently been disposed of through sale, as of the financial statement date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 46

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1107-107759

+ Details

Name: us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Investments in debt and equity securities which are categorized neither as held-to-maturity nor trading and which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Such securities are reported at fair value; unrealized gains (losses) related to Available-for-sale Securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the Available-for-sale security is designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain (loss) of an Available-for-sale security that is designated as being hedged in a fair value hedge is recognized in earnings during the period of the hedge, as are other than temporary declines in fair value below the cost basis for investments in equity securities and debt securities that an entity intends to sell or it is more likely than not that it will be required to sell before the recovery of its amortized cost basis. Other than temporary declines in fair value below the cost basis for debt securities categorized as Available-for-sale that an entity does not intend to sell and for which it is not more likely than not that the entity will be required to sell before the recovery of its amortized cost basis are bifurcated into credit losses and losses related to all other factors. Other than temporary declines in fair value below cost basis related to credit losses are recognized in earnings, and losses related to all other factors are recognized in other comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26626-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS115-1/124-1

-Paragraph 15C

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 115

-Paragraph 12

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS115-1/124-1

-Paragraph 15D

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 115

-Paragraph 17

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Available-for-Sale Securities

-URI http://asc.fasb.org/extlink&oid=6505594

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS115-1/124-1

-Paragraph 15E

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_AvailableForSaleSecuritiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid within one year (or one operating cycle, if longer) of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 13

-Paragraph 7, 10, 13

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 13

-Paragraph 7, 10, 13

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

+ Details

Name: us-gaap_CapitalLeaseObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 17

-Article 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 19

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 25

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),19)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14326-108349

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The noncurrent portion as of the balance sheet date of the aggregate carrying amount of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after the valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, is classified according to the expected reversal date of the temporary difference.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31928-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 41, 42, 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31958-109318

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31917-109318

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31931-109318

+ Details

Name: us-gaap_DeferredTaxAssetsNetNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 5

-Subparagraph c

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.10)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3(a)(4))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 10

-Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Section Appendix E

-Paragraph 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.5(c))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_IncomeTaxesReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Section Appendix E

-Paragraph 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 5

-Subparagraph c

+ Details

Name: us-gaap_IncomeTaxesReceivableNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.8)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InterestReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 25

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesAndStockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Carrying value as of the balance sheet date of current obligations (due less than one year or one operating cycle, if longer) arising from the sale, disposal or planned sale in the near future (generally within one year) of a disposal group, including a component of the entity (discontinued operation).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 46

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1107-107759

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

+ Details

Name: us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 27

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 20

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Name Accounting Research Bulletin (ARB)

-Publisher AICPA

-Number 51

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_NotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 02

-Paragraph 29

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 10

-Section 05

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5879-108316

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 4

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Assets

-URI http://asc.fasb.org/extlink&oid=6509628

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6787-107765

+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 12

-Paragraph 5

-Subparagraph b, c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The net book value of real estate property held for investment purposes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.1(d))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_RealEstateInvestmentPropertyNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4568740-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4I

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4590271-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Name Accounting Research Bulletin (ARB)

-Publisher AICPA

-Number 51

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4568447-111683

+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Financial instruments that are bought and held principally for the purpose of selling them in the near term (thus held for only a short period of time, usually less than one year or the normal operating cycle, whichever is longer) or for debt and equity securities formerly categorized as available-for-sale or held-to-maturity which the entity held as of the date it opted to account for such securities at fair value. An enterprise may also categorize such a security as trading without the intent to sell it in the near term assuming the decision to categorize the security as trading occurred at acquisition.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26610-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 115

-Paragraph 12

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 115

-Paragraph 13

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Trading Securities

-URI http://asc.fasb.org/extlink&oid=6526789

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.2)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Implementation Guide (Q and A)

-Number FAS115

-Paragraph 35

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26626-111562

+ Details

Name: us-gaap_TradingSecuritiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 18 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6

General
6 Months Ended

Feb. 29, 2012

General [Abstract]

General

General

Dynacq Healthcare, Inc., a Nevada corporation (the "Company"), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its subsidiaries in China and Hong Kong also (1) provided healthcare management services to a hospital in China until February 28, 2011; and (2) invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings. The Company through its United States subsidiaries (1) owns and operates one general acute care hospital in Pasadena, Texas, and (2) owns one general acute care hospital in Garland, Texas, which was closed on September 30, 2011, and accordingly this business is classified as "Discontinued Operations" for the six months ended February 29, 2012 and February 28, 2011 (see Note below on Discontinued Operations). The Company is currently composed of two divisions: U.S. and Corporate.

X

- Details

Name: us-gaap_BusinessCombinationDescriptionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).

+ References

No definition available.

+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

ZIP 19 0001193125-12-162577-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-12-162577-xbrl.zip M4$L#!!0````(`(>`C4![*8+S?(```"9?!P`1`!P`9'EI:2TR,#$R,#(R.2YX M;6Q55`D``[V&B$^]AHA/=7@+``$$)0X```0Y`0``[#UK<]LVMM\[T_^`U2;; M9(:21>IAR4VZX]A)X]O$;FUWNOLI0Y&0A(8B58"TK?[Z>\X!P(=>B1PGD3;* M3!(+!`[.^P'*!\_^?3>)V`V72B3Q\YK;:-88CX,D%/'H>2U3=5\%0M3^_=/W MWSW[1[W^GQ>7;UB8!-F$QRD+)/=3'K);D8[9B4R4&@K)V6#&+L4-3]E5,DQO M?1@Q\%FGX3;<=J?19.,TG1X='-S>WC8DSE5F:B-()O6ZV>V%KP`ZK*-MO8:; M/SDQ.R?Q$6L?N*T#K^EZK'?4:AXU.^SXK9YX-Y`1`_IB];Q6VA"'&XDHI.VYA^N@ MZQEV`6C"R/>G^8*AKP8TV3Q8AK\2R_@"T-V#_[Q]\HG4WY\YH2DVF$U-+86/+A\QK27+?$->Y46&,'&A`J21*G_`[4 MD`.U;N+X3OOG==[AP1H)&`.:+=(9^83?!8AC@P%EXR0 MXQ7*K!Q/SGZI_=2$/[U^L]_L/3LHEEG`!Q7(SZ91V;9I MXZ?([#23/MK@.]=[IXE[=YULD0R!)IF>0DC1M*(@@=9B-)_(X]!.RX5MQSZ1 M)4W#DBUQ1166-#^.);G/^D26]'>!(\W^Y^>(]@CM=VYK.^RDZNO:=;?UR1ZA MOPL.X:-D?0^'`%G*[[%82%$R'$,NX4.WE7,C%#=`2;$YSCN'7!Q8FGSP[L8+[\8/EZ`GO*XV0BXE6`*3D]4F-(V=4JR(L@GAV4 M*-"3EA%C8W@0XL-7 MD3]B1L27F*%^2,^'?J3XLX,%(`7LDTQ*'!0J\*/_&Y0V7T^@C$T-7JBK92%/!`3,(+GM;/S5T!ON]-N=;UN M!9)W(P/5X`%K&67?)K(%.F`?:=^/"NC4@$_O__WR^,WUZY/CRY?L[/RDO'$5MMD9JM^CXP#4(HOP M..0B'0-R@+3D8QXK<64Y03-:[W4[O\!`0 MW`R%A\=[CI$?P-OMN5ZG^REHGX`"COBK1.(CP$LF402Z<@88@F*F5W[$C^/P M3*D,3S4NAJ2UQ[>^##=R9A^BHXM_#!V?@%*)L%,^Y!`6PFO_[HWP!R(2J>#J M,ZA.J]/K=)H&][6[/@AVFS&V?]CI]S?$[>5?F9A2N)')Y,2?BM2/WD!ZP4\A M_`!F(LY`PZ90?I^R)2H^=D7\9M$J8L85DP3Y4<7PZ5KSWEZ M,03>0,1[X2L1@(Z=BB@#:R(G_0GTM<)_/^K/_,'$;\&8EY$ M$!$VRE?^%:4_0BWWKU'Z(\.?A["6J70604&./]>'_D1$LR-V+29G=C\R,#)(T329'K`EC!/:!L$,P`_RAX"H3,4.^,LU8!@DI(\XRPUKB MS,'`+L])HP_3#]+51;)0(G41X_G%$6MY7X#2LYB]]64P9NBT'`:9D4V$V32# M<7HIY\?,G_HRY\/K!/+E7_`?7^%#47!IF$CVR'.:;MOQFH<-=CT6JK3X%A9D M!!)&F>)!)B'=96G"DD$*1H'0W%Y]!D4H-6/#:!X*N./Q#R=3`C]^SBR%D!8#N)=H2FT90I#8;AX\94.DU^H_9@`,8 M`E?PY!0R,D!_@!M&7!=)M/%?68*O,0M4`D_28I[:.6ZW0[+@N!]8`9 MHJ+$'2,>*`;X`HJ+N^#*8K1'HZ[#`+>I1C6:.30)X07ZR($^1\"2.A`Q851H M01:"/,=9,7`#<-3&X]/PDGW!"3_JMIV6V]?8NTZSTW=:7K.Z>8.=?W9`UAZW6< MGM=>#OR^7&^P^_@7U_MJ#N8\N>&3`1@;8D\T7?%IF@_-N9U!(B68)HK:[3JM MEI%[M^,TFTW4DYB\KE6<=9X`#8;<4]F(0,W:CI`"%^@+7';*TY@RIT>ZW-3/@^YJD^SCX[AXX'_-%RZCJ=7FO>.%=H M+/U4SBSL!Y,G;9C4+$V'U/&-+R*U".WP=/&`D63QOVZ>1FZ625B\RR<3=31\I4P*5!_@:N82+BA'(YG0PF M4K$G2\;07XQX#.5-!)YT.IY!42/`1X]DDDT5N9`$C^?8&,P]'00'Y1UHO#L*;KP@$M*+E4V4"(4/BTR;LYZ M6$A3)9T%ZR^AD9\$;YA$(J3T8>!'>*#&U)AS<.`4ARK"M%&FP'7GXNNW+'^V/U<8=) M"VBY_6Z77N]\)K3N%WI?;N;MP\B\-,I>`3#7VL]GOC"FI8 M<2/PN],U**91I#*9XS1`AO(6TYG*#@[C=P%4N53M/W&?VH>V7EL0 M(LK'"`?GE*23@7+**D=MU8H8&L!%6E'2@M4RU]7@$^]I68:YU>$8GIZ!/*I) MTY,25:?TC7/V.O,%>\$%>YUG;`XH9-!@3VIZ2MU.J3W5U3^D%.Q%`C_1M#JRPP.T)/[+(*@-,*0)6%,(7@%5,F5/?:`!WX&26/, MH70$U<:0H+B\$0'/H>`["O2;$U_J>BB)<1H8MZ!"3&512I&X,/`&NRP6&RS^ MUF'60-?%;L@CJ-HD#W7,"3D>MN'W)$NNUI^`6&@[BY`]A,S!8A6;Q+'^,F)Q MEETP)-]4D,O^DRK'I,*)/[.PE$Q!Y03TIER572UZS$SAN22]V;CG4?.7,DNQ MRBQ_U9JPZWI.J0[(">IQH<8H%*&/%"2]CL(@C/HYX2$(."I4P$2PE.;36<4( M?U\OUZXU.OHS3<1UL)V9;\[%QY1RA5E0O,,JU,]JDU5I"KVHU$^H8H<\*P,, M(4M*;O$8Y2GJIB_QMP$QCUQCFV!HYVN>@C1FE*1);A-1;4T0@2.-4H0F'>%1 MBC7"/(,-_\SP(,5FBOJKVSF;D+\&\5#0B\"8#"S.J0TK?DB&VE!U`J:!:5LS M4`)]G$NX:!^R_>9U4A+?L17?[EL6.OD,C0@-:*F*LH']A534YT+B)?GA0UP_ M*AM-0%_0FZN5*MOEMH)6Y+\W9X1@#X$VF?(.H%<DEQR-3;71:Y9SB#:,UO6D:1XFR$(J=.@@$1/F.0^DK6(IV]7<>-\WI4?WLJ_F"E5DI':H4.9M MJM9-?S+],1ZHZ1+PAGZ]Q0#]@ZPCD_VI`ACV)]!8_0P/I%C`P65#74J_DFT^ M3_TPM)]O19B.G]?ZWN,:,`VB^_-:@.6?+*72J;3DIJ%=T.D\KA6E11J69H=0 MZVE(FMQ\DS5+'FI\O_47VEK_*%[Z$[=99I?L;+UY&X*_N,WJMJ: MM=Y_-ND/H"VEOP1ZJ']R74PR8;!6F0B]!3R0YP`J8E7UUG=LBHOY;4>O-2 M<_=2VWZI[6UM%Z6F;6V%E*PP'QJ/K3#I)<&;#48@D`3*OG\&`>?#8;Y7"0NH M2$UA-U>Q5HY/ZBZ?Y#5KQ(7CR\Y(SCD5BIY^)JP]C?)_&@4>;[FUM M3(K1.'U(3%I.M^\YG69K8XSBY%9B8R_]_X,>&#ZTL#ZS(_Y?T86VT^^T'>^P ML]>%;UX7>LYAN^MTW=Y>%[YY77";3M]K@T+L:I!8DC%M]O5+LE<*BU''Z+ M*?9*85'J0NCH.JZ[J\75DARJLKOY,D/Y>S;+1?PQ+['7(O?AI0L9G#G@I.]D M+#G=7*(RFR17GW&[)5,WXMQ7)V#/KSV_O@5^+7./.W4HC]^,-5^I^[9*S>TY M9^EW(4EPNSN:(.Q^UK@]FN`ZW5[/Z;F[>N"VUX6'P\0#/4!]V%>3>UUH.VZK MYW2]77TK\S]71+8@BPR3;!#Q+Y.UWG._+4KS]QS;^K\3? M\L)O!/JC;ZR>W,*SY\/V%N4+C[^%E'$+E:"[30<+>R7X2DJP397#7@F^DA)L MT[<5/D()]E7CEN6G^XQ^S[$]Q[:-8R4WJ7_$EA%+L=F&9O['E7Y21=LJ[&`? M%^\B\XY9U!'XFM_YBMTF\CV7Z@=JA<)CI1M@P49B4NE`-<)NBG'18DAFD6D7 M(OD([V\K]ZC7H$]Y?J,#C/]A-SHI;_2D=GWZQXEI0(A+E^-3ZCH-].`\O<2NLX5*R98X_9+^^ELEN70[Q*I"70ET)ASQC=/,FTV123J;Z&-6^7MIQ)5E:Z M?WA&+,\Y8U1,Q+:'E)F4MY3*@,9*_RP4/Q?4AEQR,1ED$CL!3>&_K-0#]#C( M0.HG./DLKO]JH+VV6O**<_9S)K"W5DS=N?$R"E8;^D(:=?95$J.YU_3%%-CW MINCB%AN;H*MB`-0H!R5T5U)_.HT`;5C?8%=X53%R3]_EXV+[FV;/*=G(,GI1[>.GN9+IEGE9Z)'MFNZA.$FJKCD=6$;;S2J:IZ7%47*'SEKJCR?D= ML)D1N!.:/`3#2:3Z$4S\%@Q5@K)H_S+Q[\0DFY@#,FSFLP#$=`E-`AYFDI?: M)(&+1#&!S8)N!?KF298I@_HB!^(YV"#F$N7819L^BDA2Q?X2E]I=L?ZIN=P-6"#?%R8V&\%4@*[.(6+EZO4G2*]0/L M<8N"6ANZ<#O=1G=L&@5/_!`;5LVH9RY>DRXH6F!W?+)H;/XUI)N.TT1?$DJ- MAPE2`VQ.KFU2B91_$"%]L59QC(N>L&A/!C0IPC;D`>H0>C7J>BFBF5ZI(S>N MTERL"J/H.[@YE# MYJX*[:I@II!A'9.$&=ZD@YX%H&EG]%+@BF'#L:#&\#9?_GQ[H96K-YB.M+MS#9T%"H?Z@[:H,ZXM;#+++J M2K@)T^>XW)9N!/J;7SX$8JK3Y1-:!Z?FUK,!![PT85=T:=[%<(@:#<".0_!K M=,G7W)>DG$]J5Q?'K['_L^Y\1^J3*$&S(!>D28`;ID&LWWQL>[2:+*)H MADW-&ZN;5'JO:@=`S`EQB@BP\5XF4[H?@-J69]-Q$A$AF/[1;1<`O]HE&YNC M8_A$X\&`K"4ZQQ23PNDYD&%J];"WDH@8,A!Z^Q)@1TRP*NU5DM+-66Y+AW2M M$:A5(+Q,]Y\^)IB5:$%I)G()"QC-BB)]M;UE\\0&YN*='8:3F:)70MB?+P,: MJ"6NGX74HMO\WK^&&)=3*N"TTNVS$<-\KPF`(->8Q.!AT`7A;A''OH&/VDV\ MTLMA`TC8J",%<@`C)4VEC-AYF4(E;;)%K[ MOT4P"_@"WY:A>TN.AJ0"+BG42F0R4+0'7(>N04L2\:P/9G7"=Z&A\'JT)IRG M)N[2I>H8A1R03L`-;X9"]]`U-592GCB7CC78<35DK%'.9`IP43TH/*[P%R`( MHG;L`T],B_^"'[DSA!Q*HXM7@1``6J"S+5IT(SC>(`?<0F&'1;D$)4$=>`%[ M6:+F9RS'7WL+0F[.<[WQ;ZFQ,E\TP#Q#!:L'IRWQ'D((J^9V`9,[YC0(E5/H M%!RA.Q`B!R\;JFOG05F?U>'="JC'0%>J.S3[ZKV-'CJGNH=G##F_$0)H$2:WDQ1[JG$.6#R@!NAK95UB[O5R]'Z8VWL(8VARD,9"D-?W M5D3473BT=TD(F^U:R<[9@-XKBVU0@/J4;G7*UVDEH6.`D$]Y;$H""(,SO&5T ME(YG-G-HL#\P#8U,S8J0V(1*W*STPT M*\Q@V3A>F![KY`,P`Z\BE`/(Z=-WAF'39"*@2J532C5PFL^P6Z[$9+I(NX8@ M1_5!MN;%\/`IYO2ACK$?TS!V=3_:K]$M62;9:%SJ MJDN72"YF*]K[0H0&R>A*@FZJI!"NJQS3+=C:C#FFD72E&T55LDCTKHZ^8]?> M+.;0H1IZSSO;RMOM-:V6Z+2`W&1ERB/791.L=K3=Z?2++LDA;ZP#5:%L=%=, MA1:3:E-[;ZUGML&R/],-]*G2,V1A>986'I^"Q%)2==X/"F_*7^W/=>%GL_L< M#$4Z<%PF!P+OPO%V&Q.G#6/-+3!QV,-#MPJ4+G9$RL?%1E$4.4%M`IXOH(5,@>U50K$>/)B64Z M[IM-YV3<:AQ:(:,F!%$6ZN-#;J\Y*&F1]0XZG7B`-.K_V?O6YL9M9.WO6[7_ M@>5-3CQ5M,.+>)M-4N6Y);,G.YX3.V??\VF*$B&+&XI4>+''^^O?;@"\290L MV[)%6KVU2229!!J-!WU#H]%MW:VQ1CGTZBMO\:GS29Z4-^*V=10(=W1WN`V! M(*TB89DH'R__GHF2X2)>`E$[B,Y;%(T79?Z.@C^H.`/ MA_NR`N&@S$)@-[^6NW0!.6(;;.7_E-/%>2S`L(*#,I@MX(6O\5^B\`^<6HQR M2WA(_)HC"]SN?Z`V12705D\XG);Z4H6>XG%[WC;&UB0S@X";'^B9R&'P/0?1 M77LB2B([D!@W&_K&:2(1E^%F-*Y&GBJGL#TK(D306GCES59R/8NFQ.OEK,HG MZV;X.`"X5REJ8IA%,-;]F(F(F&RP9:I4=K]8WI4)/N7F=&.99#M?)_\KD7*[ M)&F70^_O6N+UO!:O:*2!0YXV1/6R#.R`6V.*QR4'T8P\+]VBA@%Y!80*N9\L M\)HRO%Z0\[&\?H)7^,?1QY/'>HMK^-3&:;U.I2\;YN6<,[S6MU13_$(J$3JO MC23<60C"3-Q-((2Q7^N1QC243%F&8+5,P);S%\CY@07YWA755:>U=N'/LK MHJF\#_8;Q_'P5NZM6O[93R.Y*<(;KBY$V_(VP5O6-KCJ6KHX*IC4W+4L1@@(/[YRI M0RBE]0@*D.\B(=2,H@:*]O:M0F+!<^]14Z$CK"!:PBIKXPS%B$ MVUO"\I!:B>]+#"OS77@^=K2-HZC,;/#+&-:T]5IMXZ=,[.ZAJ;4B MVD/>O<[I@P^&8(_N>*74:!CQM260=+CE[3@UNLDSH)+QNY?EL@9[+"_$LI'W M<@N;(`)5P$&*T>H$0P9^?%7X5ZQMC53L@06XRJ%R3R!B?B""I?"#V'&&@7GE M2.3#K7`WWFZ#>A=^*Q8S%MT5@H&)/2NN,'ALV/PN%VUM,$8&??BN5SNX),#' MHTB;@Y/M@$]SX$M!_Y+H.@Y2-\,M;D!+S9V87?$8(6IROAV=R=F040\,;=12 MKK5,U#IH7EZU4S8KXN7R5['Z<;`Z"%KIO;T%'*!QCIOB#PF`?5=.H=Q&D"P0 MU-=I!_7>!\K=5HJ"W*X*4]8(YXO032L#1@0*$G[YGKCC?7G'@*U/F^"[D4?U M[@%_\XAA?$*(DS^+:A645Z1A(L`1;^?(G\Q"<,8;F0)H=2GR@G'QT%C*)5_> MKXX6--]7YJ,0$H8/@-]9GPE#`?Z,8[\&X(LE)^+,N*7*][,097AGH%PFR`IY M$^V2/^TO<;6\C[:>`E7!:^%Y/A9:B/P2VK;(K$,D`"Z04KCV5Q->U@HKU/,W M#'=MLHVM;U115>M5;L]2FDKIH3432O(D^4/.S2G>&"LM\76(7956S2@B3^B` M!:`NQU-%*#4K;_FJ[[/SQ\(8=FM8B*MV^$KI`KA@YC MJC:<)-%UERFK-DU74Q%7TFL2I9![SMR^\G-?X2'"5A=''1O#1PB`/U@S,63E M,DK$KQ12RA5+KE)_`<3RJ-7#KT#LF[/8SH>0%_F5M_=)2X+_J9'@HHSJ";C$4HKP*>*R0B=2S/1=JD!/O:F'V8YB*V@&[M M8CD"AFDATR+B-[+C=**1A:J@8W0-"WAIE*@Y<"3"FC.ES#]5SJ"#>1(C\ZK; M.1O.`;;0U5$CW"#NV_27K^\$9FR^3K2O6SS/=:/G6$7EPW*O(UBYV M[*NZ39-+^&')N\G%0]MQ41QF^/)1R".BL@SQ%NZ"^/I@#0N0Y MBD!&LGXXPDI<$WZ3&SV`6\YA:=ETL%7N]HGN>2PC#R.12IK#%./D<.."9R$L M75?+PXX!^"%!P7W.:HAB<[(,3_;\9N*"*^-F_/&\BC\*RHM'R3*ZN_QA`_L8 M*V]G`#MA1V"J4R1/K/!5TCZH\PNWUQOWFV<=]YO7>8MXQSVXU'PM@X@'_VB1 MBRR^:N<*C:-E^Q-$.HSZWTG:B(=UJH$+F`-X_S-+%A&#SJJS$"&7$5QN+/S; MTK#@@;N$_[)R5S*&#X-KL>`_=*J=HCP)L<(D'&;"MSD;_DQMP/&-/']>Y1&+ M,T11N;/JYTO[Y)Y([%P2D^@N<3G5N(6TOE$ZD/>X2[*%T*HC39TM8ISYVH\* MO[%MN]W\\S0F\$;"$S^.42B)R#&?2_^V&27*FYFE);F8O"DZYND>&7?"(O!: M>'8B=+-R*W3;R*V"SU5&%_8D`\SB+PW%S[/`^:-=&3-]`:>;U(%K,J)6DEK;B5V^YCC M.*YV3\2.T(EV(K9I#%WU/'WITNV'7+:-&=OHZ(F(I]P$JKL9J8YEU4OE@3=Z M+W?2\#LP#(S!W'II;;&.FJ&EVD5>9AG.'G?@,1,SS.LL%3$QY0[A.=_@E9H( M)NM]R7#I^\'3F#7#32C$R.D:R.'W\5>9C5%8K+' M`U/Z*'!`(X/DJXQM%&(Q7WP5V/DJ`.3A02`4E2)4+GPG>>X3WEB@@5OK-'$2 M2\2E<07]'O/,*'Z8I$R0X1N(E8`&03#W_V!H54B>\BW*+"OF"VGOH\H0^S&- M98^M832V[@MWT[#4M#B@VS4@WO)D(F0MC@&L\C*3EV<:-@]+2].CCC#7%*[; MUZP.#2>U9;YJ;#25F;0OZH3;E38WN"87(/B/.BS2(Y!U\!#ON MV9EHJ3SS/>%G&8(0.)Q6B;LPEWQW5206U4,O,Q'S50R).%`7X]9<0 M72L>&R+T7PRKN+#@#..\5^Q3@?E[Y],+L'G8>>TOO@a(6!^_"J."G9#;( M5TW*5Y<+VR,%H__\080V?$1\T3CT8T7-J!N M!7C7>$8CTS:Z M[AF&XZT2T]71HTC:FC^6IKG&Z($4I04+?@W%+FS(LEUPR!V9FK4T7]W=/)R: M[<%CVIYNVZ.'4%/,134![F^@ZD_93&2&?N0>QJ])E@%KSZ>7_M?'<,P96:;M MV"T2[]/WK@G?FKFV:<#_M5T17N7H?/;#X&/\UI=E8![.6<]Q-==T&@1V]_%0 M0K:'H::-G#:KMJ*DM!H_).F[I!CGTR):7=X[6;2NI9N:UB3P/GWOENSMV>HZ MFN7MC.PL8WGV&#;:MF&85HL9'/Z=)L?A8QO.:6QC5#L8.&&-[FF<9SC*% M#R'C"8>SO3RW+1VF^@F&@P^G))[L0GPY!IAE3:AL MT>-.:+R'K#)<73>\Q]"(#@!,QV>Q]<[Y#>[`11W^.*L"/7Q[*QQ(.+)'L4+. M8HR+-)D\W(!A*VY6%6RX.^96'R$5X2)YD'6"V4`\L,_CBAT1Q.Y0(\:T>()S M.&_T%_(H9;VG6.WUX(Y\6M2)`[!`YHJNG?P/?^P,:P%&#'[`>?JM*E>H7)S\ M/PR3(8W0OTS*OE6"I'%[]1EMMB=_.8GY@0 M^:D\Z8SG3U<15E7D@%6I#]Q>R$)Q@"YFF/*%&S9B[Y9G;2^:@*WGK]P[`*25'_*3H=:EW=U&B+7<@,'&CB;R\+<,JQXI M(0R8I\MGN0P+3\HZ+.V33I+1(N#;+O_1SA^2A5S*&17!UG21I&*CCA<_0C): M>WI^<,T`.;PRG-CUQ)1*_%;2OWQ&I'76_=2J#KN+G9O7#$^WJ&:=NNT_S MU%CI3%'7]M+&7 M5U4T;7$4![#-.&7&3KD\0KX'+-(6KEE]2D=TP9$HM[ZKLUMEO_Q@H4SW;I-K M;!467PJ%[T*!+YD"6.(01OFN3M&`ECK:'X0!\#*Z>%AJZY.8,3]+43I(P^7= M;>Q/_I1Y'9A0H(*JG)R"5(37K_W`KZ0]+SF,Z_5(:@:L:(=9+4I94DZ:/^7Y M*%%K!4_78>W(,`A!2M29`^U]SP`46)0LRAP9U,P-'341!Y+3.E=&BA1I$(AD M(;%1*#+S>;Y)P(\%87G,K)U#LHDVGNS%R?@%:VK]-_Z+G\4ZUE_5R4Z-!(S& M3FV]@9DTJ]-5K8JLQA7U\'?>W;'Q"@\XL$SL*_-D#5[V%:RC'$]FE!Y+4]&" MEDCS$]P0E>]6^]*\YAETOBC&(-Q04S-1CA#;!/OE9-T#ZUG5GK(6XY`YR4V9 MS,]5#&;EQ&S3)"*9Y6EI6>%"K5C!6]NB`7E*NGI?FA680Q\ELBI-7:C$U$J- M7.YT2_M5''P:2TF_>C+\:$UJYM&CC0/E.`.U^PE,8;DI#02OZ>Q5>VY:"5BX M^,1XISP7#A-B^5'>U\KOIQ>GO.^WI>&V39K.ECO/#U>2;24K@[*_8O6`+LEZJ.(8SQFKWZ9R!-S9'G&G526/6]% MYJZB4)YNZW=2MBZX\Q#:[K$/YIF:^PC:LAFL'/S/^^K,;7:6O_73%$,+_^M' M!=O`.VV+8*]M>2.K2>$67>Z&RJVQ9YBV;CJ.NQ13^1D4(KXX<&2X?I2#0-DS)\)@[8S\*K6805 M.F&(0L3R"/LI>YX8LBG.87OFKH;P6;IY;VY_!XOZ8_Q!!-?B MJS,,X7&L=F[(9;N<%L,T#*,]H@?3=?<0/_)E^F[+D&><_U9WNVH3_1&+%>K-`7N*#YXU[R!I'H->4 MLUJTQOJ*_(=3'%>[& MC$DF(DX.K925,,#S6*`U(I*/Q$DNKH1*L252NA:SVPPE*E!4"MQ%"KY'Q*[J M6CYU;M42#2N7VI7CZR2C49"L(JA5/Y'7\ZPX5.YJ1F%9EE'LR^+>:7[;T1J7 M3IQC33)OFZ;!-$J28$WW0<)$IERU7EUA\SER_:3F@'BP6M$1I@ID MK0NHRBW8>BJO,'N:`Q63XRQH/8,6_\@`QD7WD]/'AZ)"M`)M@<%K7!*]BF M[?HF2W5/ZBHJ9?E8086H1<)O],33YF+MR1JVTOX368](#%=_O&P[H.6JNKT1 MJ^I(O5C7<2W?*./'\I+J1*HM7]X>@T4!^3A!#P8)&B&_E'?H=I:`*:]*Y8D4 MV8S7;88/G,3.!DNG0-SG5;TO+\,15E)9+)TK4.X,55?$(?_9HFGH)FEXQ2MC M=:FG&),/L$QC)A-X)#EEY1>9;U-2PZ<+3$RLUYN4!41X M"2]QYJ]9?D341R[3&1?B*&F)@A5VAO+"K;HO;CN4W.%6;QL^X@$L-UM=)]1\ M7U5$DM/)+X4?GKQAH(*H(?9!%H,7)2KNRULO078T;VQ;34+FI399P#.6 M1'D+7NL&[S6,)9/0;"@3=DZ5BT;5:*']_UVZ4W7!]((KMTQQW7]F- M)?@*D2B+$0U1*[TV%+Y#*S,3Q;K'K'61UE)]^W6NG`@QH&'D(V8`E[Q,>/O2 M.;R$^`'U=1X6>%P-6B;Q10Y_^.RGYRD/I01\D_@S2_G9^?M$7\UF_/CCIP]' M/VFGFJ:W:;VCOUT0N#9L^Z0$\K]F9P7XH"G/4KP'YU;HTC7YOT[:EKMZ#$U; MU5O8/4T?Q65ZC^+1:&2($AUW]/)04N[!FI&%U37LAY/RZ)05Y(;3V7]7TL?= M'6^?A0)C']VCX^7C[!C?W:-9$)-8JWCJ.2#,-$GK3>D%W*,#[TZE>S9\$A=1SFK2N7SI-E8A(BK M4U3@N=2GE'C)6DX#-L+:QH@HE"?;:8]%7@&.ANM7^1QW-LIA;4-P%1E/&\7! M`_"0)CQVEHDX;56PE\?!86E@.CYWYT7FN,K[1$/4_ZHJY>[`_0_\=.8NB^-; M:!KAGE#V>L^1L5Q>XL*[&/.HYPE6"_87&311?@)0BK^A6`(L1%&V\#&-HOJ^ MP#B2_'X3!OGLQR//^/8(S$IP2'\\PO+-+&ULD.9I.=P\*%^P[&^/:G,L#QI/ M!YACQ%L2HZTZ,=>_LJO?J>MGZEI\3->`9(F>EEQ=E9AZ%_);JVSS<._;_/8= MM==:N7C_)NP_7+0*WXJ%);<\`[`:8=G!#W;7NGJTDM';"O9RY;CH)J6Y6V[N MN?FA3-'%DA+:^P31"MX2'L9SP*,T/NJA@6W"_YHJW^,#:*;L'3,#6M3[FC5W M>=9TFK7^SQJMM2'.6@_76H=65<97P*D$_+&_32:,3:=57PTJP%64'M>2*]D* M79SH;%[YDA&;PD_XRRX#%Y^D"[\ZP,43<7(W*^%QH_[FOGV7@$^QWNXN*3G6 M5<>S5,NU[TU2G-RD_N+'(_'?71+UJC_BZD`P8#N.:MH&8>!@,6"JCND!#CS" MP,%BP%!=3Y\Z]BN8F`\M>#\0TVB92_!3//?$JIV'1L/;D M:YD[%CP?DI0!13)K>7*KY*D?9[(&:;WWV18__!#;L:ZIQL@&R?2-[:J6::GX MFZF:H]$K6572ME7-]MK%&0ZV2,DW$X@K% M92M-9,TU,^30/BL/$JW::J8[4@W71&/M1#M!2\W2=-5PS%?5G;MDIO5J_1T[ MVDC5++U'"Y!$\7Z@P$GZFVOHQD[634]$-$'E*:2&9^BJJ;L]P@1)#9(:3VK8 M#2O@]G;FQ^+,/Y;!K.JEU%4[%;^\2NL$S+X3/&G=8=&!\>:9J@5&NO*-:7NJ MJQEHU7F.:GF>-.I,RU4M2R/#KE?KTE!',%>&J0UT!9*P?@)0V*ZM.LY0O6V" MQ)/$Z5T0\A;E8!$4;-M27:[(U>U\^?KAV@K?>3UY'W-VOKIB',B>9 M'Z/L2$CN`,Q]S*DG[*[CT7MQ;N\#('X1OPZ!7QWB<9?^ZZXSU2YY`;*N>@'B M5'[34R5?<^\VI&ZK(Y-L2(+"L>M@;E:?C$B"PIZ@,%)=VU$UTR(P$!ATU;4\ MU=$'EO33Y54.ZI1C1WDF/\_3<%SDS?*=<1++TJP1%E\M:\"3:;7G=?,RM]=( MQ!)4""H$%8(*084V"^YX]0""DQ3,)7X1O_K#KP[Q.'`?5UP=(>^WF?@I4['H M\L8R_"_/O^U1O0?:,3AT!-!&P:$C@/8'"`,O:%M@T/ZC"09DD!1@+3V/P?K` M_GIDX1/'B&/$L:W]2/$1W;%.:K:Z1V270OZ27T#9O#;&;US2L^&BFIU>K4AS[GE>E.*/[7Y6RX95=_;Z'KCOL@\UVP',9CCN-5+115^)X$`6U M7W`9])_F$B"8EGF7TK.[:(S?M^RQ0=U2"P>0'^5W7D-465$O3U)&K'[*, M[6&>C*V:NJ?:9I]JXARJP.TE/'#9NMYHH/#H,F\''?`>=H(&<6Z'J2W#\M/$ MR=CM@I5KS`D;[`=I3HQ4#5PVVW,/V9SHCX$.5H2!_QQZU29"19,21QU9IFH[ M?4J7.FCC8>C[786!^^_+N`-6)=X0A,>_8U-?SQZ5Z0\I/#%^Z)_ M,31=^W*9?#&^&"Y^T8^4(@[%@[_#!]TX4@(V">=^E.$.WT^.:YJ:9C4I:_?U M$$ITXR&DF)8]\)LW3!T>Y6L[IZ6J0+A,0DY6P`*9_,DSYL MZM$=6*M"JU>VJ?@J^]BZS6=^SAM^D_C0 M#C3R+H0V\P2:G_G0\&*1)MQ M9$B&JS\K"0J'`4^@D_X0;(H-]_P^V;L*<=' M_&_X^>C5Z8.R^]8F,"J=[NZ&[+[UR8//#V;$UZ)(%P"DDI45IY0P0^1F.5@M M5_"7F/\919@?W^)$\PGA.,&'*X[#.V&>*6R^B));QC(56IZ&$YAZ%55&5D0` M+W@`T1A42)783!DTS,">`WUR)6=[CDT&[!J\*OP:IHH_#J,P#YEX#3@&RS&] M+>O>9,5DPK*L')"D^+M,&1=9&.-?>%K3(@TS=JI\S'&@6!PG#LK5E,_@IY(O M8X#;9!8R6$(X:I@C)E8'='?/0;8I$L3#0UDQSH"1?BI&!.A&2J(DOCH!.N<- MWN*-3K/P:J9$0$[$&URPE,L'>(8W6,1%5L"*8E/X&1K/9VE2P!O8\57JBP59 MMRA6LUA-6(,QB4_^A-?#:U*WLQ`'L(3+$6VZY8*;C_^TQ!)+7'$K[HJ M2>CV$8^DB5"J=$4&5(P)@1Y")1INM'2P##1?F,Q#5-PSG$Z7]-8/%R5#\ MIQ-80R`(`/GB;HE3S>'+\*:Q-OC$9DM0@U9!)6+:A#+FMA$:Q2S-?5`/"2#& MY^J@"9T)*`66AK[08^SK(L2D[2G\IDP1R;>@`T1?K=%$MU*,K%``SP#$KL(, MZV(%C;%?@%I+A7P!M88#TSW3E+JI_/=XX< MUDW5;HN9FUDXF2D3P,E8:/P61VH;5C#\*N2>`YA$8(AQHU:T(EY$,?<_7"L M\K<-9,>2H]/VL@?B45^V1'_7L-!_@U^%_R;]#I9QHZ]:'7&9-,%7S8E8I=+< MY$;]W+]%L)3"!ZWW*+P*\:C55F8\FL;E@^MM>B!IV:07B[P:@1(D0'N0XI4\2)VNL]G(55%(5N@8K7`8>REA%%5+8;L49 MJF:8JF;;Y5*!IAHK;9$TE#D/#]1!@\I=$$Q38H#`DB03L$%:O?RE:P:EBR[ M;$L>&6RIYUW8C_@Q`Q2C./<#F/)2H(-ON4%G2IAUQ'A$L]63:)'*%25?15<* MGUDD-\A@]*4%V)@4HZOK0,P-],`0;6*^A$K/P[GP^`-@9QQ#@Y*RRK<$]WO6 M>F55^;;A<"RHP/6)JP(0$:&3#JB/<3L(%GN93X"+-R M@<_]@/''X1$QH74S(#B!NTG*I1:0<=J,N8..FZ-)+@$)#43CAQU,C_P:Y(Z:2?9V(S/BTB%#@#6G9_LP`Q8"4 M6[5"9"E*QXP?#Y8`YL-^8J=B*B-HM7,Q)%;B>A)GJ+D1*XXQ%W/H%1X20JBE MN7Q,3126*^IR_O?PJS*'WF<8I4/EMZ*IE&.^Q`'%28&L#Y'%8,$#+[-7+_CH MMF?<\^BVY=W_Z+:SOZ/;U#4=6']Y!Y[Y!GK'=4:#.GX^\#GXEPP'U2,Z$W&A ME8&5Q\]WU/&Y4'/OI0'\U-U]YO;U9S`C..KVC0H2`7N&W\_<)7N'KLL'<$2> MNKO_Y4X:P:]G\#LK`^E//?\?XSP%IRB[X*94EJNQR,$?1>GATV5`-;:@GC_J@/U[**33C=-2Q&`\*!@2(EW\U#&&% ML/)"*Q+]++8JR*+:\V+0U9%UZ"?\"1!-0)QJYH'C@9#129)V:@VU7!\A@RRJ M75A4PXIIE?LW9&71`NFS5"6H$%1(OA!H"#0$FD.+@[WG6;0\87N"YZ\BLM;V MOC".#;=/(9"#N`>RAS#03QVO1S`@S=D;9+Q,S4F@(=#L)$@VZ'JZPRXIOR7G MMGMAVRG9]7./F&(B^:ZC-,,*8;?2,COO3E2J"Q/)9=J?S^ MY%;IIZYSX#`@0+Q\JY>P0E@Y6`]IZ+=FD(]$)'>O3_&QO$1E'3B73TIJI]8B METZ\@@?S3F;\Y.QKI5FPO2[8P2LHP(K7OETIWE'5ZE!J:#]#B0Y=T[X]:@JH M-2YA^?RHKNB!;M\N)>MJ'91'-5K?WOZ49R[7ZX`GX<@Z@/,I6IZ7&L5/-&.B MZF19U2;%6QPR45`*R\U-IPRO<,=RU/D-D\6XERIKE27'L#`\+T=9UMMZ=QO[ MDS_;%9.3>$,<@#>U[O2FJO#:S(LDS44A3.SST]G%N[/_D6V+JETJ+^J#-;AP MV<[8"73.;JLB2XU"5Z?*!WBR'$U0EY`+RR/%.#<%J[F2/2%;FC7&RJ;6EK1Z MD`#L0ZVF#]L77$(&UK^ZC4+4*5-N\%]QLE33K9K+8=4":Q>P:I2N"AN7,*3B M?A11'+\YZ&;I-G]=F451^ERTL%*GM@9L%$Y9L]<77-B*:\U[5;9R]/M7MC+W M5^.)NGXY77=XH9N]S4HR'5A)$UU[PIHFV,P8/YQ+T=O8W^#C&55A&X=7(-LUU#_86>UZZJ>)NHXH@2;8^3E!5XZTAPQI5WLJ??N/5U:62 M*G]\"WVG_B0O_*CY\Z_H`1SCS6;9*YKYH<]\LP9D^1N7D#2UO9U:DKH]GZ#! MK[U[F8*#A=-Z']%]#I0<\W6LG,G(^L=8N:SJQ?<1`6B]LL9=NV6-&Z>:1=;XOE6L:FAD=!$T.DCR3D<$#`)&YQDPJIM! MR#@84XM`0Z#9A7T^M/BY<6II2Q:[0Q;[OI>+10>P"1C=9AD%2PD8'22!'"=/ MCI!!NH2`<0`BH\/P[K>9/3KUVF8V_-!Q!R:9V<^[`LQ#OX>4@+%&-!(P"!@= M)*$<)V00,DB7$#!>OLCH,+.'7?7L(.I"$^>(<\0YXMQ@.=>E=@:UK7J9Y.(X M-45W]FAX43ES@L;:0T@Z`6/OP.C/\0&J>-\+0/104K@&J9#]`Z,_DL(\-3HN MJAD$(+K,ZD%'#9YW#04D/@ZB1GD^2QE[8)5R7J+[!.\= M"+#2^X+%F2CCS;[B9Z9`U\DD%/6XPWS&.WP+#_KQ[7>9TJ[P?>-GRC>NH1JC M$>_OFV-=,U3/-E^I2LJR!9O@+0C1K2AH_[CRZKLG7!]YJF=*RD>J8>G+5&/] M\QPC9TH1IVR27,4P&VNZQ^+^S8KG[0[7U#^7A*@C>Z0"OD4Y])LPBI0Q5O\3*_\H5BUGJ1ZJ27+-4,4]=Y1:+(0HJ5TJGYX`J+,E>-2)J_G=1'F:*?NK) MUE9-M7I1!>%U;6S)+S]\7V0G5[Z_>/TNS/!*@2)EY].WC7Y^$]7=WR99GO'2 M4V]P#C_[MW.\N.`25M&;"%CUTU__HB@_-!L#(L*X8,'Y`H:$+?WLA_&O29:= MQ_#G19+YT?FT\\%/+#^?7OI?%?P3=/`;F_YX]*X0?_SB?=&_`/.U+Y?)%^.+ MX>(7_0BF.!0/_@X?=.-("=@DG/M1AL79?SK1#=URG/9P'T_A\XU:-PYRV'*R M=3EJ#[\8=X[:,#QX;KBC+B>[G\/F+_V<)L4B^QA/H@+E96<+62U3*CEQGVG^ M"2554VK)SYNUN_L,JAR;&>.'YKB5>N!"QHXKT;LJD3>.P=Z/@?([=)8J9Q=O MED`K:50PYG-ZB MF<'POIT$573`F\`K>J9(R8Q%`>\,6F70!>AM^'VQ@+&G:)FH^$(]W4D]W3< MV?!I'>.X\6;KEFIY+CX7A?XXC$27FU[KML<>>#W/*-"U1X0O@V*.,`6
[6`P:#P`,G!EH8$!(F):V+GLY\!MF*_`9XH2\0<(/+"?#ONJ=V@ M:X`"I.:$TX^B'X$7)SFRC-^:A?(S*%)D'?)!-TZX$ZQ`^V$2-.[8ZEH$`G`- MA``=^,OJV+CN&..];R#O6\.28\(N[@6U)1:W&N+>Y34H[F4$^_D:^D!+S9,` M)KT<:JEL\&<6\5ZQ@Q3X@8](#S5KKSW02@B@,;]G#08)-B"R/I]!OZ"I2_,!WLG6E)VXE*#_!>-$<"/!#]&J"9)8+!N@ M1$1#9DFV"',T((`AYV`0H%RJ99*(K6!@P)_,JH>_RS!:5_"I5?F,<&N`PQSL MD0EC02;>K_Y6JW6@$)84`V$PAWD.Q!R)*0QQA2AA;9%-9L`X-#C`*$3C#F@$ M+,08C4%17H9T8$3L*L&I#$K[K;8R3I4W;.(7&09$@`%\#0JY4$D%;,,7IF$F M[2Q^EQLLJA9_U@H";*!^3UA)(7=C!-%HY71U$,95WWSV<`AOH47,4N,"XHT? M<2!?S!@8/>LB,3VR1-XFZ2+A8OO%F"/?+0NR"P8H")3/+%E$#/[ZB\1(96U< M^R#"BPS7@K#&&P8T3/G;&1C#J@0(3OFXR#DLHW`>EM!6#%!UG81#"(!E@7UP1>O)+X8>PTD+>_44(Z_@-,$GE2X'KJAC,&FQ%0!UM M<;[R-]HMG2JJ8=5Q.Z6+K`UJ;^V`AR;Q:PL!Y*8OK^*\Q5F7SI8?K;N4<\7# MZS``Q(X"!],#`_32@1.^:ST'X+JB`2G-G(K4R@L4-NA7+CV1DHPUUP_W4#MQ M\9@9O.L"T&WN_[S7]:(#"AR]T!M21^[];T@U]G=A)W5-7>^@Z\;N=L?2>&02 MWHIPV5>.7UO$E$*KAY>S7J[?MJ^'6VK936)\MYS><_,O;/JD.;3WZ:.UWZ>; MV3!FS[_(Z]9*?WGO,!G0*G^6B:I"&C1;`YBM^E0CS4I_9J44=L]\ISFMTI[B M@63JD&:K'S*UPWP=UH'[3RQ7RLWJC*77X00CH]ET7N1,2#@P)NJHY M(W4T&JI4Z/*M!EUU8=BUY;;DW-X'0/PB?A&_B%_$KYW7$NU0L[T)9/)S^U5^ M/Y[&>+UJ6/0R@+FM>;+KYY[8GJ9AT;!H6,,;5H?-HAPQ/!#4SU$!&UQ$51(>!`B'E:+WG)4 MVQWJ3:P$B:>X2\ZU5,>E'7&"1)TC,3+5D6T-%!(=WEB??:]_LH!7UI&IA/+@ M?[%81"$C_VO?2V%DJY9+J0&$"/*_""HD/`@1CS2V+4VU#/*_"!)UD,;45%<[ M]!O!"!+-A%175TUSJ"YYA_\UK-VP>@$B=I#-PW5UH9Z`(@@\137,GNF:@X6$AWN6)^= MKW=LD3*\[*],1?3G29J'_^$_D`=&YC9)38(*086@0E`AJ!!4""KKXSW@VUNT MU4J(>!F(Z/#CJ+8'G8TG?A&_B%_$+^+7L]?V&%;98E[]69FLU/Q8M3H/=L290/,G)?T_U+$IU(DC4JD,U M#%=UK:'*B2Z7C"*B%%$@?A&_B%_$+^(753MNG.JKSO-%2491SWT;G\DOB MD5PMX8!$PYX!8=FJX_7)P"9$[!L1GFI90Y417;X7 MY9'0/BSQB_A%_")^$;\HCZ2V+'Y-LDP9LVF2LC+PT5DAH$A3JC1.]9[5^"PIZ@8-BF:O3JN!Q!86\9)9HWZMDQ MN4/(*'G#8C8-X&*83NJ:_3)92=([!D2 MNJZKCF,2)`@2)4FFXZGV8"_WZG+?*"F%-G6)7\0OXA?QB_A%22E+22E)K`1A M-H$6PKA@07F#>1)G_!B>DDPICMHG`Y6VG@D*%/PBJ)#4("@\#`J6;:J.2VD`D'AV-$MU7@)Z2H4[Z1X`?&+^$7$GX1O^AZNRTCH(LD\R., M=K:BH?`:RRGHN6_KE")=Y,AL?0C#\%1#H_`&08&@0%`@!4)0N6]0U'54;412 M@Z`P3"AT>&5]]L'HQ%Y/T4\ZDP0E086@0E`AJ!!4""I]AHIMJ2-[1(@@1+P( M1'2X<)370OO"Q"_B%_&+^$7\HKR67>2UT`F_/EJNY/:2DT,9#@0%@@)!@10( M0>5I,QP,7;7H!"!!8:!0Z'+5*%)*D0;B%_&+^$7\(GY1Q;/:H+A,(8 M<8PXME^.=:CBALJ=,318P/:RUZO;QC/*)(FRA0_#THW'O["9M#T:CSN-5[;G M6G37&9)>,>%JWFF5@3EA<<[2W9AS>M7,&#]*>^@`[:/Y%39[+)T_?^^31NM\2.L9S(.?WTXM3_B55 MOL?O[\+K,`N3>.\P&=`:?Y:)>INDBR3U"08JJY[(!GZE#=X'RQT^5>#3AX:]BF7Y]]R)WX1OXA?Q"_B%YUJO-.R M>)MD>:;X<:"PKPL69RQ[O6I8]#*(N:UYLNOGGMB>IF'1L&A8PQM6A]Q_VFTM M<^>:8(X*@)]CYPIA+"Y7.K!3[(_8*WBR.*5MJZYFWIN>?L0CAA^;ZB$D#$.U M]*%&J`@13R$D7$\U]3X==25([!L2JFF.5$_O4PT$`L6>06%9MJIK&D&"(%'+ M"=?356VPJSH_5/%H03/RIS!T7T+2L6BR@\M))A/5P,ANVHED6F-4&" M<@H)*B0]"!*/)&GDV*IA46890:*&A&:K(X($0:*1?^H:JJ,--7S7X8$-:_/K M/)^QM*SC'%]5R1#DCNUY75BFJ>IZG^KWD:C<,R0\5QUYM!M*B*A(LDU=M;6A MAB$$D]TMLM0S<%:5`2*ISCZ:;ETR(L@T983]DA3+=,>*"@Z/*\^^UGOV")E MD[!.,O3G29J'_^$_D+.UY\5`&QTD-[?URU7=(:^<`$&`($"0,B&H/&[77%=U MEU(2"1$O`Q$=/AE5X*`3[,0OXA?QB_A%_'KV"AS#*C`L;AJ?K%3F6+4W*#[Z MO)D'MJ..;"H729"H]X\,6]4=@@1!HK&EJ'FF:O?JZG$"Q9Y!87)0C!S*1R%0 M-"2%.=)5SR90$"@JDD;JR+3@GZ&JCR[WBZ*?%#T@?A&_B%_$+^(7U1]N'+RK MCMQ%2481SGT;G\?VR%5=MT\I\J_(#]D/%/H7VB0H[`D*CF.IFMVGLB8$A7U) M!=75+'5D]"G7E\"P)S!8NJ8ZO3I01U#8$Q0,U=3!7K#Z=+'F%F#H<)>&E2PB M*I>$\229,^58IHJ\4I68Y>1-[7U1Z*IF]>EH*8G'_2#!-E6/:A$0(AK;?(;J M4HH((:)QYD5U=2IK1("HTT,\G3*&"!)M2(Q4P^V3CT6I(8/=*J2M5>(7\8OX M1?PZ#'YUJ-\.-=N;R.:O298I8S9-4E;&-W/_*QV#V[L1>FS;GNKU*D&9XIK[ M@H*A&KVJ^T1(V%>.B`E0Z%4`BZ"PQQP10[5U2@P@,!R;NJ<:%AD+!(5C0]4- MD`U.GPI['4*.R!L6LVF8*^!*D2?5IQ7!2:(:F20\"2H$%8(*0>6YH6*Y%CCM M?3+."1)[AH1NZ:HSZE,GPY3$1CV!0;;42V=5`1!`>2"Z8Y43QM8E;,.GXI" MFA02('X1OXA?Q"_B%]TPMVV02UTB*^/EBNYO>3D4(8#08&@0%`@!4)0>=H,!T-7+:=/%ZF1U"`HT`G` M@7K.%&D@?A&_B%_$K\/@5X?Z[5"SO8F+7B:Y'RG1EJ7-#C`<^DU_S%$J97;H M"##XO>\V(>!@$>#9@`"]3UD\A(!G#DI0P;*#QX#A>JKFT26*AXL`7;4T6QVY M`[,%.KRC80@Z081^QYO-4']K?677U^]YXX1APCCA''B&/[Y5A#%8N/ M/C3=28T,0')J=`-T_4-77]A%TW1,"&O8H]N&D[W1MHBYA29G5L_ZS,``@A MD#8Q"I0N<5*1^U"W2:^:&>.'#VR<%GYZ6X_-\%3%T'3AZ(^K`?;4N3[,63LK MKHHLKT=FZGS.]+W/&:WN+7%B/`=,?C^].-T`B7&J?/\4W;X+K\,L3.*]HY&0 ML6Z*WB;I(DG]G#5Q0//6^WGCJ1,T/[V='Y*XA`R2N"]IWOHA<3OLZF&=A7Y; MI"GT=9"E_/NSA?M?=":-L+(E);JAJ9[5IXP?P@1A@C#1-TP8MJ9JAD:8($S4 M%XX'^\(8:]2!44+X+8>)Y)(6G>:IE]*F4_T''1X=> M/(5X1[PCWA'OB'?$NP?$2CN4=&\BH^7IP"CTQV$4YB'+7J_:);V,D&YKW>SZ M.1H@#9`&2`-\]',=JN)IM]7,'2N/L\DD*>(\4Q;^+:_OB&<>_,DDQ0ME&AIE M(`IE1USI3R#DORB[D+"R;=!,MU3+Z]-U0X0)P@1AHF^8()U"6-E:?F@CU=0H MX86R#7IK;MB)J<0YXAQQCCA'G"/.O8CM.'E!-X5.]VVFDIM+6*$P M&6&",$&8()U"6*$P&6&",$&ATQ>4J4J\(]X1[XAWQ#OBW3W"J.+C=M>'NX^] M/IQ_"L+K6N_++S]\7V0G5[Z_>/TNS!9)YD<_ITFQR#[&DZC`&\+AYPET$L8% M"\X7+/7S,(DS_#5*LB)EE^QK_B9*)G_\]->_*,H/96OO_32&M[//++V8^2E[ MXV?AY"P.WH51D;-`P3;AS=_8],>C=X5H]8OW1?]B:+KVY3+Y8GPQ7/RB'RE% M'(H'?X9.KFCLBL`'P?-OZ$:ZBYGG;@!`@!4)G\XJOL8Z-XT-9(AYUZ M*)&\3>X3RY5?DRQ30!8HG(%"GHPK,;.ZR[*1>ANI;^T/F<8S#.ARQD!Z1E%R M`V!0N!Q6%BG+&.;AY_#'23)?%#D'@9),E3%BBB?F!Q+/4'(.#V6<&7Z> MI^&X$`WF"6_J+33EQT#>0_BS;G9;LM_8)/S+Y@5-;6TW`1;XBPS:*#\!S\3? M?CS2@'TLPKL*)\"DZOO"#X+R^TT8Y+,?CSSCVZZK##NV"N4+%KRPK1-:OC-: M_\JN?J>NGZGKAB&T83_Y@>&NE56VKVA:>ZV5J_=>5X3:SW)%Z"QE3`$AEL\R MA8$8#C;)]-UR<\_-#V6*+L*O_9H@6L%]NN3W`QNGA9_>UD,S/)7_55[4C&;K MWC$SH$6]KUESEV=-IUGK_ZS16AOBK/5PK75HU6&5B'ZSG9],Q5'V*@!H6#2L M9TGLWG6IC$_%'/<@DI0$R(N%)`UK2,-Z=HO%VK%(X;L9TS29*W*C$S<$DFJK MZU@?@>/V"PG,L1)C/91FD01&D@A!NI8 MEA^6>?2(4T9/M3HL6]6T/DG'?1QP(40T[W)1'>/03TP2(!HDN:9J&1HA@A!1 MDF2HCMTGO_J@#\`-NS+,EIS;^P"(7\2O0^!7EWA\2?'X%POI.XZK M&G:?@E8$AOTI"<-1+;U/EY2_O-A^\Q1WPY92E9CE>+HQC"?)'*PI_^NAEFX%.FPU7/SJ4XGJ5:[L#VKH9O./8*`[;CJ*;=I^LD M"`//BP%3=4P/<#"P<"QA8(<8,%37'*E:KZZ5.43/<>@W!#R_;4\<(XX1Q^[M M03[MSN6NZV:]8W$R#V.JG+5WTX>&1<,:9%AJM;*G?\U2_XJU"GMF2E+D60Z/ MA?'50"3-CAC4P^TL?:2.+%O5>W7P8N?3UFL?M9^HT!U;]6RJ"4"H:,F*D:G: M)"L(%2](5G2Y;A3AHN@#<8PXMO\1](9C76*2+IZ@Z->`XBDTK"$-JT/@[%*\ M[#J`3E5IAKT_KYWJ??)@*#WCN:=?HRR]0YY^G9*S#GGZZ:CT*`JK(1#@@'A(.!>LT=AE.?S22J*#/\)3*T,Q\D*LF$)AR0/"`< MD#RX*^8TZ$RI85>M>/X<%N(7\8OXM6[X7>)Q4"%YJBLSF.TJ*O-\V--/'L0A M3[]!J2H'/?W##[D/VV\<>BX_G7X@CA''^L:QAI@4']']ZJ1&>H&<&MT`N:FT M7$63_R0?$J-ZK6A-\;H#N2^.T^".H]QN/$;7\14_3\,/TBAAA@=K%ORHS?A6 M"<+K$&L^--_QK_TP*KW,YBF<61(!OS-\+Y\QY8:A&FU4E(B+^1@Z2J;K:TLH MTR3E+Z=LD:0Y_@*TA4EPJKR3!X`V49^R:<0F><:;6"0Y<#;T(W%V*(0.\YD/ M-DM21(&23"9%JH13)6/P(C1,^[*@(.-<>R*%3 MY:+5\$V8SZJI419I.`'&L*\3QCB^8*Y30`4NM#^@4?EWC@LYJ9(@?BJ$D\27 M0T72)OCY\Z2(D5Y`@+]8I,G7<.[G++I5#-6T'14%D)PJ/-*FJ[KI-7\LP9^% M7Q6`3SX#RF,DY@,;IX4/TV%XJF)HNL'?KW]U^:^Z"@L@6P#/@?O1[:FR*=8# M*[NVSN27'[XOLI,KWU^\?N^G,;`K^\S2"Z3M$D35FPCX_--?_Z(H/U2/\1D^ MG[[_.IGY\17[#49['K_UL]E9'.!_WO]9A""J@>,97U30S&]L^N/1NT+D/WSQ MONA?@'3MRV7RQ?ABN/A%/U**.!0/_@X?=.,(4#H!7D8@U+2CGT;NR#+M!K7W M(..)!J#+`7CXQ;AK`(:I&9ZYBP%\\,/T?_VH8)B:"W@L``'59-V'XI\0"$U0 M[$#="`U8(5!\E7ULUH_N,RA#;&:,'Y"'"FS'$U0;'^,L3XLYGWL^ MD'&U>E87U<;QV/M1]^>Q-J0D<9H;E"1K\%H>;'MXH?@-P$`7-V\5:Y M3!:@95S#.M&U$\-2E:-.5APIQR"GYBP%L0;ZEH$\%0(O4RX^G%THGY)31;=` M3EU"/PW6GG,!S65Y9EK%<2,-?0W\<1D(1'Q_QIJ"9HU>O5.5F%DYF*&?G M88XB,1=/H9Z=)4G $Y5U@@KD$+^Z!-IE4??MU'U.@#)/X4J;M&ZDXYM9P; M4LYW<$29^:"*P"``WJ%>DRH+M`[N1_C(Q[I7L&B`\1P[8S;Q"Z2RP?@@#+@" M9&BO\+_4Q$A=QEF%SZX,!7ZO?VN.J=9CV+8?@18/<)8F:`D'RT-^")+W9;D^ M#,H:@KB&X#\%1L2L(!X:0O,N6.N6\XK/2%*D=X+K5/FG'X.)ACV!5<6RY1F> MA6#"I9/9[3+4M!+M5Z##Q6LS,/M8QFV5!`S56Z3JSR+!L4KS!>#N8BOR@DX5<[& M&0YS`4Y5F,V@`?DV[SF3*&YT6IO9@GDJO-!F5@(MIM?KR^6RD*0X3 M@,PE@:0\X^-K(+O!_3&+0G9=K@UA8Z;I+0Y+F&O<'P$5R^>0?V"ULE6!L1-\ M*L-5Q$)!%#X)OZ>8RMD2*;7-UR*G-<%@"+_R0_P%F,(5AH3,XS/;8$,U9DZESYTI M@4J4W"$P`-]`ZIL=JDN3!E#S!;ZQC7R6,G82`:ZB[E7-R94+%J286,AA#(Y$ MAK0&38VUK(5XXPIO/!.9P7>\IG#?`\<41#E\]ZW54P?=]]WFN.-\U.S8?NL,$[?$Q'U/YO5`D=]B%H[G+2L MB9;JVF)'X!ZA+L+5HW"U_9[Q4^+JO%;(4AH)!0YB+EZQ1>J(#A\+6FM2NBX] MBFC,0J#%3]<9Z2L0_GNKC25`;]5>N1:XB/9+4YEW\O?:-.'#K)]I6"2H.'Q4 MDP"Y-$T`;+X,EG:;+;M>4/8V"XK6TYKUM'T*SE.NI]_C9&5%55C+B@7&O@6F M`+>Y`!TXGA)5'*QHQ"&ZZ]>`TG`*ZP"-JV3%I11!V#4B_W(65BLWJUSHTIJ: M)P&8(JHXPB0"G-Q.GH*U(4/#291:*,UB2Q6F;#K MM;(O;_5CK/S#CT5L5M,UX:@VHA["IT#>7N#&AY\&F?(F@?\HQT?@;+XY>B5V M'0+EJ@@#>`M-_7&M`:5`PL/@-LBG5MA2,9`:>/]K(C$_@08L"+,6$;= MI0O]759Z.WS?)8G"R:T,XJ,$_B>:ML+WUK53Y7=@*&H`0$[9B_^U=7*;NJ`OQ\^^-V(9S*:JG5D17PRZ[# MI,BBV[+Q>OLB!:$)*ND&9Q+>%O28:^@Y53X((@0\JID"4*4P?.DT""<#26F3 MN4;!X?:')&:]8S+W;W%JI(?)@M7H5VM:JV#5S$??.UX*@-7HN3,4-JR8$X^A M<)^*.^%"719SZ)6[=-L$@DIO+>!_$)N:-5QJSE4L:D=J%DG&UTH[`9T7[%:ZH]K^F."* M2-<9+_(%:_3MUKE-E4VDKW]G5[\?6M\-JV"#I;F'Q,6=IL>W,5^NHHX#$2M3 M`*L"X!^C0.O`]Z/%I-[>1Q/1AWI@PLVKOX=Q_5DX7/S55/D>W^Z,46S:=NM/ MFNI!SO9%PTKC/G-S,FO+OCG]:.+3C`YA1IMSV?33]CY[)/%[@)ACZ72]HB7< MJPDQ:$+Z-2'FOB:D0TP.J_!_I91$AM`FO=/+\ZM#J!U/`]S7`+>S8GJS&#_& MURS+9=I4F?AS`H[:2>9+F[#_*W)'O.C/H4+.CK^YAF[J+V4^;3UD;/#TIT/)^+IA*4Z,D:JZ9&L)'B\ M2*%)`"&`;*M5Q<=>9U9=MM(FPH9C6N>;\G0X^(J91[D\PLS/+OC*),EXBL4W MNNK9CFHYFLA]N:-)HVQRP=(%RPL_4L9)'&3\A(PXK(!I$^^+-%DPO\HQ595'GB>W]0MT0/2>!T0%(Y62D\HE M9J7)8^I\!)M"DWT\&G&J MO,-DF[2USE92?N1,Y%N)\@P13Y/+9HR5!Z(^ MREH9T"7[NF!QQI:[0]$@"SDLM8P9ACX0"7T'15H>`"OK8"#315*F./8FL5DQ M,6]@TP_^752!.R[!9'(^GUA,UDQBF71V-ID4\T*0=LY3(W%F4S8#VC'[4PY( M)HGQF@NRWL=WRGLN:!\CU.Z45!LEVV5]?.UG@`I>O_![G#)0M__!7.4-,NY^ M=0=TR_%,;RW9&\EXH@',B(3-L:V:-^CNA! M8+-LVS;L?@ZHG*+[C+9Z2;KFW< M.9!.,G9,_\/6BFZ[KJN;?1C`P^J_N#H,P>L#_0];"9YM._J=:WL+^H59@8KF M0YK,WR;E+=SG]27+77^Z]@GR=I`'Y,>OLQ9_/L4Q+S/ MKK&F9AA<":TB/H='4$"ZKFBVVX8V72`_'5DZ;^^:9K82JO,BR]%TS7F1Y7@: MYAATN681E15&/Y>7:Z6*H0?H#UVQOU]T20G&<@W"T4X/=<'PJ2A6+4*[BVX_S6^=6 M5QO10-,MW=:V#*O*"-U`M.B4T!,(=';3BSP'T,2Q',W8LL5V#G4HKL9DZ@=7 M>D3]"PO8W.\U`FC!O^T`X-:0!^#J:%\:KJ[H=5+V"#!JLO..\?^_#]**?B"9 M#UL/:KF,,@M M*6RYJE&)&/>!&"O9B_TW>B2RHVBJ\QCBRO@](VY)8\.V+-5YC(U;0GY\8SPP MC&.K\)2[#W2SG7/K2SPJ3*;8%ZS+-1M,&A75T?=/8!^6`6?2^EZ!X0XZD2^P MA8=1SX)JFKKZ".I\W+X@M@V(6+J^5UVW@$AWG%/7(UBD-\1[)*?FNO9><:P# MT#OHE@0&%K#ZQGP=,>Q$TO\58""Q8NE[MY;RV#TB;2E)=3;>L[>&W!NF.I;G2`4+8-6OQ M*!9N;O6>6OJT.9]]IHZ*EO"^3-'=::--TF&?*(M4F)S,NZG%O'5$Y&.1_"7E MDZYX.@RU-5G2D]2M),F2(*G)07B?-0:/J6D;3Z"6>3=G^E!L$/=`O42REB9I M$B4]E36J[IZ*N(^G=W!_54FW5`2FJ1B&6H.@1A'O';&QN!NVH99O%.P;,4T@ M?1^\8Q-T6?^DM4&EP/,^;_)J-MBLF/>.22O=<`]A3#P_1'L(Q0BN2K7W;KRT M%6565JA8B/--2A?3R7DI!MXNXPOHDW`3\[(+E`1-'1^%NH01XR_&UBD\P7FK M4J%0>(DGD=.7L*=HM3GN[FX:>7=*U#UI+[)R,_DL,=S+>1(H0W^U6:6)X=03)A"[ZZA: MVD0>>_7DR<0+D,Y8VN[SX5$+H:(_B2?D@_.6:--2/KA/)J,L!8S2Q[/V1/QC M*?&^IDGJY?D`(!\434QI_@5%)!QW'B[],&]Z#`IK"=H>H0@HB:I^J?UQW']`KJ.H>]:OR(!N%=5H4/0"F=84N:O#C#,@Y3&M*"`CLDU#0& M&_%.85'FU-J4N#$KA5)HB)2#\RH)/*5?RCK0-Q.Q9*N@64>Y:B`D\^5FFFS2 M-+"4?T7!>R.]*XHEQ/[7E/DED!]`L34BX2P^=>A3M=Q2&OM]>\3AR"E4PL6T M957AW::^50W9=4W"DM*!FR1Q6=&`(;WF+;26#X=:)D/LQ>4=_P]O$D;PY4]< MH/L/.NF6HI>NL=>/V!U5UY1BQ7!<CH M=0CVZF]1N%GG*3RU5^9Z(!;H/5VIA]H%RM#S:AZ%54W3=8::%UA,GUFT^@#V M?^U-FK;!0,7574O4\S4#=(+0G&E5S73%L/7C$/[T`VQP_U";[M:6#75+%02V M^NK6`S>?MZXH(I_L'_D#2]YZ\=UU%.*Y_>R7AW^!._@^2'N[@I7%&X;V?#9O MF(9X![(YB$'`MSS04EQ#W#N'!U^7@M7KN;.FB0KS,&!'F^2Q5JWS)+E_,Y@, MJ::F:^+A5W,8@\!O7;G-MLW'%Z1']$.+D6J`G68^KM8:0CO:-(^V<)UG6=S0 M&422--=R%/OQA:N!,0C\E@OB8*$]USHF_,%%R=8<3>LTI3Z9;&A1LEW3,6QG ML&D6.4J]BHNC&TK%8"A&:@VB:XDCR[9UJS<471,$P,L1KT7V0XJV&AGXR'2L M]BB.73='LRLF6#LH@\RD*_O9FG-J4^FX?>BF6'CV-*;241),2ZE8Q`?-10@4 M]!"8C[,:/IJ%8 M6I4=!T39+7X):EE-L>5* M](`\#9^L5U6]?1B#@NLF0&TV?.^06_-!*?K6"^B;NS!*\&A,O)_9'YFQW)]''Z(:N7%/OJ&L6;==[><2N*-5W>?_AGQ<_EPN\ M-!NQ)Y3-JM`,@I(>B*\V":S!5GN61VBX!?NXRV1KI>J6M0-TP]!\$W4=55-;8@BGC,VH MV-?.&RH'6B-F14/5C]@#KI8FAVKI8I>P]L"*_3Z[C$)2D]Z?Z_64OZKEFX+8 M#1[34C[.!S:1P)LS;+%U1S,$6ZCG?C+`<8]EBQG!Q-5UVWO^FW/=QQ3-5TU4;C@X^5/%POO2`1C?\#T_EL;$YEE33V[H$.@M0\ MTUG1':NR)@TA?6+>\E=*UBS$*/OV@81274-5Q&CM(V,="JS%=J>:FGCTT!+8 M.M6<'^?9%0<)]N#!!B,U^]:(`4\6$)K#OV-R?^H>9KI9B M&IH8W7I\O![P-0];PTYE6(K9'=\-6R"-\PK3?6M+BRO9E#,A_4`*BQM4:;(C%E@( ME_Z,\FSG_.(MUE7`?8F6HIQJFY966(.WC3-(@`"455TTSDYGD[?3?AM&F$F; ML/Q/YY4F^7TWD9,VL!Q1>?5EZ1[$]HX0IB_F M">`5CMW-GSSE]Y7V6N0W/NU4.++D_5)?]U?"K-X]!-[T[\O?-YXO_<)\>F'> MS#U#B)'@(+R7XKOP/D`\:R]*"OFK\NYKG`0UC-\G6YPB]6_(!LZ)P=F*TP/I MM85D']5I#()SGM+UN9(8O0*FHTGAGDIZ!!@Z9L"\F-O_FQ,]`ILIYW;A',Z[SMG`" M@AM@2[::P)KI2I863EGMTRDUYUN`8BEA+J#,`2KH&$04TS?IB[BY9[S!D$R3 M:B+]A9AZ)A575"^D5S%#CJS]*[QG&=Z_+NO]-`-MJ714,KIES M#JM1>\LXY"N%_(FV81,VDNM94V"=V`^FA!]+B&2:''?CS6I%F_&L*#R@:I=4 M=R"KRC$/E[!$V5^KHL+94N"C5)MMS^W.^\)JMJJ=FOYQAJR0N/0B@`?*SENM MJWR>&A7;^"98VV,&BYY-=;(!LK$XQH_9DD85+A#"ED:QX[@LH50V(D#Q`-T/ MDP1S&4E/53_N@?8^K/T$JT),I_#J^69)NGE#QGI:T"3CA2@$M7M>&A9CE]*? M7@1;#C&AXN)"U-2HX-NEE&^7O/OV%#9(&6S-Z1OIU45E1[UX#6P.T@K4![F_ MQRI:^6;\4+%A8:/CU^FEN_R],/7`6Y"9"8Q+[;SCS("Y8;"P,^F:A>LE`QOF M]S`F5QW7YM/&EZY@(Z6-K\QQ(6\4#L-4=W^L=`26QQ))X`B[Y]*[+R0D&PU\ MKZS>239*]7THLEB$`PN4H=.-LC'?\#,N0I)?.)IQ)R\U:?![J,F2)5<]Y6?7 M%%>$1[-B/W?9O`5U()"-*P2L4L)2"S-515A;A.6BM8N:Y1VL=O/E!=)0UU:& M]A81XS]1/37\*U\8Z2W*RCN&]@O]'>;"F2G=F>/,],4M+Y`"M@@3/]VGTU>1 MD8SF-=87HG\&A!6#D('AHB6PLV-Z'P/851CB;,A?O]`/JS6 MG$GEJ#PHN@+WD9_`3H.ECFGWRQD?+=` M=0?^`0XTWT2T+Z?+/N/LD-$M)0AG*B!_[2IFQ98>F?@;Z=^,;QP>;PJ`?E"Z M+VSO.8W%^%%7@(8L;5/R5K\@OC//4''5A[=9V7CJ]SK-I(G^\ M]A!6>!*\6;*]R#M+#;2<(Y#2BR#=NJMCXGB1O[@CEY,S%'WV^1$[9(J4#?UR@CKV_7,X*^_;O!,AOY^%?N>N`/MK(V&#X.$7>YZX+R6[VH[YE>R M&[ZKQ&"*"`F0H5A"'FE)N'>864D!C$\5^4!\OO<]:O8HQ#)M9T:MYUIO M\FK7NZJUZ0@/C4]PO#6LXU=.(%?Z$3&5)]T!5\-DNK@Q;/A&L\*L`30[\2?Z*(/U:T?A"? MGX=3T`]92`*(O(C">ZI6C5]"V&3#KH!9*.Q6XP)[8*Q,_370'@W]OZB2)MY: MND0[ITH?+F3DC^++,XKOY(57=PQ$.0.O^2RD9Z+)T]4XT%9[825YOA)CTD MFN4G(87[OAT=?R-=DW]'[JB7D"V?1E.Y)=\,+WD\&6:/XMA4')E*M>U$OFWY M%R$:KL^XS&U]#X=#MQPV8W#DT6'@S7AB'NB`[34-2(/_Q>#%W%8,-C1U/.O! M9^54>Y*;(B1,9ZYY5C=V??<0@ZAC9)ZT`E(X+XR?>/,Y!PG0@[2.K$<&5^YY M!7C&@=^JF4><%JJ=$65AL_W"HK@XD^3KR8O?/7`=2,>D*UK%?!E*<'@TBDR4 M+*#*`[@Q:&?N_J7OS:CT)5QN5FP'K3&25BP+FAI$&3GW#VNX8\*6/E`^YC@P M)E0)<:>X"X0)]PKII-O/7;]"B4\P?=Y/4]>WHS]8?H?'\ST2%WX%/B8O]5M+ M,V5%J1XH@1(-"T9#&4+O>);O"O#SAGBK"/)D;ZZ@/V?+><9WVQE;,P)!4NSY M,89"0U["^R.L:>K9JV0H`C*^&V4=])\&=['M+A"^PCB)W[8X&-T3JP(#CMAM,!UHS0K4H;`]`&; MED*>.`/&5WZ6%I*4O+S4S#DOY>[#5E1)Z'A8R1D9=DG[(@Y@&:[!A.%LYJ^6&=-T-/+DYP_6'7+\[K;M!N MSGY-H^*$.HL:`)N$TPP_;A'"^4IN3_"+2`_I5+,G,P`%[G[$JF:E)5I57"]X M*%]Y;[7^WV`2KYN^7GD:UOHW$^P.QE4CK3%=;<(CTUR/\F,J%"^R1;CU(=X@ M0&D6VC9D=DX87$;(2>2]3XKVIFL$(192Q((I"$,\9&1') M/1Z:9T,?XL$:V_OP::>LJ*T^\\+)=3>O.X1W93T`J_C>\O@LFX7(9@XD+\\I_7V.D M*?W]WI\E=S]=N-H_+D`G`0/]=,%OKP@=@)(HFVXRR[Y@6O^X*-HP)#/AZ1F: M(?0F/MU\$'WW5_KZ?!SZ2$/S'Z,=3%+!4Y+V;3E6ZSB_)&7[I]OV]B@SOB^3T2\TG?OVY M+-%-):[]Y`LT2G!#]M".P1[9>48Q-#G!'B#QO\X5-VM$-^,L`!9QK#3YL8Z,:BF*:\R2>_[_CP M24V!FH&:.%-#/#>P>ABG-4ZKC9%_>LKG@W"TG-Y8R8^81RWS_/EVG-8Y3>OH M1H_>L]XI)7N?B5;I:>K?MAT[,_4I6:)/)*YER;9JM<83A/>1M_[I@O^_U^VH M[Z4:V!M\+IR@RI;CR(ZJC[SPXGE!`SY`?G!'7GCQO&#(JN[(EN:<*2\,[(WU M;17E][)>ED74'<1@C$^0OG$T5>N%6"O&D=6&5EE9)615496.4M6J;'' M2J-7+S[O7/C&,;Y=X![_ZI8UF![8TAW3FM/:&D9J8[0-.%S-HZTH]^03&.DU MTNLET*M./0X:UC=[=V"+8L`ORX<]G9C-&-4?.6&,ZH^\,$;U1UYX,5']\_8B M=3`C9^%FLF3',5L[CG="=OY(L9%B(\5:>Y-]^H[#WX/G3<:E5U@BX'56$Z`H M!K"C)@A->[P=WVI_&]:`&J.4K@6^"$/QI'A` MUTU9#MOI-A( ML5.CF*`F^8_8SZ86S=GUS[&MEOUS;*U]_QSCZ3K)##ATS>:Y?Y,\EE75JRM? MYKJ,C\^BRCJOC;_CYG)6?+UO',^J!/_S8Q/>N;B8F*X^$9.,%?\'R'3X'&(W MY:LX9LF8OS#LC?B3G6#K;?E%4>?93_#H6FU,C7B&`3U'-E1+=D[J/MA3W!$< MN:+,%;:ERXIZ2I'^-HO5;&L\&4TX7I@^%<8W5-G4%=G13^E\XZ7JPQ/D#U.1 M3?COM,Z_#M2,YWT0=MX7M$;*G,\2;WSX9FJ@*^VN$.AJ2FD%S\17L,DFJXKFZT!)4`Z>["):Q^ M_.O?&S]Y*`&ZBF\_SF^=6UUM1A1=5W1-$S%LO;_#^(TIH#NVHMF.>\CX[X/I M%RR4\\AYOS+(X.9!FEN48ZC[,73`= M:9XMUL;1-<>QAYWGY\C#[]^PZ2;R$Y_%;S=1Q(*#5D@U;-4R!*;>-4AG*"U$ M7#-TUST8RB<&F\)_V.PWSP_^"..X1\5XB6K(W(.P.G:?4-LIS$O35A6U-=3_ MN;S\9Q@F09@P"9[%\2\OX4\_?O]U$BWAA_\'4$L#!!0````(`(>`C4!M*ZD5 MKPL``%F^```5`!P`9'EI:2TR,#$R,#(R.5]C86PN>&UL550)``.]AHA/O8:( M3W5X"P`!!"4.```$.0$``.U=6W/B.!9^WZK]#U[FF0!).CU)=7:*D/1,JDA# M07IKWKJ$?0#5&(N111+FUZ]D#!BP;/E"1S)YZ0M(!WWG^W0YTK'\Y;>WF6N] M`/4Q\6YKK;-FS0+/)@[V)K>UA5]'OHUQ[;?__OM?7_Y3K_]Y-^A:#K$7,_"8 M95-`#!SK%;.IU:'$]\>8@C5:6@/\`LP:DC%[1?R3T+[UZ:QUUKK\=-:TIHS- M;QJ-U]?7,RK*^F'1,YO,ZO7PU^Z0SZWS>L'/GI^U-M]TPE\FWHUUV6A=-,Z; MK7/KUYN+YDWKTFH_;0H^<21CG%K2Q=Y?(_YK%O>&Y]_6(LU[&U'WC-`)K]B\ M:*P+UE8E;]Y\O%/Z]6)=MM7X\ZD[M*U79:TA/A??5VL+CZJM\[K%ZVS-]^I<1]8UA=*7!C`V`H: M<,.6<[BM^7@V=T7#@\^F%,:W-6>)<5WXL7E^?BWJ_S)DG`ZAB0[Q?.)B1[!S MAUP!>C@%SF_-$M:_#QYW0#A+#]E_"](;XNN&BIW&41J[^=#OC7MSH('#B[1: M9O#XS>\@?_K5):]EM3YB+VR\C5Q[X0:(NKRI88.%M<+L1OT!;PP\!YS-IYB) M7^!]J]FTZM;&'/]WU*(5FK1"FT&;>:M=8N^8=T6W(G37WV'S@[XS1OXHZ$!\ M')P@-!=C1ZL!+O/7GPAF6O5F*^Q'OX0?_VC[?@2-BT;@!J/ISI>-=VM89T$I M]UMB^\(R/ZXN+J^NKYOG5ZV+SU?<]5>?(BV/"*%-=T$@:J_M\W\>:&-W<`I+ M-/S%;!98JV-.[;K^F)+9H?O"'R-9&DZH`Y1/36K%?`DRD+ MOIE33"AFR]O:^3MQ9-MDP7O>`&S`+VCDPC=@*90E5-&5P:3FQ7";%:$95`>> MZ(WOL3\G/G)_IV0Q?_1L=R$68/Q3FW@,>PMP-E.(2M_-8[`B,BD7?RBB(OQ[^7O#.X8IYN\TZB-(E1_T_Y"Y`HA>ENM601GZHH0HNM%8!%SF9 MP3-Z@\@8*6$]MFPU6%:'%K)ZJ3FK#"CX;(LE>?R7EJ\*NUG@A0Q_TISA%]Y^ M0I=\/2,E=5ND*CRF(`JIN]*:NCZ%.<+.P]LHS M16*M.`1[P=N!(25:EA6O!K>9T(7T_JHUO>T7A%TQF@^:8 M(;<+R(?>R,6357)K,K_)E2I$=0Z@1NSQ=(DW>08ZBTI9-O#'%-6:8=5A7!67 M$9.^1*BIFZ^I]:I`=3Z01LS)A_L,FT5(G]"`%\8H'BV8T/:@:)7<8L7F@O+E\ M6/#$-:#H$"-&@;9M+V:"+1[7BE//#IG-*4S!\_$+K)(4NL07I]B]\3-ZDV\L M9;%B@G[4MYL*(S=BN&@[#EZUJX^P\^B%2S"9(.)+5XGX#`B-&`FXVK=[8BEA_ M!WFO">L#'4X1A3OD8YM'\_?87;`MM#UMI]9ZO^QFL>[[RD7=61T<\59N'<\Y[.G7KQ59/DR5+@N]$8OM7A%(RILVI=!_GV*1ECEJ#=;0$#F4QIO!&;4.EKO1)/ M0X_S8_HI)T48>5;<91^5FK0W2$@TFUS)1-F5R_RA]G)X[,CR MD<27`PB>G@S:FR2%Y,+Z22`'`7LQ83:P9BR3URK>P9-T`U)\\8K1G0NN(8ON M%:+DX7VO5,795>C%\JT:+7IQ;]<-"5%O3$G]V-5@ME9TDQ%]_@]`+IMV$(4> MG2`/_Q/XL,__Y!/:$.@+MF$`+^!),P0?K$6&GV]5-BP;/4LGV1;=5R M\4ZKECC0F9.I9`N<4HQ70&A'=$3.!=-/3HZ/O`HORI`T-_XB2VZ\,&ZMK&OS M%J$^<)\[?("AXAZ$>UC]+=NKR63BG;+V1.NX\%\PY^MN^=T'WK1-V-:V&7Y) MNDU2W8!^W3T/PWMI?$6P&['7H0@P?HY-Z!:Y;>HGHX(RB-D&+=T_1DA-W8]Q MP4CA\2G.Z`F([0@.,F);+SV\S9TF:+)JE/&D15U9U:+WV+2_''CT]NZUE8LE MN=[I:B6'7TP96"305%Y#F5KU0S#97),Q<>B=MFL.X06':5L?)KT_7:WRAW"R M.B?U]$&7C>4]@!G??*M2^T,\F;V3>KN%I@//X67N66:KO:H?NLGF&B->A137 M*U:OK\TBEDB=#Y4H^B3U?4J:CBGKT]_@H7SA4<_)-S4EF?E047XWI;ZI5E-A M[;YJ65E(N]4^A*/NEE`HUWH+97VU"#CB;E`.)BE=+[[PB8HB@S/6&W=-M<7* MY3LE0H2W$6;+TDJI=:+BR..5M4KTWM^M>)+O3U)'KI3@EM[;N5\)Y:T)WSME M+Y\IXF.B'[QZ=/%_TCO2\QBXD2U4]A%:S%IOL_[<4O6S]55N3=MZ9V' MSCN-2,8>@KV@@=\&88=9=R&)EE+KG:AV\OEEK96C[?M*K@OI$7[!/@XRG7= M.=3U$+G`)^5'WU\@SX;>.+CLN?V*J+.OBZ+F3DPN1W'76D5Z;P1+_+IZ/WR! M[-$8`_J)ZDC9HZK8C\?(S*TU/U8/'M4T>@) MB.T(#C)B8.NC9?"8RC-IVWSPI_"$["GV@"[%T[+\D_E,_KI0MT`X'!**!,OT5TY,OA253EQ=3^$D]$W9CQ`S+UG`SA!EHN%Z8?0YKYR,NW?K2T,T;\1;RO_S?U!+`P04```` M"`"'@(U`D.HY-^\I``!HE@(`%0`<`&1Y:6DM,C`Q,C`R,CE?;&%B+GAM;%54 M"0`#O8:(3[V&B$]U>`L``00E#@``!#D!``#E7>MOW#B2_W[`_0^\[`*7`.TX M=F;F-KF973AV/&=3;7XU(-%8[\D M[>ZJ4OVHJF+Q5?SQ+X_W"7K`>1%GZ4\OCEZ_>8%P&F91G*Y_>K$M#H(BC.,7 M?_GSO_[+C_]V?4)2%VWNGMX_.;H&/WI_=LW[X^^0R>?6\+/ M!,DJUE(F/1=RA_O:V MH3TZ_-OG3]?A';X/#N*T*(,TW'%1,2*^HW?OWAVR7PEI$;\O&/^G+`Q*]GZT M>B$I!?WKH"$[H%\='!T?O#UZ_5A$+T@;(/1CGB7X"J\04^!]^;3!/[THXOM- M0A5GW]WE>"76(LGS0\I_F.(U?37T">_H$XY^H$_X0_WUI^`6)R\0I?QZ=2$% M]*XCJV8Z=*;E358&R2!5>P:S"R:4 MBLW"CL"$&DF6=]L@>HKC`VKQ;XZ/WS&$])M?SFH//DFCCVD9ET\7Z2K+[YF1 MG=P691Z$92.(J5]),N0[;%6DK"=Y5\\@#QO1Y*,&=DUQ&&;$>S;E05*U;,6^ MRK-[*\5J-3(+IE^2VV0?40=.CHMLFX?8YCTV`90]:6@[5YJ1>$(X::S&Z<'7 MZQ=_;EA1D$8DDE-F%.^XT=^#FO\?KW\\9,^<%EOG#4V-B?"BBAE=$@:_G_L M0S+QD1H/P[(*BEL&B/1\ZR#8T-[BZ!`G9=%\0[WIZ.#-41TY_U!__9N8 M*GD3W.XB4=T`,B*WGJ)6E;J%F&(6'Q#9B>KQ/:-HB=#?&9D/[YY$>7Q!/A8Z M8!PAL`WT5!;:04L%9PM[*JCL@9(B1CO:*`H2N7!&3/"Y"E-RU#9S'11@DE1+GY+O]OEI#"V<+4L7W[:%'"&(3$BWD M=E$Q-.;!6&!LXW]QD)M9!D<);1<]I<56T9(!VL2>#EJ+H/1N[:$:8U[A=4S' ME6GY);@7=1=B,O>6H%*W,0,1C5,;D"O0,X!ZB+^C1938[FR'ETJE8<[)1-87V$` M9:_C4'!`]"):=:1="N-$C'6!*F;$<7LPB[Q+&`=5(41!6-H>T3 MP9B46%7>>+H4SLU$]/C^5"@C4KS[2=0L<5[@3]/H"F>6%,V0H8;^%&C,X-WT*K?H`D3&S7`OO` ML2]04*)&`F(B9G&533.+K7*7\0A+A`G(;(6JY\T(A?16>3DWF%N\CM.4OIEY M(6D#V22V%](/>,<^#Q1NDQBH&RT0VZ\&F'2$8;8ENEWA$!,];Q/\!9?U2%_6 M7RE9@!(2`QB=]$1![SY9T2K33P=J%K3C62#"M4`U'U`J,P))SB%)<4F#&7GQ M+"?:!@D*DB3[1E/V@OX2;#9Y]AC?DUP^>4)_//K3?RS>?/]N\>;-&^9YY(L_ M+;X_>EM]4:)S?)MO@_P)';];(+;_F%*=;-?;HD1OC]AWY%_2)AL@FSR@,V/7.-SF<4D:3MU!R\EA'$NG/N]D,EKG#J=6I&JD/4`.CVCA)B@*Y2J8D@ MV%?TG00*U'<'(]CET'!F?YGC31!''Q\W."TT)B^AA3%WI>*\J0L)G9NY0HN> M@=2TJ"8&-N\AFN.*&*A7FJ*M/>B/PNP>WP2/F!M>2B.0D!:J'U(HWNV#!(0` M_8]4"T'DIK2($?O4_U@C*(-'+WJ?:IULN3J+BTU6!,G/>;;=$!V3+!"IM[($-)R;V,K.WFWF! M9J*$"D%AO84W`-Y-T;`>K++\@`11W)F@V_$#]8[#D=&%@:*D^P\+%/10`KF_@Q<%WJE= MX2#Y6-#-G[M7<)G3_*-4+"MJN6#BA"$8/D1H6)Q'!R-]>O9&N5#%AG9\J&$$ M7+@=,H(9T<:(&!/;>].RS>?S1KM)9X&SH.?BZ%"Q/F4`N<-T M)H`?VDVG''.@B;(X3I$6=[%^"]XK*\PWF-2>?H$EH8_U8JSKNU MD-"Y-RNTZ!D.H]U9#+#CVFLNGLQWXZE3M#.X4U8J*1=78)?(Y&MC0(MB5H>4 M72YY*U>_(!UEL'KNW.!3'-S&"9OZ)Z-05I_C+DLBTO!T:%D^:2H3F+/#N)(M M/-[93'F=NZ.=8CW#X]C;.83R";PBPL2H"D[`O[,IGW)TY:+Q)VXO@R?]F0`9 M,>PI6['JHO.U74JPD[4B->0'*6MJZ#U<@W3?5-2PIU?'-3=\/AB&^19'7!C1 M.JF,'LQ/U0#V7%5,#.&M*DU$%D3I$<<`[[.#$"0[!C#/G:SIP?WW2U9BL^Y5 M2`GCLPJE>6\5D#GW4ZD./3-AE)[TI^9:U[^B39:SVXVR%4H9$-#.=6RK@[OE M:;")*48<%'AYF\3K:N>XVD-U3%!%PTR@=*N%J3@`RH3IU1$4-F),B'$AC@W8 MLX>!Z3MY6.-+&+YL)\F+.9D)SS2-E@H^@S/5Z::1(B'G>R8\]<)/F#R_PTY. MVL2K8T]^6P%XHF$\C_?D\%Z3MV#](\35('F<+I$S;PD8IR MB.+%T(3>XQ171^%II7PV(;#&:2BW3R4'4#C7@^@$W1($(5")=WA^UO4FOGRRZK;N6D+//X=EO2'.TFH]T2K6Z?)425=5/` M4WO+V+0/@;J/;(ZFZMY<-N43`.XXFU[]GA]==S9%5H_A)WGK)R'^4:C,4/=A MJ"T]"SVKX:31*L&`LQZ7>7W*B<%57;HEI`0KK"M3>J^L[CX91%%=L0ZB,J_U M>;/Z)LOZ/I^+HMCB.>^4TA8TF`:!7S4,IL+D3=D">T!%!>B/K]\WK'#;OGIJBN4@VVY5V6Q[]3N&F68A0S["C+42:_9=7-`&>Z%PD]K[6[ M_E9Y\V&/#&Z8(U)W?VS#TX`,:/H*"`<`N_N#/8FZXW7W*=Y.@<:32&L'91=C MNT'VJ`JQLC![]-WB^^_>+GXX_H$-2M%+`S=$/`[IVLLQ$!<=[.7C_1 M4;!&"JI*?'3DH+KFUDLJZA6KR$,76(D\P*`/"]RKO@*Z*7SI8B9OAXRU0]AI MAY@)`COB"?NFP2N(ET&$:J.N"FD;BEQ'1=` M-7$SE01EJRM&U'"BE[R%ULROX+J:N9'YU)?,C]63SF(\4%QS0I6(G_M%`+`[P6*'06\[P64PVXY1H_@\!QJ?8O(\^#R)P\;@JFV3 M9T]I$/YF5`[,31R>3W]WH?9SG&8YVVU3[:"10.V3P819F;I\D-VG<1YBQ0H, M91NA* M/DM:1L\&?@Y2"<>FR+AWQ<6MBHJ#GZBT@=`[9ME>%@=:.3Q)LF\T"IUG^5FV MO2U7VZ2IHKR[!$M3J]A.!M#>BR%`.SLO;`2XWW=AKUU_';:1@599CAHIJ"VJ MS=_5-F?U);/]%C"`?D]?8R-;#GS$?T!-20FA.33B'Q&D)Z,N<ZQ<@\'TJ.A^3.$YJ`8CI^5'.!>8S)R5I!#>HGA,+/K'9X, MF`?#\&^HW(.B'"=+J3WQ!/D(64(*[P'*$9G(^F>M^6-O^B;ZUV8/.1B>KMW! MQ\'525/6"]_K+T614L.XK$9YWF4EI,Y=5JF':*VNR)(X8OE;RT3&2:O=C5&% MHFBH.SOZ+QPDY=TIL>UEO@[2^'>FVR7YERA\C?.'.,17^`>BIO5A)@[&T` M2-X&+=B=VZ6U;OW]Z+@D63FC1T7%@/**`S(C*5A-[(^/&YP6)+=2QS":`?)&I^`VRXGN5YB=)JXA2(#* MB(&V>RI5[VSR%%*ZW]JI4$.4!M*?65QEQO(!IW@5ET!W!HS3_796W;7[46UT M9\1,Z9J\B3/@N;>XS_V,HS@,DNOM9I-4&V[/\NVZ4#OR,%$^95%FL/7IE%J. M)WF5B9(]0ZY$(2H+\<(6J!:'&GG,VIG$QM9A8LR$X!N(=69902QJ$7`N7->` M*LI=ME`/S*1KR&H6&)N8OIE>E94U-SJRCYQ'.!6CX8?QF,)&NH MV@P4IF.>XU6`=]-G>)/C,&:QB^`ZN:>'Q:I0)FD&)0>,AQN`X!U<0>["V\R59V?7+6[R+-J&]$\8IQ\'CV$*.!X8QW?VCB318!*4#SB_ MS4!?%MS$F.%,B"\382838.`37[(>K^VL^U-??LQW*<]SAKW9+JA%N$F5=CAF M:-[_KERL+)T240*-$.1*=P8&?3+WXP&9#@I/[!330K`D9\,&XI#$@WD&U3,[=U5`C4?VKK.>_->LK\"6DH:BJX7!< MPZD[JU>#UI.BISBFSG#\YOCX'7,%^LTO5W3;05I5+^]HMH=$1^S6Z,U4IY:N MIIS%O*,LW-*-&:(Y`1-U!!6"TVHZ)!.:P^M9;%KDI,.U)PQU:?O:-V>9B7Y7 MJ9[B-5W9$3GD=.T/N4FKJCW44?T+EN_2DI%#;=-2J]_=IR6F!=BHI5*D9S'M M#<[[/1&[O0&F#QH*`?)^C4F;'7SJN%%/O7C;HX)U4\62ZQX)F%.JHW=K%$!= MSD!M,>12K4^ZFL8(.RL`#P8L^Y"."U0K:@HFP/5B+93>BK&4`V;-6*..9&RF M''<"KAO;HJDF1OD$=X'2N5(5HX7CF1"X/DQ!Y\+.B;O00EMQNB5@=GOU/^!5 MEM?WA-T$C[CX^%CF099'<1KD3QZQ_!F56_;@)EZR1R]0Y^&(/7WAM$BU05KDND7ILYK6JN=] M2BJV:MQPU[A9JP)4%O8,F\9U7T!@UWU8O=M;V9@":L@8+%6^'S][I$"Q3Z*' M+&X1\F9X@%[6'!/G<#;#11L$]:^L;B?O#)!QTD_=S0+9%)8#/L34Q^0);RR9 MZV&^IIU3W6@RSY,\3#8GO%[!-,_T[1:4"1+,"5N1)5#/+X^$:P&HR'T6%[5^ M.-JU0W.I>!?_%=[09DG7'PF#](J/">7[$)\G:"!Y2!XA'#@*C];<)/#R#^F$ M7OZ:>HGDR946QU96J8%HO(;;R,9;O,0ZE`*IP^[Z*W1KMS:\`Y=B[CQ96^^ID?=[-O.AO-#"`"'QD!9>[S'W$ M3.T`.4!'6H8"[AQQL17B_LC+,`WU3@CC<>8)X%3`/^&B>(\:!T7!'NJTBSH& MG>&=[&6[!*4+GN`6##Y'T&D!DU;R(J9JXR5L+!QL)7-,+PX,:Y;9!$`0`M'0 M*J)H-.P%_+.G-`A_0U6]L9#8`LM&YSDF9S`@6#5"[9NJ&:4O=3"48IC+.M-KWO(`M MZR;&2YB-[TKX_EA\ M#[3A"+['Y<=\C@2,:EIGCP5\=D>H3\_^&J[=),^B[WPPD[?#`+F8`I6D*?^# MX_4=T>R$Y&C!&G_9WM_B?+EBRG.7>ZL=990D@!1D'.@VX1@F!B:]&*-KSUX; M82BHI*&4B:-QGJ4%_.7N_=3!<=(P#_):&OK2(J]FFSF)KF*2,A68%'U_;KHQ M`'YJNN!?/_24U,E]MDW+0KF7GZ9&)/QNB>I&U[X.E@DY#36R(?H34`,%`DT] MC=)6-NE4"Y6>WN`$@B]#S=$,#7[#M,7K-:O!,_U^S"ZK(-DM-WFXKC2VYH[[ M33(WXP_[JD&W0X:Z#(QD_.W#5+8%N&=Z+ELWK`-X1]93[O/C\\JNN5$5RNFQ99$D?L;MJ6OT#+%:(B$).A M2*2<[GFE&EWFV4,C#T]<"1Q=I>\/'25C&#W$9:P<40P2![9X="'EOBZVE M%(A]N(-4[)LSM=D5LUG6I>V*I0:M"%\R8O6"ZP1KMGYDR68PAVZV\'I7Q<3; M)SPYXV9;5&Y46]'#-E7BP]H)_@#QE%M*G@OF*2M\^.(3X&=X3J+_VQ8ER[;H M=!"-JW&".[OW;[)I,IYY'@73NQJ*4 MP>V-_`T[PRO<)[3CL"F)+N6"Z@` MFQF83F4U-8O[DFDF^O0WM-=8W8)P'69A;^BY:;-G3_>;Y+L M"4_M#^;)RE`D!4.2[9#@>9"8AJ;G@D,7H:QP,.*#6TJ->'+@.GWSOXL1.Z*K MYYUG]!:VTW[]GFN2M)ZDT451;`,2MY8KYK(GWX(\VA\GCA<'L#=Z`OCM!ND1 MLF!V28]66&6]:98>B`I75>,@NJLVK@6SC=3,U@,FV_&.Z5E;@<@\.!7,@:/K MIA4NN%:H^L-*-L#N:4_M`2Z')$V!XW5ZNB7I;AH^D9$O"=XA7V;U:YK70U]) M\+<3`9-O#H')9Z$V_,YS4WOE>E9K$`P%/L/5_]Q:QFFPB4DRJS^Z82P` M;*N*)<2]C2J&W!#;5*Q4$RW(,T;TLA'QBBXCM5)0+<:'0Q;CD)XRKROV%LF( MZ]%3%B0C2.+@-DZ@%\SZ,$_"D!T%N<(ACA_H=@?C%A*Q^N*`>!T M,J5,W:WA1SL!@)NYAH)K4>0SH1@>*Z;$`!D,FN$1.T]*]Q^DT9#`H!/C2Y`P M@ZL.&&H9'@0/$P5-`TD[Y*^.1M?2O`PK`V'7^/P+,7[C,=C;"6F6X"MX(OP/ M."5/(_F@19MQ//X$T1X07<1L&;P(CWO:F!M=R^A3U-.CF4GM,:$-7.DA\6N\ MW7@8EBYSO`GBJ-X#8=P:^VR^!"-KX3=TOB_*Q8X7Z7NO-M.SL.(D>UX"S+)O):L(U8M'M$WKYM:J)\8H?RK32 M%^*"MF!7)T_?**Q!-GR#;)L&X4K`R@OFN8F`\T%O2J(8@747#`W1BLMK21IQ MI$R84#A)0_"1<)1`YX%P`FW%=F\3`R7%UV"BX&PMTD2"3B$E'V*!>?`;'3W] M3WC&)3<>)S+3)2V^=]$*I-HJ9=YY(=T'5$Q1M$0R-.]^'00BW!]LV* MN>J/VQHGGX.2FN(3]3P'X=$XF(R!2AD*.I=7`?8IID"\0?@8LQ])/P?A79SB M_.DDC3Z2;S;T9],P+&'V).%20E-F7$).^)1+H99AMU?S,V-M)7B3=5GAX](4 M/`^2P=G6Y#A\G%$8O^!I+-3WF8:1"YZ&$CV>@9ANP;,5_LP6/,+W%.TB+/;8E3 M`'IT]/0_Q1F7SGB19LN7*P/WE9/# MN*].?=Y]9;3.W5>M2,]\=N1T#GE&]S6?V;=$<)G'I,/:!`G:(4E=.+(N$#T3 M'`:WZ\R/!"8F?]WZ`S)V*$ESB/LVB_A*$BHS(7 M`3<,L(6YG_6;\H,D^7;*B3-8L8%6.Y8 MJXM%D`C=19[K[6:38#JY'"04ZGF2?;M(5UE^S\9:FMVJQMPP\<82'!]J#%F= M1QDKO?KGW#GN*LA0?L0)`-]P.B'`L-ERRF8#DJS8YK"74%4+-9=!'$G`=TF@ MBHSWU>P6$]_]#E`T?/_A\BM?*0U4Y6QC+:'*8MLU(WB"S-TG1?4A':L469\0 MK%B_1.6]TOQ[5!"%^(4JR"[JJBY0J\SBRUPK[`;%Z:V49K>+@=6@'].^X+[7 M],)TWP'YN#NSE4:2*?NJJ]7DCN/%P@UBIVB._8'M&)D@@]WQ"HL'P%3N`M62 MN3.,=.`D/".U$P^>O<[4+E_J63G^U"-I#=%L^OLA@2)ZBF/J_L=OCH_?,>>G MW_S"59@Z>0CBA&ZH/L]R6DB*:$2Q[C6#,9=;U[4$0SW3D&46QXNR<,N&,'3` M,ZR%%=>(UXPH:#@/R.#JH`CH,9ZTMK/7LWB/**!,AZ?E/""L!]<,SY=ZUM=M M,)CS'4WHW2'LQL)3[/[38[O<%K$#[C*111>;L,-X.WVX%JO-V>% M\7Y;_42W,S4"4,;NH@QY$:23H3+`HL&D^*J[-CLBZHN@0:.#HW$,O.YLILU;D*[`8,B?V[NG,EY)MLZ]`0X\'[QYR/E)XD)-D35L:6J4S M,QHNJ-E$(S#=R4(E"\!"-05,Y3=;R^>@_'[9%G.*B M(&..VSAEZISA(LSCC<&.#U-F&&^R@\8[E1FG<]^R4:MGE#_CE)A;HI@4=V]T MO/9I]"$HXF*YNB3-UJ0Z-_BQ_$`4^573(C:"8(W1'K+(,,VE@!FIK8H]@VT$ M(4X26^A@LNB>7EX:^CN5AYA`H.6>R9#7K@KGG\M\':3Q[TS94](_94D M'LAR5:]C!/&G#$X]B6#GOCZAUGWW9UZ^W/=R'WJO MOD<3O-?Q.HU7<1BDY4D89EN:Y:TO28N$,2ZT_=@HD4`]V@3-T.G;1LASW\N- M5E9B\/O=&NWP.+%H)Q54P^GC M4P#4VY^`V1-3E&IF?OZ[L\4=?.@W"4R1\\%YW/X6W=U=R)J@;L((XV/FD'CG MTG,Y]RI3E90[J2]2P09Q9H0W]4W?.[%>]`&<\A?I&;XMB:Z[R[JITY1/7$L0 M=\1Y&<1I#>>D*+!-ES'?XZ!.7\[;?-TSG/,\"^`DZ)Q`E/X9IX@^L+Z?OKV3 MOGHF[YLO6?]8/;?UW>K)K_SJ)@%;TR;:S7)>["*]PD'RL:!+/^2Q_%T>JJE5 M2P&@I\@L(`H.E!EP0Y\M,U9188K4KW,B!6$FAKEWYWX6L)-FDZ`C?D:EH$H, M<[#.S4;S3)J*011[*)3SI=8BO'$U+4R-LTGY?7(WC9+F#E=XZG'C`'(^5P'< MNB#.P@)26RGXRK/B@YX(8*&A#[V;Z$'"1A5^HB-"O*X=,P=P^! MR5!5SN*-#6F'C#)Z'ZS()#HQ%O^&7`.13#L2^EK@Y8K$Z_B>A7[%D$=&"9!P MJ95N\RHQ&4SZI-*E]ZJ_TJ,9*YH95>2.,R%K79Y500IFL4AV!)1!Z6+L=J#!GO+`9N3V"KO/!I4?B\YQD!$!^V&1% MD/R<9]N-;I'*6@I,$C40+)]768IPGFH-TJ]?14!$MF+A+X+Y"(-DRV=MR9,3N[\91:]*O!%'3T]LF$./PP$EL M0=!+%SYE!0<"\':%DNAY413$$<^V.3T*PZZ/8%K=!@6.:-TOG!9&=RT,DP5T M\\(8X)U[&(8(2U7TSEU0KTS/ MD"@+8CQTFJL]J$_&3X1M>^_-.0@1-%U?HN'QQ\"4_8"2P0L3TP4KSL8X+@]B M\T@P,H"MCKSF<.>U7DU73H=+,Z9X#SH"C_@ M=(NO<)BMT]@@7JL88#Q&#X'W%#FUC6.";57G\X2X,4:*G?>:5D` M`KTAC#;8:^AA`KZ14CISB6LVQX%_$MUWI@Z[0V]2,("%6P37..%RN;H)'G7% M@4PX@8JUF(/JE&G1L[DOT&*J4[]F2>=V+;:_@)[#,KMJS(L)&^$58Z6^EI"6 MS1^K%,'1F23/XX4]]A72&&-M8R^I4;YB)P,]F*N9!)FEFX'ZUGU<-F7O3MGF MNS5.0ZO[L.UD@'F=/=`]%S07`.&/MMH)3)CC\B7RZU$9]`-60CRV3UT?82'! M3PLUB+*-D*K<7,=DO9KSGP@OQP:X&[0N9OHSSM9YL+F+PX`X!@YT6V8,^(!V M>9H"ZNSHU#&YW[UIII'@Z'"T)01/W2JU.RDD+5EE^;T_:[:UGE=XD^5E?=#` M+/H;<8(:H0DH@1FJV*`,4:]3?VM@Q8E:5K^B^'!@-C[&8ZL_?R+*D+_)7^0# MW29*_OA_4$L#!!0````(`(>`C4!&UL550)``.]AHA/O8:(3W5X"P`!!"4.```$.0$``.U=7W/; M.))_OZK[#CSOR]V#8\M.,N/4Y+;D?SG7)9%+=O;VGJ9@$I)P0X$:@'2L^?0' M4*1$4B0!D*`)0JZMVGALH(GN_G4#:#0:O_W]9>D[SY!0%.#/1Z-WIT<.Q&[@ M(3S_?!318T!=A([^_I__^B^__=OQ\3\OIU\=+W"C)<2AXQ((0N@Y/U&X<*Y( M0.D,$>@\K9TI>H:A\Q#,PI^`_2:A[WQX-WHW>O_AW:FS",/5IY.3GS]_OB.\ M+4V:OG.#Y?%Q\K5+0!EUUB_^[-F[T?8O5\F7`_S)>7\R.C\Y.QV=.;]^.C_] M-'KOC+]M&WYCG,R0L*6/\!]/[&L.DP:FGX\RPWMY(OZ[@,Q9Q]/SD[3AT:;E MIQ>*G$Q9O]'%Q<5)_%?6E*)/-.[_ M-7!!&.M'."ZGL@7_K^.TV3'_U?'H[/A\].Z%>D=,!H[S&PE\.(4S)Q[`IW"] M@I^/*%JN?#[P^'<+`F>?C[PU0L=\_]^N$TBD_XZQ=X-#%*[O\"P@ MRWCT1PZG_V-ZEV/#6V/@_LG5?L+_?")'Z:3M@!]"AA]._RK`-/"1Q^%T"7RN MI8<%9("4&ZX,G5<8[#TS'1PN8(A8%H-VQL?TDGL\D*DEC!;81?1;#[ MX5\!NKCU@Y^Z1I^AUWKPUXBZ?D`C`K]`S(0B"9*2;AJ'POP[8GS>$T@9QRI. MHIZ$QB%.(7.@`*._8M*3V0.@<^_JCKZ*BH:!WJ'GR$-8YGG$/@WE-L^^^SW((3,^:[Y8)JS5$M4,QLX#$A#^6^[:AS2 M#PHG,\8Y8LL%]5$5>VL<&/\I8*L9'$%/=;(34]$XT.\P_,J6\_>0/"S8*D!U MA'O=-0[M(0S][6]1R+]Q>GIZ<>H<.RFA M[(^,J+.AZF3)QB-G8_<#-_<%GX=0`B+2`O_-[W7C'C\Q$0(W3`FQ%2/T-Y0D M^YTH#3$13SR(>!1KQ'_@PQ\=GXZ20,[?V*^VXWAD9(OC+/SY M]X_G[S]>7)R>?1R=_W(Q.AM]/,^,,`N`,!_*VN9R18*@DP&44@R4U`/$@^'XV.G(BR,08K3FVWD>U2$6,V,(\/[M8' M\Q)-Y/X^?%6(V4ET<=:#+E*&V)H4!8PG[YK-,S76D6LW?-W(LY7HZ+Q''=VR M.0OXFZ'>LM_1&CWMM;5'5W*L)?IZW[N^_A<"(J>M;4O;=%7/6**I#SUH:L// M%,X19P.'W\&RS/F5-1N^CJ2Y2A3TL3<%73'."-_6>_#EO^&Z4D.%=K:H2(:M M1$>_]*"C31`C8^K5JXBJIL/7E!)GB;)^[:4:S5\%`9G?(`SY8<^SE+T4E(.@G-QKB<`?H4ZR^BQW,`5AMP0C^DZ6^* M*$U^_?MV:)FP^WU`44TP2*UK+3I`KE2_4U#A,2NMT' M1'-6.\#)BFWV"9L!X@!,+Z[!=8.(\3^%+F2R>/+Y86ZRZ*MR%#5=[("(,H>5 M@LZ;V\IWK[KVIN!P*4N*L,Q@X8#6F: MP<[YU<.ALKT=>%!CKS+F.V!`W!.X`LB[>>%Y4P(PE+:U`PCRK%7&E0<,@DT^ MSB-X@9E54:5'*&EK!PCD6:L,7.L`P2]]QA$FLVM$5P$%_A<21"LF$C_B4V9I MGJI@*]&8H!UPTLQ_9?Q]P(YG(R(9&%F(#`EE[X?S%94=A,`W1MF%2QF[53A/ MA:W'@$172Z#1E-/J4X,!^X?=K9?=79A[$C!W&=9$+@2][`!*$R93C%@5Y$R9 MOO?!YGCNSPBMN#2J`5+7Q0YT*'.80L.R*&?)@EXXV0AZV0&0)DRF&.DF/OJ^ M'XQ<)R-GHM@(DEF($"+UG>Q`2`,>4X!8%3*-KR\E$A#AHK2M'7"09RU%03=Q MTI[,4KYF M"M>"Q!K9[L:!HVG*32N&.SA*[S.O(BG!()=1D6]L'!Y:Z;4ZRT*":TLS;TC$ M!KX3JA`DY>T/`"<*C-N8BI,MYE(/DI*6ML-#EF4;,W>NP`KQA1($%$Z>?#3? MU(:IQTA])]OATH#[3K-\>MJL9*2J\3RW)57;L=>%>&S,.))>$QW>8DAM%=3- M-KQ_5.S"2_)[[_T^!X052>8[35KJ"S8!GC]"LLQ71"Q'2TE3DT$BJ=429,@R M:N/&NV(%*(S<"_M9"95F7-NX"\](4SS;6(D%$7^ZMMBEJXZ>-DK\;C8*TPIZ MA3*`Y7ZBNH?)J-"RN59DW<:$U7TA;C=W]P&)=1N&!#U%(9]U'X/R(I_"N^8Z M/V([+%]!6KJR<4U"\GTZ]%A^==?'2UH:AZE7`$%9DIV<8*Q<9^^JFM26'B@T M>P..M%1L7&6//0]MV+@'R+O#R?ZCZE"TO/4;AE2%8^/IF$2!<5Z*_#L,)[-' M\%)][JY"Y0UZNH1FX^7Z*0P!PM"[`00SZ=*,G*[A#+FH^L**J.,;\%K(R<93 MM'WY2V\FW["D()=.S]IZ2GG]AG`\@-V;(Z7(*3;+RN?7TX^_CCZ>'2!NI*1B MXU&;'FEW&O)Z0VC'LM05TC4T\Z`T'-DP\=\X+':7?R#/O[9+ZO4`>OT*N87G M=;/JK"F7^T&^7*[S[[E/_,=;^5Q=<03?#WYR0=\&Y#J(GL)9Y.^7B!1D[ZO0 M,,XQ-"Z^VYIK2VKSYL\!F)U.2"Q3+P[N[A[.E#A=J>IL#6A:L&O)Y;&\!#8E MX<=1N&"3V%^[6:(6)<5.EJ)#BLT.8MNFH.*.TD@)$9L.5J.AAL4.0LJF(*'Z M+0W)7E9C0L1G!_'?GH_<%=<8$CVM`4A37CNHZ]HS2"27%C4];`2%RJ)"9_S6 M"##4KB@J6ML+`O%:0F?NZBN&IK:_I)/9]I[A-J-9$)8ZJW_%:4?;F MZKMM1R2(056V[L,T_PL"/UQ<,1A.R!Q@]%[_&_3XX MFI"R#4W:9&!CTG62HTG#G7R395ME-*FNBVW84>;5QFSJ:\@&SS92L=JP-U[R M1)&-%55`I*:';0A19=7&W.:B""57K+9!08H_7?%FD[*DMBYQE]]?-7?LMS0. M!0K[%5EV.K@>WT\U0ASD.4Z@+MBJ"OL-&0/-F.O]/)(_7,_U?'9Z=G81:SE^ MRGX*XR#A*.HO'B0.`H>KI'%'O)2C'6A18J.UF+ MD@9LZUH_F'3U;+>(OF5BWM00BI@T=N>(EW`6$)AYGNCFAF9Z M+8U7(;OYV/`Q]RH2T97X982;2B566G9\6YXC+ZLI7'$1XOD-ZU!Y^5$;?7M@ MJ5L(G66@O?+!4IE8O@"$N=PF.*V3'U?,WV\HJ-ZCA_B0,=BA!#HH>MC3\\!L M?5)S7K%K,&0@"+CHXN)U+\<3,-RYW1:++&4Z0\:&'F9;/QYNS'(^)P\9@%BC M_%K%MHY1]^P;TJI@Z34?P8EE5?,A*UN)IRZ>\^Y_LU.V/63BN`04N3P#$/D1 MOR%1MD"J#;N=G@/K\D__`]%\P3@8/S.SF,/O MT?()DLDL9C)3GZ$>%"THV0(4W2+HM/9Q;PEJ?"$P7L:5QFHCZ]QA^P&-B/"J M92N:QH%/^11#)^/I0G_HA7C$VY_&&TA#`:,3!4VVDV_[Q@&$9,'Y?K'Q1Z=WA[DW/LANAY M4[E><*E1F9!Q"WL9A1:L6@?+1E5=&OYYOR:MM,D.Z&2Q>F'^]DO##NMPX-1: M*IUNC8Q`F]UQI%="EFKPJ*L=2D^(&GO_%]$P7C+R!3TS,A?Y,.?+'P,]2Z`N M/G4XJ'TUZ75:H#=",2RW`* M@<_K@:>AL0J("?N]`:VML-JN`^`UHC234:2J8\DZX(H_PBO$SYR]* M,C.YVC>3!^!#MF3E+W?PER4=23##EY:ZGW29=*! M:(XWCYVZ:[;P99;H9H_:?V"2+'XK?)T*B3=L:I1;VYH?9NXWF.`9UQ1>P\V_ M&5%?@14*@2_.B)4D\(9&;5+KH.I'[[YQ7R3[KT1+8W"_JW'H:PD!&4Q)2J'C M^K3]G:<5Q)$N1>*[$-R@L=<$6_5D#A%G#232A\BHN0%T39Z M-A1@Q86J=_L@2F$H/\&5=3Y$6$G+H9,2N0:B*MVPW(-UH^U>TN\0L20C@@[> M*^_]H*A4$B1BK"#PA/PX.*."HT+7`X62C!0Z#4+UA";Y%#^%!-UV1(U#8+_G MY;HEJ:M^K4FO\$G*J#SQO@+$K6B^8;A+06JKVFO2<8"\J;?VNF_HU":UUM5_ M372G%3+A<4JJXZ)H#2'CH*GIHJ@JRY7'!;W4B@?KQ#;'[I\1(O!A$9#P$9+E MAJWXCQ40D.IKG-8U:7$?'LW%T?&A94_I&$S"+H1>?'N-9TSQ:F[RV)+J?$#@ M:BX/&VOO[-G:-\"T@B%9\Y?*V6]6_,^R?JNT\P%AJ[D\['SE4U[2[2,GDD0/ M!XT=R*G3HCP]1??+1O':9 MKD#A,)'51"AV1C*R'GH7YOF&<#RL^";U(O`9YS)QV'H"AP.UEC+IM,3!F>F+ M\/81,TFBAX/'#N2D*R!A>L2L1$:M(V;2-`\'H?K%9&-%!7GQMW:8AP.]EC+1 ME69N4L3L9C:#;CB9W;RX"X#G<,I6K!/,I33&'O^'G_D]`[_F>%Z%Q.%@K;54 M;*R%4,[^/63C\HKY^C6SK"R)PT%;:ZETFB[>TX:W7"ACI@)"UDS:_P!^I`:S M0M^<),_.WH\^]OSPS2OC2T8@/8GCQTY69O$':# M]P-V/>'K(5JM_/@(#_CI$=X=G@5DN5&YX&$BN=[&^3#5<\LV?'80?NOGKNBF M3LT]0%7E];)-S%-Y"Q7N`T+(JHVGCYE*#IQOYJ>K+P<7&EH/!RF&;90=BKB+AMWD(4S"QMR5H.N$[$8U:I]HKJQ9G;!^-G@'Q^FG\;$'Y' M@1?/9<(H($JREW&`Z43%.R2U$4NGD]M($U#&KALM(Y^?CL>U8GCQ;@(7$%/T M##<.NP8P\KT/$C@MQ=/I1*@+0.EK%VQ:SY3SJ,%,;8>#A(FZ1#J=@W0A8WM' M*7XH+Y/T4_$<8S5DFE$Z2"QI%%6G&3'*(-.U#B_-/6.^F%=MK]JR"WH=&M#: MB*73.S7;W%'=+['O1/0%8F8[_E%.C14/KH].V?^<8V?7F_U'2J`'\%]&%&%( M*5N&/#$8<"%<0^H2M)((8LIV[L.JT[%E!X2]2T`1GKHVZA$=)`S_;-_"8F#.9.3ER/5C%A,P!3I[3O&)^ M.?"1!Q*M9LD8XP/:JG*[#=4F MA0':>'W*IL">^*2UOUAW[HSGV(_.]N/';.O'?//Q::??-#) M?+$'FRE*8C<:@0.0Z=A/KD9&S]?PB;\O]0V0/V#\1#+'>KC.C)69`"0A0#A1 MQ^8]!7F?T=7GC',Q\D#)YX>\HG@&[97N\!0"_X;R?1>30UF1`X$G^ECGB;@C MXA]P-E^(/5#\#2?]B-XL#-=S"$WT"\_REW#Q3(CU-E?SS:^GDM-H>?3*."AQ-4"3>P@9,Y>`0H_GB4-,%8Z!1R699C$])R;HY"CV<8&6 MC^6.4N8^KR/"3_@WE\BY(I^*+(NNTS:CU=/$G>AC,LN.:@KC2P%7`0UI/.Y8 M2]NJ=>)YNPU5X[Q`*W`4)F_M@AF@([D%B,2W]#,I.G>8B2W*O>TC\"@EJ6V< ML!-3YIOA+6TG2[P'*]ORNQNL:-E?WZ4/5U$V(I$CJ.UCG)G+J"EKS>K<#=%6 M`P+1'%_QC'GLKA\)P-17F?A+\K\2FDY*U,E2[0/:E3R*K%2B8R^VFA^7_(Y; MW-$\JY567LYVFS$Z0`.>PF>((\C?4)UCI&"X)9E>"2TG2ZR76NA%E@1V6M=! M4W)F\0,<1T_5.9B5S8VS+[&P,TF5:FP-T)KXC;4`A^RWK.<\K1\C:5$EV55Y M>LZ68!]U9$M9$[U^(^BDQ;K*/U)[#"3H8IR5R0E_:VE-V!N@M>7J$?`@[1A[ M$C4+),VQ),4H1VP3%N:Y19EO.O%'"PV3S_:1)5Q2L0&&D]DC>!'E/,OT["7Q MN:P(12C.=Q9T,\[D%527RW5NPN<@;3^^:<56Y])92:.2K*0\F7[@O$1A>KDD M-QSY,EIJ-'JR6O$0)6Q8@8B)%JVNZH)MM^5_@)9^A[V(R62=N8/U!09S`E8+ MY&:*JTDZ@9+LJ/0+^7N&NX\XV:_T05NT4F3N%\OU6@WPYK" M54#")#E!S@%(]#3.ZJ65ERM%VY#1US7OWT[XP/D1%_N/_P=02P,$%`````@` MAX"-0/.'!\+P!P``XS\``!$`'`!D>6EI+3(P,3(P,C(Y+GAS9%54"0`#O8:( M3[V&B$]U>`L``00E#@``!#D!``#M6]MNXS80?2_0?V#]U`+U1.R`U3FDMQUO,&HQYAPIW5!`NDG M:R8,\16CA@7DEIL5F2BI=<@5(XL-N>(WS)"Y#,TMA98,G[P>>`/OU>O!B*R, MBWM[4"AK,Y$![Y<]_M9;V^I!G30L]T>#;SMFTG6LQ1C\FKH'0^/1MX1 M^75\/!I[K\CYIZW@)_`DY/=*:G_%UI1`+(0^ZQ6,NST>2+4$I9$W_.O3Q=S* M]5+!\=U"17Q/'%MRA>,A%]I0X;->'RHID76]U8-30;&(V!`FF MN+]5D.(`'2GZ6ST6,1Q1'Z1:OV,A32)SUON6T,ARUR/4&,47B6%[`HG8B0") MA)Q2(:2A!H::_8TM<61LCL?,5@[/8(#\YZ!\AMS<@-"5C(!;<&PP@;C4B?;&'@N8A$,BB2 M8IT.RP!E[`0^GIGXS3['BFF`M*&Y@(9,.Q-Q:?HT\I/H`8H[RYKULM:Y+=Z\/3W?DQSWHGSH^2Q\?UWXD=:+8 M1R8@PV2,59M=G'C`B8??TE8+?F2*7<";`@Z[%`[9YG/!Y7+PZT3<1!Q5B;`@ MF(**,!TM3;1<,=AN4,'_L4;/PCE;VB0.^>&*^1'5&G8.?BU=;53=-!Y7:=P' M1SYS>)NZRAUT!#<1C"LQB!C^>?\MX3S0GHKS&\HCNHAP"S^'R$$HKQ7%8Z8Y\Q,%]K$*=^T!W+2^KM): MZ`*>R;:3/O32QVXLYUE'9-=3Q_K]K$_%%:/1>XTK/(CBI30,%H@;#&\STRXE M-[MO7.PBN0A,4F3+JL4F&7A'J(M08:1J^$#S5VYR?JDG)U/N@M\4_"^:S4(8 MLQRVL=7XE]ZZ*?BU2@'HXP)DB]#QT,0#/DEAN$B@K]))XKU2;EY.JKP4<;H3 MPP/HN63F0FK]F:GYBJI*>BF_=A+BC:J$``!!!`(0Q&)T7#1Q,3?2_VJO[B9R M'3.A:_=8#5)N9FJ.)RP.26\*BT@=/TW\?*!<_4&C!%+'!RZH\#F-ID(;9<]/ M*W/:?>)NQFK.,1"06$3,/5M,4@#MR&LD3RK&EV*2*,6$OX&-B=!1[0?FD'13 M5G-FD6&1'(P4T#JNFD^@8(&;P!]?+E,#J@=-%0DW-S4'$QD&*8!TE#2N$Z3` MA16T`LIR*@P#YTUEN5`OY::FYG!A'X?D0!T]C4=ZD,`56T$.YS<,UUNP33_W M_62-;D#W9L74GLP4`KRN+/<>"N,FN.9\80\D72#BP4*A+V([*PFFW77#H'D8 MX-YG"9FFYLQA_Z6;LII3ASWUCH+F0Y\@@>78IG#U\9')I:+QBOO5"_WV>F[B M:LXJB?"8W`TN&C.1_115OG085%3^CU!>(_D;LP0-NZ6QK33^3T9-=+K>NG MPV+E)OS:K^P\!<^E,D34UKTV5>&F5;X7,KU9=:C@KWZNU\>FOG?4/_8&=SK( M;6QCPBX([4S(]5J;8+$T\P=+>3,,&,>:7J\_\@"@T89:'7SH[Y0?$(!JD?`A M,2AK801.,`+>F_]D0['HN)T=4EP^ABFHG'YH@BUQA7B8'9%2>UJMC0BI7EBD M1/>7E,8'CXA:Q2&+C,Y;FL9'5M1M5P@X+?WMJO<[7T!RIS[LQ=#V78W@/;(\ MLM>U9SVC$OB\TGG1UN6/009W;X:M,7V"DPFH<9,@PDHQY#6[,XM(^E]S[]PBM6ZE M_PMH;$#N+IOJR$D\+'ZYS/A[@?U'W^3D_J&BHS'9;I9?% M\T?*!1XSS@2DQUAJ&LW"VD1YRB&[($^C\8AX]>,!!D.P^*QB<:IW@C`B#'*^-SV^I"G0>B_\&\3)G]OT"H?*W MT/CV90WZ^D]6E[[9RKS67NWYI[0O&A;^!4XJ3KD$GM_\^HNSBA/WBSV_*U?I MWM.N6].EZOL[+"YAN[39+/#\D\'I,-W3P^._4$L!`AX#%`````@`AX"-0'LI M@O-\@```)E\'`!$`&````````0```*2!`````&1Y:6DM,C`Q,C`R,CDN>&UL M550%``.]AHA/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`AX"-0&TKJ16O M"P``6;X``!4`&````````0```*2!QX```&1Y:6DM,C`Q,C`R,CE?8V%L+GAM M;%54!0`#O8:(3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`(>`C4"0ZCDW M[RD``&B6`@`5`!@```````$```"D@<6,``!D>6EI+3(P,3(P,C(Y7VQA8BYX M;6Q55`4``[V&B$]U>`L``00E#@``!#D!``!02P$"'@,4````"`"'@(U`7.0P MIQ`8```UF0$`%0`8```````!````I($#MP``9'EI:2TR,#$R,#(R.5]P&UL550%``.]AHA/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`AX"-0/.' M!\+P!P``XS\``!$`&````````0```*2!8L\``&1Y:6DM,C`Q,C`R,CDN>'-D M550%``.]AHA/=7@+``$$)0X```0Y`0``4$L%!@`````%``4`OP$``)W7```` !```` ` end XML 20 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6

Contingencies
6 Months Ended

Feb. 29, 2012

Contingencies [Abstract]

Contingencies

Contingencies

Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has recognized, in fiscal year 2011, an increase of $12.9 million in the contractual allowance and related interest expense at our Pasadena and Garland facilities. For a detailed discussion of this, see Revenue Recognition Policy under Notes to Consolidated Financial Statements. Motions filed seeking a refund in some cases in which the awards were voluntarily paid have been granted and the Company has been ordered to refund approximately $3.7 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. In September and October 2011, the Company deposited these amounts as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. We anticipate that similar motions requesting remand and a refund for awards voluntarily paid will be filed and will likely be granted by the 345th Judicial District Court of Travis County, Texas. If and when these additional motions are granted, the Company will be ordered to refund an additional $7.7 million, not including prejudgment interest. The Company has appealed the judgments requiring a refund to the carriers. The appeal of the refund judgments will progress simultaneously to the adjudication of those cases remanded for determinations of whether the services provided were unusually costly and unusually extensive. Voluntary payments made pursuant to the Decisions and Orders are premature payments by the carriers and will likely be ordered to be refunded. Once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in the underlying stop-loss fee disputes and that voluntary payments refunded to the carriers will be recaptured.

The Company maintains various insurance policies that cover each of its U.S. facilities; including occurrence medical malpractice coverage. In addition, all physicians granted privileges at the Company's U.S. facilities are required to maintain medical malpractice insurance coverage. The Company also maintains general liability and property insurance coverage for each U.S. facility, including flood coverage. The Company does not currently maintain workers' compensation coverage in Texas. In regard to the Employee Health Insurance Plan, the Company is self-insured with specific and aggregate re-insurance with stop-loss levels appropriate for the Company's group size. Coverage is maintained in amounts management deems adequate.

The management agreement for the Second People's Hospital required that 1% of the drug income, and drug income in excess of 40% of total sales, of the hospital be paid to the government. This requirement was designed to control the cost of drugs by discouraging the sale by the hospital of drugs purchased from other than approved drug vendors. However, the local government has not published a list of approved drug vendors and therefore has not enforced the payment provision since the inception of the original management agreement. The Company has been advised by a local attorney that enforcement of that provision is remote, so it has not accrued the amount that would be payable to the local government if this provision were enforced. If the government were to enforce this provision, Dynacq-Huai-Bei could potentially owe approximately $1.6 million to the government for the period of time since inception of the original management contract on the hospital to February 29, 2012.

The Company is routinely involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our Texas facilities' fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure.

X

- Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 21 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "
"+ text.join( "

\n" ) +"
"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "
" + text[p] + "
\n"; } } }else{ formatted = '
' + raw + '
'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+'
'+formatted+'
'+ "\n"+'
'+ "\n"+'
'+raw+'
'+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 22 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6

Basis Of Presentation
6 Months Ended

Feb. 29, 2012

Basis Of Presentation [Abstract]

Basis Of Presentation

Basis of Presentation

The accompanying reviewed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $1.5 million and $1.3 million for the three months ended February 29, 2012 and February 28, 2011, respectively, and $2.8 million and $3.2 million for the six months ended February 29, 2012 and February 28, 2011, respectively. These reviewed financial statements should be read in conjunction with the audited financial statements at August 31, 2011. Operating results for the three and six months ended February 29, 2012 are not necessarily indicative of the results that may be expected for the year ending August 31, 2012.

X

- Definition

The entire disclosure for the basis of presentation, or accounting, and significant accounting policies.

+ References

No definition available.

+ Details

Name: us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6

Consolidated Balance Sheets (Parenthetical) (USD $)

Feb. 29, 2012

Aug. 31, 2011

Consolidated Balance Sheets [Abstract]

Contractual allowances for accounts receivable $ 187,059,000 $ 188,513,000

Preferred stock, par value $ 0.01 $ 0.01

Preferred stock, shares authorized 5,000,000 5,000,000

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Common stock, par value $ 0.001 $ 0.001

Common stock, shares authorized 100,000,000 100,000,000

Common stock, issued 14,543,626 14,426,960

X

- Definition

A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6965416&loc=d3e5074-111524

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 02

-Paragraph 29

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 02

-Paragraph 29

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 02

-Paragraph 29

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 02

-Paragraph 29

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 24 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6

Fair Value Of Financial Instruments
6 Months Ended

Feb. 29, 2012

Fair Value Of Financial Instruments [Abstract]

Fair Value Of Financial Instruments

Fair Value of Financial Instruments

On September 1, 2008, the Company adopted ASC Topic 825-10-25, "Financial Instruments" (formerly referred to as SFAS No. 159, The Fair Value Option for Financial Assets and Liabilities ("SFAS 159")), which permits entities to choose to measure certain financial assets and liabilities at fair value. The adoption of ASC Topic 825-10-25 had no impact on the consolidated financial statements because the Company did not elect the fair value option for any financial assets or financial liabilities that were not already recorded at fair value.

On September 1, 2008, the Company adopted ASC Topic 820, "Fair Value Measurements and Disclosures" (formerly referred to as SFAS 157) for our financial assets and liabilities. Management uses the fair value hierarchy of ASC Topic 820, which gives the highest priority to quoted prices in active markets. The fair value of financial instruments is estimated based on market trading information, where available. Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value. Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. ASC Topic 820 defines fair value as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, ASC Topic 820 establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:

Level 1 Quoted prices in active markets for identical assets or liabilities.

Level 2 Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.

Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

In January 2010, the Financial Accounting Standards Board ("FASB") issued guidance related to fair value disclosure requirements. The new guidance resulted in a change in the Company's accounting policy effective March 1, 2010. Under this guidance, companies will be required to make additional disclosures concerning significant transfers of amounts between the Level 1 and Level 2 fair value disclosures, as well as further disaggregation of the types of activity that were previously disclosed in the rollforward of Level 3 fair value disclosures. Further, the guidance clarifies the level of aggregation of assets and liabilities within the fair value hierarchy that may be presented. The adoption of this guidance did not have an impact on the Company's consolidated financial statements.

The following table summarizes our financial assets and liabilities measured and reported in the Company's statement of financial position at fair value on a recurring basis as of February 29, 2012, segregated among the appropriate levels within the fair value hierarchy:

 Quoted prices in active
markets for identical Significant other
observable inputs Significant
unobservable

 (Level 1) (Level 2) (Level 3)

Assets


Investments available-for-sale
 $ — $ 18,281,129 $ —

Trading securities
 1,424,399 — —

The Company's investments in Level 1 are in equity stocks at a cost of $1,967,570. The Company's investments in Level 2 are in perpetual bonds traded on the European markets, at a cost of $8,435,146.

X

- Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19296-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Paragraph 17-22, 27, 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15C, 15D

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13504-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15A

-Subparagraph a-d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13537-108611

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 44A, 44B

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 3, 10, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15B

-Subparagraph a, b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 157

-Paragraph 32, 33, 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6

Document And Entity Information
6 Months Ended

Feb. 29, 2012

Apr. 13, 2012

Document And Entity Information [Abstract]

Document Type 10-Q

Amendment Flag false

Document Period End Date Feb. 29, 2012

Document Fiscal Period Focus Q2

Document Fiscal Year Focus 2012

Entity Registrant Name DYNACQ HEALTHCARE INC

Entity Central Index Key 0000890908

Current Fiscal Year End Date --08-31

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 14,543,626

X

- Definition

If the value is true, then the document as an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, POS AM and Other.

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: dyii_DocumentAndEntityInformationAbstract

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6

Foreign Currency Translation
6 Months Ended

Feb. 29, 2012

Foreign Currency Translation [Abstract]

Foreign Currency Translation

Foreign Currency Translation

The functional currency of the Company as a whole is the U.S. Dollar. The Company has designated the Chinese Yuan Renminbi as the functional currency for its subsidiaries in mainland China, and the U.S. Dollar for Sino Bond in Hong Kong. Assets and liabilities are translated into U.S. dollars using current exchange rates as of the balance sheet date. Income and expense are translated at average exchange rates prevailing during the period. The effects of foreign currency translation adjustments are included as a component of Accumulated Other Comprehensive Income within Stockholders' Equity.

X

- Definition

The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32157-110900

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30857-110895

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 52

-Paragraph 30, 31, 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30700-110894

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30690-110894

+ Details

Name: us-gaap_ForeignCurrencyDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ForeignCurrencyTranslationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 27 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6

Consolidated Statements Of Operations (USD $)
3 Months Ended 6 Months Ended

Feb. 29, 2012

Feb. 28, 2011

Feb. 29, 2012

Feb. 28, 2011

Consolidated Statements Of Operations [Abstract]

Net patient service revenue $ 966,716 $ 1,688,813 $ 2,811,689 $ 4,138,628

Costs and expenses:

Compensation and benefits 2,019,312 1,604,895 3,696,681 3,603,843

Medical services and supplies 343,508 365,464 566,626 784,020

Other operating expenses 1,349,336 1,550,251 2,672,125 3,354,188

Depreciation and amortization 160,287 44,109 310,098 90,954

Total costs and expenses 3,872,443 3,564,719 7,245,530 7,833,005

Operating loss (2,905,727) (1,875,906) (4,433,841) (3,694,377)

Other income (expense):

Rent and other income 1,257,844 196,608 1,260,442 977,266

Interest income 338,305 353,763 606,203 740,453

Interest expense (143,265) (9,750) (294,589) (20,300)

Total other income, net 1,452,884 540,621 1,572,056 1,697,419

Loss before income taxes from continuing operations (1,452,843) (1,335,285) (2,861,785) (1,996,958)

Benefit for income taxes 493,030 666,679

Loss from continuing operations (1,452,843) (842,255) (2,861,785) (1,330,279)

Discontinued operations, net of income taxes (169,547) (715,258) (732,213) (1,384,909)

Loss on disposal of discontinued operations, net of income taxes (229,201) (121,577) (229,201) (121,577)

Net loss (1,851,591) (1,679,090) (3,823,199) (2,836,765)

Less: Net loss attributable to noncontrolling interest 56,005 1,728 83,520 2,763

Net loss attributable to Dynacq Healthcare, Inc. (1,795,586) (1,677,362) (3,739,679) (2,834,002)

Basic and diluted loss per common share:

Loss from continuing operations attributable to Dynacq Healthcare, Inc. $ (0.10) $ (0.06) $ (0.19) $ (0.09)

Discontinued operations, net of income taxes $ (0.01) $ (0.05) $ (0.05) $ (0.10)

Loss on disposal of discontinued operations, net of income taxes $ (0.02) $ (0.01) $ (0.02) $ (0.01)

Net loss attributable to Dynacq Healthcare, Inc. $ (0.13) $ (0.12) $ (0.26) $ (0.20)

Basic and diluted average common shares outstanding 14,456,127 14,176,960 14,443,627 14,176,960

Amounts attributable to Dynacq Healthcare, Inc.:

Loss from continuing operations (1,396,838) (840,527) (2,778,265) (1,327,516)

Discontinued operations, net of income taxes (169,547) (715,258) (732,213) (1,384,909)

Loss on disposal of discontinued operations, net of income taxes (229,201) (121,577) (229,201) (121,577)

Net loss attributable to Dynacq Healthcare, Inc. $ (1,795,586) $ (1,677,362) $ (3,739,679) $ (2,834,002)

X

- Definition

Gain loss on disposal of discontinued operation net of tax per basic and diluted share.

+ References

No definition available.

+ Details

Name: dyii_GainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare

Namespace Prefix: dyii_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Rent and other income (expense).

+ References

No definition available.

+ Details

Name: dyii_RentAndOtherIncomeExpense

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Weighted average number of share outstanding basic and diluted.

+ References

No definition available.

+ Details

Name: dyii_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: dyii_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Total costs of sales and operating expenses for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_CostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_CostsAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Gain (loss) after tax expense or benefit, not previously recognized and resulting from the sale of a business component, which is recognized at the date of sale. A gain (loss) reflects the amount by which the consideration received exceeds (is exceeded by) the net carrying amount (reflecting previous provisions for loss on disposal, if any) of the disposal group.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 47

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

+ Details

Name: us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Medical supplies consumed during the period, such as bandages, syringes and drugs, used for patient care.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(d))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_HealthCareOrganizationMedicalSuppliesAndDrugsExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of revenue recognized during the period for providing services to patients, primarily on an inpatient or outpatient basis and from office visits. For financial reporting purposes, patient service revenue is reflected net of provisions for contractual allowances (the amount needed to reduce the entity's gross billing rates to agreed-upon rates in contracts with third-party payers) and other adjustments. Significant revenue earned under capitation arrangements is reported separately.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Audit and Accounting Guide (AAG)

-Number AAG-HCO

-Chapter 8

-Paragraph 10

-IssueDate 2006-05-01

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6491461&loc=d3e8184-115640

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6491461&loc=d3e8195-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

This element represents the income or loss from continuing operations attributable to the parent which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4613673-111683

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph b(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.13)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 10

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, and noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.

+ References

No definition available.

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

This element represents the overall income (loss) from a disposal group apportioned to the parent that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items after deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph b(2)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of income (loss) derived from discontinued operations during the period, net of related tax effect, per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.

+ References

No definition available.

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph a, b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cost of borrowed funds accounted for as interest that was charged against earnings during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 34

-Paragraph 21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 9

-Article 9

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher OTS

-Name Federal Regulation (FR)

-Number Title 12

-Chapter V

-Section 563c.102

-Paragraph 9

-Subsection II

-LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy. It will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net amount of operating interest income (expense).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 10

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.10)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of expenditures for salaries, wages, profit sharing and incentive compensation, and other employee benefits, including equity-based compensation, and pension and other postretirement benefit expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_LaborAndRelatedExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of net Income or Loss attributable to the noncontrolling interest (if any) deducted in order to derive the portion attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.3)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 5

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 28 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6

Inventories
6 Months Ended

Feb. 29, 2012

Inventories [Abstract]

Inventories

Inventories

Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.

X

- Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 3

-Section A

-Paragraph 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a, b, c

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6

Investment In Real Estate And Notes Payable
6 Months Ended

Feb. 29, 2012

Investment In Real Estate And Notes Payable [Abstract]

Investment In Real Estate And Notes Payable

Investment in Real Estate and Notes Payable

In March 2010, the Company purchased an apartment in Hong Kong as an investment for $2,014,207. This apartment was used as a security to obtain an 18-year mortgage loan of $1,245,775 from a financial institution, with a variable interest rate at the lower of 3-month Hang Seng Interbank Offered Rates plus 0.7% or 2.9% below the Hong Kong Dollar best lending rate quoted by the financial institution. The effective interest rate at February 29, 2012 was 1.1%. The Company has paid down $32,090 and $31,651 during the six months ended February 29, 2012 and February 28, 2011, respectively, and the current and long-term portions of the note payable as of February 29, 2012 are $64,319 and $1,059,320, respectively. Depreciation expense associated with the apartment was $12,912 in each year for the three months ended February 29, 2012 and February 28, 2011, and $25,824 in each year for the six months ended February 29, 2012 and February 28, 2011.

In November 2011 and September 2010, the Company borrowed $116,339 and $65,000 as notes payable from a financial institution at an interest rate of 4.5% and 6%, which notes are to be repaid in 36 and 24 monthly installments, respectively, and are secured by specific equipments purchased at our Pasadena facility. The Company has paid down $28,683 during the six months ended February 29, 2012, and the current and long-term portions of the notes payable as of February 29, 2012 are $57,224 and $66,583, respectively.

X

- Details

Name: dyii_InvestmentInRealEstateAndNotesPayableAbstract

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Investment in real estates and notes payable.

+ References

No definition available.

+ Details

Name: dyii_InvestmentInRealEstatesAndNotesPayableTextBlock

Namespace Prefix: dyii_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6

Industry Segments And Geographic Information
6 Months Ended

Feb. 29, 2012

Industry Segments And Geographic Information [Abstract]

Industry Segments And Geographic Information

Industry Segments and Geographic Information

The Industry Segment "U.S. Division" comprises of the Company's Pasadena facility. In the prior year it was classified as discontinued operations in the consolidated financial statements. The Company at the present time has the U.S. Division and the Corporate Division.

Certain previously reported financial information has been reclassified to conform to the current year's presentation. The impact of such reclassification was not significant to the prior year's overall presentation, except for (1) presenting the Pasadena facility as continuing operations under U.S. Division, which was presented in the prior year as discontinued operations, and (2) the presentation of the various subsidiaries (except for Dynacq-Huai Bei and Sino Bond, which are now shown as part of the Corporate Division) in China as discontinued operations under the Corporate Division, which in the previous year was shown as part of continuing operations under the China Division.

The Company had made the decision to sell its Garland facility as of August 31, 2010, and its operation was classified as discontinued operations for the year ended August 31, 2010. However, the Company closed the Garland facility on September 30, 2011, and accordingly its operations for the fiscal years 2011 and 2012 continue to be classified as "Discontinued Operations" (see Discontinued Operations below). The Company plans to either sell the Garland facility or pursue converting it into an ambulatory surgical center, if and when the Company can identify and generate a steady referral source for outpatient cases. The Company intended to sell its Pasadena facility also, and had it classified as discontinued operations, as of August 31, 2010. However, since a sale was not consummated during the 12-month period following the decision to sell, the operations of the Pasadena facility have been reclassified as continuing operations for the fiscal years 2011 and 2012. The Company is continuing to revamp its operations at the Pasadena facility by modifying the business model and controlling expenses. However, there can be no assurance that we will be successful in turning the facility around.

From March 1, 2009 to February 28, 2011, Dynacq Huai Bei Healthcare, Inc. ("Dynacq-Huai Bei"), a wholly owned subsidiary of the Company provided healthcare management services to the Second People's Hospital in Rui An, China. The Company organized Dynacq-Huai Bei in April 2008 under the laws of the People's Republic of China. Dynacq-Huai Bei was responsible for funding any operating deficits, and was entitled to any operating profits, of that hospital during the management period. Due to continued losses at the Second People's Hospital, the Company made the decision to terminate the management agreement with the Rui An City Department of Health, and is currently in negotiation with them to finalize the terms, including the effective date of termination. The Company ceased providing healthcare management services to the Second People's Hospital as of February 28, 2011. The Company has written off the fixed assets and inventory balances as of February 28, 2011, and does not expect any further losses due to the termination of this management agreement related to the Second People's Hospital. We have accounted for the operations of the Second People's Hospital in Rui An, China as discontinued operations, and have reclassified prior period financial statements to exclude them from continuing operations.

Dynacq-Huai Bei and the Rui An City Department of Health had also previously entered into an agreement assigning to Dynacq-Huai Bei the right to manage the Third People's Hospital in Rui An, which hospital is currently under construction. Dynacq-Huai Bei and the Rui An City Department of Health, in November 2010, mutually agreed to terminate this agreement, due to continued delays in the construction of the Third People's Hospital. Accordingly, Dynacq-Huai Bei will not be managing the Third People's Hospital.

The Company has also organized Sino Bond Inc. Limited, a Hong Kong corporation ("Sino Bond") to hold and manage investments in Hong Kong. Sino Bond invests in debt and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings.

At the present time, the Company's subsidiaries in China and Hong Kong are not pursuing any new line of business and/or projects.

The Company has invested in various bonds. These investments are classified as available-for-sale securities, and are carried at fair value as of February 29, 2012, based on the quoted market prices as of that date. As of February 29, 2012, these securities are valued at approximately $18.3 million. The Company intends to hold these for a minimum period of an additional 12 months. During the three months ended February 29, 2012 and February 28, 2011, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had gains of $108,491 and $69,584, respectively. During the six months ended February 29, 2012 and February 28, 2011, the trading in initial public offerings of equity securities on the Hong Kong Stock Exchange generated losses of $57,101 and $14,995, respectively. The Company, through a subsidiary in Hong Kong, has expanded its investments in debt and equity securities in Europe and Asia and has engaged the services of an investment banker to recommend such investment opportunities. The Company's primary investment focus will be on growth companies from mainland China. The Company anticipates making short-term investments in these entities through initial public offerings (held mostly through the Hong Kong Stock Exchange) and pre-initial public offerings.

Discontinued Operations

On September 29, 2011, the Board of Directors of the Company approved the closure of the Garland facility, included in our U.S. division, effective September 30, 2011. Prior to that, in August 2010, the Board of Directors of the Company had approved a plan to dispose of the Garland facility due to continued operating losses. The Garland facility had experienced decreases in net patient revenues and number of cases, generally attributable to the loss of physicians from our medical staff. The opening of a new hospital near our Garland facility has had a direct adverse impact on our ability to retain members of the medical staff at that facility and consequently on our patient volume. The Garland facility was operating at a loss, and the Board of Directors believes that ceasing operations of the facility at this time is in the Company's best interest. The Company has estimated a closing cost of $625,000. However, the ongoing losses incurred will be reduced due to the closing of the facility.

The Company had an independent appraisal done in October 2011 for both the hospitals, and based on each hospital's valuation, expected sale proceeds, and expected cash flows has determined that there is no impairment charge required in connection with the foregoing disposal activities.

The Company has discontinued operations of all its foreign subsidiaries, except for Dynacq-HuaiBei and Sino Bond, and has either closed or is in the process of closing them.

The Corporate Division includes interest and other income related to the investments in available-for-sale and trading securities, corporate personnel compensation expenses, and general and administrative expenses. Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.

We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. There are no transfers between segments.

Summarized financial information concerning the business segments from continuing operations is as follows:

 Three months ended Six months ended

 February 29,
2012 February 28,
2011 February 29,
2012 February 28,
2011

Revenues from external customers


Net patient service revenues


U.S. Division
 $ 966,716 $ 1,688,813 $ 2,811,689 $ 4,138,628

Corporate
 — — — —



Consolidated
 $ 966,716 $ 1,688,813 $ 2,811,689 $ 4,138,628



Income (loss) before taxes and discontinued operations


U.S. Division
 $ (1,584,878 ) $ (593,099 ) $ (1,989,527 ) $ (513,394 )

Corporate
 132,035 (742,186 ) (872,258 ) (1,483,564 )



Consolidated
 $ (1,452,843 ) $ (1,335,285 ) $ (2,861,785 ) $ (1,996,958 )



 February 29,
2012 August 31,
2011

Total Assets




U.S. Division
 $ 8,416,886 $ 8,763,015

Corporate
 41,530,838 50,550,958





Assets of continuing operations
 49,947,724 59,313,973

Assets of discontinued operations
 6,651,726 6,909,527





Consolidated
 $ 56,599,450 $ 66,223,500





X

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 131

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SegmentsGeographicalAreasAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 31 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6

Revenue Recognition
6 Months Ended

Feb. 29, 2012

Revenue Recognition [Abstract]

Revenue Recognition

Revenue Recognition

Background

The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.

Revenue Recognition Policy

The Company has established billing rates for its medical services which it bills as gross revenue as services are delivered. Gross billed revenues are then reduced by the Company's estimate of the discount (contractual allowance) to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for actual differences in estimated revenue recorded in prior periods and actual cash collections.

Contractual Allowance

The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. The following table shows gross revenues and contractual allowances for the three and six months ended February 29, 2012 and February 28, 2011:

 Three months ended Six months ended

 February 29,
2012 February 28,
2011 February 29,
2012 February 28,
2011

Gross billed charges
 $ 3,692,503 $ 4,954,275 $ 8,746,618 $ 10,924,743

Contractual allowance
 2,725,787 3,265,462 5,934,929 6,786,115



Net revenue
 $ 966,716 $ 1,688,813 $ 2,811,689 $ 4,138,628



Contractual allowance percentage
 74 % 66 % 68 % 62 %



A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers' Compensation ("TDWC") and the workers' compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers' compensation claims will be governed by the network contract.

For claims arising prior to the implementation of workers' compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers' Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the "Guidelines") became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.

Based on these Guidelines, the reimbursement due the Company for workers' compensation cases is lower than we previously experienced. The Company has continued accepting Texas workers' compensation cases, and has not made any substantial changes in its focus towards such cases. Our net patient service revenue for Texas workers' compensation cases as a percentage of gross billings has decreased primarily as a result of lower reimbursement rates for workers' compensation procedures still being performed.

Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the MDR process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings ("SOAH"), receiving positive rulings in over 90% of its claims presented for administrative determination. The 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards, once the definitions of those standards are determined. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC, pending a final, non-appealable decision.

A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court's decision has further delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases is not anticipated during the 2012 fiscal year.

Through February 2012, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims. In most of these cases, the carriers have requested refunds of the payments made in the event that the SOAH decisions and orders are reversed on appeal. Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases. Motions filed seeking a refund in some cases in which the awards were voluntarily paid have been granted and the Company has been ordered to refund approximately $3.7 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. In September and October 2011, the Company deposited these amounts as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. We anticipate that similar motions requesting remand and a refund for awards voluntarily paid will be filed and will likely be granted by the 345th Judicial District Court of Travis County, Texas. If and when these additional motions are granted, the Company will be ordered to refund an additional $7.7 million, not including prejudgment interest. The Company has appealed the judgments requiring a refund to the carriers. The appeal of the refund judgments will progress simultaneously to the adjudication of those cases remanded for determinations of whether the services provided were unusually costly and unusually extensive. Voluntary payments made pursuant to the Decisions and Orders are premature payments by the carriers and will likely be ordered to be refunded. Once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in the underlying stop-loss fee disputes and that voluntary payments refunded to the carriers will be recaptured.

Due to the uncertainties associated with these stop-loss fee dispute cases, in fiscal year 2011, the Company recognized an increase of $10,254,990 in the contractual allowance at our Pasadena facility (and an additional loss of $779,583 in the contractual allowance at our Garland facility, which is classified as discontinued operations), and $1,751,478 in interest expense at our Pasadena facility (and an additional interest expense of $132,339 at our Garland facility).

Claims regarding payment for hospital outpatient services remain pending at the TDWC. It is expected that these claims will be adjudicated at SOAH and ultimately in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the determination of "fair and reasonable" charges. In 2007, we received unfavorable rulings from SOAH in all of our appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Court of Appeal in our lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 cases. Consequently, the Company is bound by the Third Court of Appeals' ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a "fair and reasonable rate" but also must "ensure the quality of medical care" and "achieve effective cost control" and be the same or less than that charged to others with an equivalent standard of living. This ruling will impact cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided in 2001 and 2002 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals' unfavorable ruling, collection, if any, in these cases depends on the Company's ability to establish the criteria in this ruling. The Company anticipates that it will be given the opportunity to establish the criteria in several hundred cases currently pending at SOAH during the 2012 fiscal year.

We are currently pursuing claims against two healthcare agents relating to contracts with certain of our facilities which set out reimbursement guidelines by several workers' compensation carriers at a minimum of 70% of the facility's charges. Discovery is continuing on these claims to determine which carriers are involved, the amount of reimbursement due to us, and the data used to determine "usual and customary" market rates for medical services in specific geographic regions.

Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals' opinions and our legal counsel's advice that settlements with insurance carriers have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. Any monies collected for these MDR accounts receivable will be recorded as current period's net patient service revenues.

Accounts Receivable

Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility.

The contractual allowance stated as a percentage of gross receivables at the balance sheet dates is larger than the contractual allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the contractual allowance. The contractual allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.

Discontinued Operations

Revenue Recognition Policy

In China, the local government Department of Health establishes billing rates for a hospital's sale of prescription medication and medical services. A majority of the services provided by Second People's Hospital is to cash pay patients, who pay for the services in advance. For services provided under the local government's social healthcare insurance program, we are generally paid at approximately 95% of billed charges two to three months after the date of service. The remaining 5% of billed charges is evaluated by the local government Department of Health on a semi-annual basis and may be paid to the hospital after that evaluation is complete. As of February 28, 2011, the Company made the decision to terminate the management agreement with the Rui An City Department of Health, and is currently in negotiation with them to finalize the terms, including the effective date of termination. The Company had bad debt expenses of $-0- and $21,991 for the three months ended February 29, 2012 and February 28, 2011, respectively, and $-0- and $24,755 for the six months ended February 29, 2012 and February 28, 2011, respectively, related to denials under the social healthcare insurance program. Since the amount of bad debt expense is minimal, it has been included with Other Operating Expenses in the income statement.

X

- Definition

Revenue recognition.

+ References

No definition available.

+ Details

Name: dyii_RevenueRecognitionTextblock

Namespace Prefix: dyii_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RevenueRecognitionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6

Net Loss Per Share
6 Months Ended

Feb. 29, 2012

Net Loss Per Share [Abstract]

Net Loss Per Share

Net Loss per Share

The following table presents the computation of basic and diluted loss per common share attributable to the Company:

 Three months ended Six months ended

 February 29,
2012 February 28,
2011 February 29,
2012 February 28,
2011

Basic and diluted loss per common share:


Numerator:


Loss from continuing operations
 $ (1,452,843 ) $ (842,255 ) $ (2,861,785 ) $ (1,330,279 )

Less: Net loss attributable to noncontrolling interest
 56,005 1,728 83,520 2,763



Loss from continuing operations attributable to Dynacq Healthcare, Inc.
 (1,396,838 ) (840,527 ) (2,778,265 ) (1,327,516 )

Discontinued operations, net of income taxes
 (169,547 ) (715,258 ) (732,213 ) (1,384,909 )

Loss on disposal of discontinued operations, net of income taxes
 (229,201 ) (121,577 ) (229,201 ) (121,577 )



Net loss attributable to Dynacq Healthcare, Inc.
 $ (1,795,586 ) $ (1,677,362 ) $ (3,739,679 ) $ (2,834,002 )



Denominator:


Basic and diluted average common shares outstanding
 14,456,127 14,176,960 14,443,627 14,176,960



Basic and diluted loss per common share:


Loss from continuing operations attributable to Dynacq Healthcare, Inc.
 $ (0.10 ) $ (0.06 ) $ (0.19 ) $ (0.09 )

Discontinued operations, net of income taxes
 (0.01 ) (0.05 ) (0.05 ) (0.10 )

Loss on disposal of discontinued operations, net of income taxes
 (0.02 ) (0.01 ) (0.02 ) (0.01 )



Net loss attributable to Dynacq Healthcare, Inc.
 $ (0.13 ) $ (0.12 ) $ (0.26 ) $ (0.20 )



Basic net income (loss) per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted net income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the calculation of diluted net income (loss) per share, the basic weighted average number of shares is increased by the dilutive effect of stock options determined using the treasury stock method. However, if it is anti-dilutive, the dilutive effect of the stock options is not included in the calculation of diluted net income (loss) per share. Stock options with exercise prices exceeding current market prices that were excluded from the computation of net income (loss) per share amounted to approximately 2,367,000 shares and 1,139,000 shares for the six months ended February 29, 2012 and February 28, 2011, respectively.

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for earnings per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=6945512&loc=d3e4984-109258

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1278-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6

Use Of Estimates
6 Months Ended

Feb. 29, 2012

Use Of Estimates [Abstract]

Use Of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company's estimates is the determination of revenue to recognize for the services the Company provides and the determination of the contractual allowance. See "Revenue Recognition" below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.

X

- Definition

Usage of estimates.

+ References

No definition available.

+ Details

Name: dyii_UsageOfEstimatesTextBlock

Namespace Prefix: dyii_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: dyii_UseOfEstimatesAbstract

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6

Discontinued Operations
6 Months Ended

Feb. 29, 2012

Discontinued Operations [Abstract]

Discontinued Operations

Discontinued Operations

Under ASC Topic 360-10-35, Property, Plant, and Equipment – Subsequent Measurement (formerly referred to as SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets), we classify assets to be disposed of as held for sale or, if appropriate, discontinued operations when they have received appropriate approvals to be disposed of by our management or Board of Directors. Cash flows from our discontinued businesses are reflected as discontinued operating, investing, and financing activities in our statement of cash flows. We had $6,651,726 of assets of discontinued operations and $615,598 of liabilities of discontinued operations as of February 29, 2012.

U.S. Division

The Company had made the decision to sell its Garland facility as of August 31, 2010, and its operation was classified as discontinued operations for the year ended August 31, 2010. However, the Company closed the Garland facility on September 30, 2011, and accordingly its operations for the fiscal years 2011 and 2012 continue to be classified as discontinued operations. The Company plans to either sell the Garland facility or pursue converting it into an ambulatory surgical center, if and when the Company can identify and generate a steady referral source for outpatient cases. The Company intended to sell its Pasadena facility also, and had it classified as discontinued operations, as of August 31, 2010. However, since a sale was not consummated during the 12-month period following the decision to sell, the operations of the Pasadena facility have been reclassified as continuing operations for the fiscal years 2011 and 2012. The Company is continuing to revamp its operations at the Pasadena facility by modifying the business model and controlling expenses. However, there can be no assurance that we will be successful in turning the facility around.

The Company had an independent appraisal done for both the hospitals in October 2011, and based on each hospital's valuation, expected sale proceeds, and expected cash flows has determined that there is no impairment charge required in connection with the foregoing disposal activities. Because we do not intend to sell the accounts receivable of hospitals in discontinued operations, the receivables are included in our accounts receivable in the accompanying Consolidated Balance Sheets.

Corporate Division

The Company's operations at Second People's Hospital and its various proposed businesses in China, including but not limited to sandstone mining, mined coal trading, natural gas stations and sale of artifacts have been classified as discontinued operations. The Company's two foreign subsidiaries, Dynacq-Huai Bei and Sino Bond, are the only two companies that continue to be classified as continuing operations, and its other foreign subsidiaries have been reclassified as discontinued operations.

The following is a summary of financial information related to our discontinued operations for the three and six months ended February 29, 2012 and February 28, 2011. We have reclassified prior period financial statements to exclude these businesses from continuing operations.

Discontinued Operations

 Three months ended February 29, 2012 Three months ended February 28, 2011

 U.S.
Division Corporate
Division Total U.S.
Division Corporate
Division Total

Net patient service revenue
 $ 93,711 $ — $ 93,711 $ 734,538 $ 339,910 $ 1,074,448



Costs and expenses:


Compensation and benefits
 11,196 — 11,196 657,684 285,781 943,465

Medical services and supplies
 46,580 — 46,580 250,524 130,807 381,331

Other operating expenses
 195,171 — 195,171 660,700 232,608 893,308

Depreciation and amortization
 — — — — 10,754 10,754



Total costs and expenses
 252,947 — 252,947 1,568,908 659,950 2,228,858



Operating loss
 (159,236 ) — (159,236 ) (834,370 ) (320,040 ) (1,154,410 )

Other income (expense), net
 (10,311 ) — (10,311 ) 2,762 56,790 59,552



Loss before income taxes
 (169,547 ) — (169,547 ) (831,608 ) (263,250 ) (1,094,858 )

Benefit for income taxes
 — — — 267,827 111,773 379,600



Loss on discontinued operations, net of income taxes
 (169,547 ) — (169,547 ) (563,781 ) (151,477 ) (715,258 )



Loss on disposal of discontinued assets
 — (229,201 ) (229,201 ) — (187,041 ) (187,041 )

Benefit for income taxes
 — — — — 65,464 65,464



Loss on disposal of discontinued assets, net of income taxes
 — (229,201 ) (229,201 ) — (121,577 ) (121,577 )



Total loss on discontinued operations, net of taxes
 $ (169,547 ) $ (229,201 ) $ (398,748 ) $ (563,781 ) $ (273,054 ) $ (836,835 )



 Six months ended February 29, 2012 Six months ended February 28, 2011

 U.S.
Division Corporate
Division Total U.S.
Division Corporate
Division Total

Net patient service revenue
 $ 318,587 $ — $ 318,587 $ 1,288,049 $ 831,232 $ 2,119,281



Costs and expenses:


Compensation and benefits
 166,803 22,511 189,314 1,334,918 556,100 1,891,018

Medical services and supplies
 267,551 — 267,551 476,252 406,452 882,704

Other operating expenses
 533,115 98,493 631,608 1,282,304 358,232 1,640,536

Depreciation and amortization
 — 5,175 5,175 — 21,180 21,180



Total costs and expenses
 967,469 126,179 1,093,648 3,093,474 1,341,964 4,435,438



Operating loss
 (648,882 ) (126,179 ) (775,061 ) (1,805,425 ) (510,732 ) (2,316,157 )

Other income (expense), net
 (21,056 ) 63,904 42,848 2,813 191,474 194,287



Loss before income taxes
 (669,938 ) (62,275 ) (732,213 ) (1,802,612 ) (319,258 ) (2,121,870 )

Benefit for income taxes
 — — — 585,218 151,743 736,961



Loss on discontinued operations, net of income taxes
 (669,938 ) (62,275 ) (732,213 ) (1,217,394 ) (167,515 ) (1,384,909 )



Loss on disposal of discontinued assets
 — (229,201 ) (229,201 ) — (187,041 ) (187,041 )

Benefit for income taxes
 — — — — 65,464 65,464



Loss on disposal of discontinued assets, net of income taxes
 — (229,201 ) (229,201 ) — (121,577 ) (121,577 )



Total loss on discontinued operations, net of taxes
 $ (669,938 ) $ (291,476 ) $ (961,414 ) $ (1,217,394 ) $ (289,092 ) $ (1,506,486 )



 February 29, 2012 August 31, 2011

 U.S.
Division Corporate
Division Total U.S.
Division Corporate
Division Total

Current assets
 $ — $ 120,954 $ 120,954 $ 260,020 $ 118,734 $ 378,754

Property and equipment, net
 6,530,772 — 6,530,772 6,530,773 — 6,530,773













Total assets
 $ 6,530,772 $ 120,954 $ 6,651,726 $ 6,790,793 $ 118,734 $ 6,909,527













Current liabilities:


Accounts payable and accrued liabilities
 $ — $ 615,598 $ 615,598 $ — $ 604,302 $ 604,302













Total liabilities
 $ — $ 615,598 $ 615,598 $ — $ 604,302 $ 604,302













X

- Details

Name: us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6390789&loc=d3e2443-110228

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 43-48

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

+ Details

Name: us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6

Stock Based Compensation
6 Months Ended

Feb. 29, 2012

Stock Based Compensation [Abstract]

Stock Based Compensation

Stock Based Compensation

Year 2011 Stock Incentive Plan

In August 2011, we mailed an Information Statement to all of our stockholders of record as of July 29, 2011. The Information Statement disclosed that our Board of Directors had approved, and the holders of a majority of the outstanding shares of our common stock had executed an Action by Written Consent of Stockholders in Lieu of a Special Meeting (the "Written Consent"), approving the adoption of the Year 2011 Stock Incentive Plan ("2011 Plan").

The purpose of the 2011 Plan is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and thereby encouraging them to devote their abilities and industry to the success of the Company's business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved 15,000,000 shares of common stock for future issuance under the 2011 Plan.

On November 14, 2011, the Compensation Committee granted stock options to purchase an aggregate of 200,000 shares under the 2011 Plan, with a weighted average exercise price of $1.07 to two employees. These stock options will vest based on certain operating performance criteria, and expire after five years. The shares underlying these stock options are registered under the Securities Act of 1933 (the "Securities Act").

On January 12, 2012, the Compensation Committee granted stock options to purchase 250,000 shares under the 2011 Plan, with an exercise price of $1.10 to the Company's chief executive officer, Eric K. Chan. These stock options will vest in annual installments of 25 percent beginning on the first anniversary date, and expire after ten years. The shares underlying these stock options are registered under the Securities Act.

On February 6, 2012, the Compensation Committee granted stock options to purchase an aggregate of one million shares under the 2011 Plan, with a weighted average exercise price of $1.00 to various employees. These stock options will vest based on certain operating performance criteria, and expire after five years. The shares underlying these stock options are registered under the Securities Act.

As of February 29, 2012, there remain 13,650,000 shares which can be issued under the 2011 Plan after giving effect to shares issued.

2000 Incentive Plan

The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of February 29, 2012, there remain 2,023,066 shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.

The 2011 Plan and the 2000 Plan (the "Plans") are administered by the Compensation Committee of the Board of Directors (the "Committee"). The Committee has the power to determine which eligible employees will receive awards, the timing and manner of the grant of such awards, the exercise price of stock options (which may not be less than market value on the date of grant), the number of shares, and all of the terms of the awards. The Company may at any time amend or terminate the 2011 Plan. However, no amendment that would impair the rights of any participant with respect to outstanding grants can be made without the participant's prior consent. Stockholder approval of an amendment to the Plans is necessary only when required by applicable law or stock exchange rules.

Generally, options granted become exercisable in annual installments of 25 percent beginning on the first anniversary date, and expire after five to ten years.

The following table summarizes the stock option activities for the six months ended February 29, 2012 (share amounts in thousands):

 Shares Weighted Average
Option Exercise
Price Per Share Weighted Average
Grant Date Fair
Value Per Share Aggregate
Intrinsic
Value⁽¹⁾

Outstanding, August 31, 2011
 2,206 $ 2.41 $ — $ —

Granted
 1,450 1.03 0.52 —

Exercised
 — — — —

Expired or canceled
 (283 ) 1.79 — —





Outstanding, February 29, 2012
 3,373 $ 1.87 $ — $ —





⁽¹⁾
These amounts represent the difference between the exercise price and the closing price of Dynacq common stock on February 29, 2012 and August 31, 2011, as reported on the NASDAQ stock market, for all in-the-money options outstanding. For exercised options, intrinsic value represents the difference between the exercise price and the closing price of Dynacq common stock on the date of exercise.

For the six months ended February 29, 2012 and February 28, 2011, there were no stock options exercised.

The following summarizes information related to stock options outstanding as of February 29, 2012, and related weighted average price and life information:

 Options Outstanding Options
Exercisable

Range of Exercise Prices
 Shares Weighted
Average
Remaining
Contractual
Life (Years) Weighted
Average
Exercise
Price Shares Weighted
Average
Exercise
Price

 (Share Amounts In Thousands)

$ 1.00 – 1.10
 1,350 6.0 $ 1.03 — $ —

$ 1.86 – 2.05
 1,200 9.4 1.89 — —

$ 2.50 – 2.75
 587 1.3 2.54 587 2.54

$ 4.90 – 4.96
 236 2.6 4.90 236 4.90











Total
 3,373 6.1 $ 1.87 823 $ 3.22











For the three months ended February 29, 2012 and February 28, 2011, stock-based compensation expense associated with the Company's stock options was $82,244 and $(102,963), respectively. For the six months ended February 29, 2012 and February 28, 2011, stock-based compensation expense associated with the Company's stock options was $149,934 and $4,251, respectively. The total unrecognized compensation expense for outstanding stock options as of February 29, 2012 was $1,464,000, and will be recognized, in general, over 3.8 years. The weighted average time to recognize the compensation expense is 1.9 years.

X

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 93-6

-Paragraph 53

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64, 65, A240

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 36 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6

Comprehensive Loss And Accumulated Other Comprehensive Income
6 Months Ended

Feb. 29, 2012

Comprehensive Loss And Accumulated Other Comprehensive Income [Abstract]

Comprehensive Loss And Accumulated Other Comprehensive Income

Comprehensive Loss and Accumulated Other Comprehensive Income

Comprehensive loss consists of net loss and other comprehensive income (loss). Other comprehensive income (loss) represents certain components of revenues, expenses, gains and losses that are included in comprehensive loss, but are excluded from net loss. Other comprehensive income (loss) amounts are recorded directly as an adjustment to stockholders' equity, net of tax, and for the three and six months ended February 29, 2012 and February 28, 2011 were as follows:

 Three months ended Six months ended

 February 29,
2012 February 28,
2011 February 29,
2012 February 28,
2011

Net loss
 $ (1,795,586 ) $ (1,677,362 ) $ (3,739,679 ) $ (2,834,002 )

Other comprehensive income (loss), net of taxes:


Foreign currency translation adjustment, net of taxes of $(10,246), $68,535, $(13,344) and $166,069, respectively
 (19,029 ) 117,242 (24,782 ) 308,413

Reclassification adjustment for foreign currency gains included in net income, net of taxes of $(384,283), $-0-, $(501,273) and $-0-, respectively
 (704,051 ) — (921,318 ) —

Change in valuation of investment available-for-sale, net of taxes of $1,293,508, $369,802, $(97,599) and $358,550, respectively
 2,402,230 686,773 (181,256 ) 665,877



Total other comprehensive loss, net of taxes
 (116,436 ) (873,347 ) (4,867,035 ) (1,859,712 )

Comprehensive loss attributable to the noncontrolling interest
 — — — —



Comprehensive loss attributable to Dynacq Healthcare, Inc.
 $ (116,436 ) $ (873,347 ) $ (4,867,035 ) $ (1,859,712 )



The components of accumulated other comprehensive income were as follows:

 February 29,
2012 August 31,
2011

Foreign currency translation adjustment, net of taxes of $3,600 and $518,217, respectively
 $ 6,682 $ 952,782

Change in valuation of investment available-for-sale, net of taxes of $3,402,882 and $3,500,481, respectively
 6,319,638 6,500,894





Total accumulated other comprehensive income, net of taxes of $3,406,482 and $4,018,698, respectively
 $ 6,326,320 $ 7,453,676





X

- Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for comprehensive income. Includes, but is not limited to, the following: 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. Components of comprehensive income include: (1) foreign currency translation adjustments; (2) gains (losses) on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (3) gains (losses) on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (4) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (5) unrealized holding gains (losses) on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (6) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (7) the net gain (loss) and net prior service cost or credit for pension plans and other postretirement benefit plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e689-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 17

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e681-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Reclassification Adjustments

-URI http://asc.fasb.org/extlink&oid=6522872

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 14-26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e640-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e709-108580

+ Details

Name: us-gaap_ComprehensiveIncomeNoteTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6

Consolidated Statements Of Cash Flows (USD $)
6 Months Ended

Feb. 29, 2012

Feb. 28, 2011

Cash flows from operating activities

Net loss $ (3,739,679) $ (2,834,002)

Less loss from discontinued operations, net of income taxes 961,414 1,506,486

Net loss before discontinued operations (2,778,265) (1,327,516)

Adjustments to reconcile net loss before discontinued operations to net cash used in operating activities:

Depreciation and amortization 310,098 90,954

Loss on trading securities 57,101 14,995

Deferred income taxes (1,655,662) 272,534

Noncontrolling interest (83,520) (2,763)

Charge for stock options to employees 149,934 4,251

Charge for non-controlling interest sale and issuance of stock awards 166,666

Foreign currency exchange losses (gains) 152,435 (157,939)

Changes in operating assets and liabilities:

Accounts receivable 691,455 1,112,382

Interest receivable 13,493 110,183

Inventories 76,332 55,313

Prepaid expenses 74,293 290,635

Income taxes receivable (1,710,119)

Other assets 5,316 29,979

Accounts payable (371,967) 291,070

Accrued liabilities (4,766,187) (802,185)

Cash used in continuing activities (7,958,478) (1,728,226)

Cash used in discontinued activities (696,218) (1,239,848)

Net cash used in operating activities (8,654,696) (2,968,074)

Cash flows from investing activities

Purchase of trading securities (4,909,498)

Sales proceeds of trading securities 3,494,738

Purchase of equipment (157,753) (6,794)

Cash used in continuing activities (157,753) (1,421,554)

Cash used in discontinued activities (101,651)

Net cash used in investing activities (157,753) (1,523,205)

Cash flows from financing activities

Proceeds from notes payable 116,339 65,000

Principal payments on notes payable (60,773) (44,567)

Payments on capital lease (46,103) (42,635)

Contributions from, and distributions to, noncontrolling interest, net 100,000

Cash provided by (used in) continuing activities 109,463 (22,202)

Cash used in discontinued activities (23,222)

Net cash provided by (used in) financing activities 109,463 (45,424)

Effect of exchange rate changes on cash 230,293 484,536

Net decrease in cash and cash equivalents (8,472,693) (4,052,167)

Cash at beginning of period 24,315,160 27,665,945

Cash at end of period 15,842,467 23,613,778

Supplemental cash flow disclosures

Interest 728,788 22,804

Income taxes 0 0

Non cash investing and financing activities:

Investments available-for-sale (278,855) 1,024,427

Accumulated other comprehensive income 181,256 (665,877)

Deferred tax liabilities 97,599 (358,550)

Equipment from capital lease (discontinued operations) 34,592

Capital lease obligation (discontinued operations) $ (34,592)

X

- Definition

Accumulated other comprehensive income, non cash.

+ References

No definition available.

+ Details

Name: dyii_AccumulatedOtherComprehensiveIncomeNonCash

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Charge for non-controlling interest sale and issuance of stock awards.

+ References

No definition available.

+ Details

Name: dyii_ChargeForNonControllingInterestSaleAndIssuanceOfStockAwards

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Deferred tax liabilities, non cash.

+ References

No definition available.

+ Details

Name: dyii_DeferredTaxLiabilitiesNonCash

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Equipment from capital lease (discontinued operations), non cash.

+ References

No definition available.

+ Details

Name: dyii_EquipmentFromCapitalLeaseDiscontinuedOperationsNonCash

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Investments available-for-sale, non cash.

+ References

No definition available.

+ Details

Name: dyii_InvestmentsAvailableForSaleNonCash

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase during the period in capital lease obligations due to entering into new capital leases.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_CapitalLeaseObligationsIncurred

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The increase (decrease) during the reporting period in cash and cash equivalents. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

This element represents cash provided by or used in the financing activities of the entity's discontinued operations during the period. This element is only used by those entities that separately report cash flows attributable to discontinued operations. If using this element, it is an indication that the cash flows of the entity which are detailed in reconciling to cash provided by or used in financing activities reflect only cash flows attributable to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

This element represents cash provided by or used in the investing activities of the entity's discontinued operations during the period. This element is only used by those entities that separately report cash flows attributable to discontinued operations. If using this element, it is an indication that the cash flows of the entity which are detailed in reconciling to cash provided by or used in investing activities reflect only cash flows attributable to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

This element represents cash provided by or used in the operating activities of the entity's discontinued operations during the period. This element is only used by those entities that separately report cash flows attributable to discontinued operations. If using this element, it is an indication that the cash flows of the entity which are detailed in reconciling to cash provided by or used in operating activities reflect only cash flows attributable to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The effect of exchange rate changes on cash balances held in foreign currencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate unrealized foreign currency transaction gain (loss) (pretax) included in determining net income for the reporting period. Represents the aggregate of gains (losses) on transactions that are unsettled as of the balance sheet date, which is therefore an adjustment to reconcile income (loss) from continuing operations to net cash provided by or used in continuing operations. Excludes foreign currency transactions designated as hedges of net investment in a foreign entity and intercompany foreign currency transactions that are of a long-term nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting entity's financial statements. For certain entities, primarily banks, that are dealers in foreign exchange, foreign currency transaction gains (losses) may be disclosed as dealer gains (losses).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30700-110894

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30690-110894

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 52

-Paragraph 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_ForeignCurrencyTransactionGainLossUnrealized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents the income or loss from continuing operations attributable to the parent which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4613673-111683

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph b(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.13)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 47

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.14)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.12)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 13

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 15

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 27

-Subparagraph f

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInIncomeTaxesReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount due to the entity in the form of unpaid interest and dividends.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid for interest during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net cash inflow or outflow from financing activity for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash from (used in) the entity's financing activities specifically EXCLUDING the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in financing activities. Such reporting would necessitate the entity to use the Net Cash provided by or used in Discontinued Operations, Total element provided in the taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net cash inflow or outflow from investing activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash from (used in) the entity's investing activities specifically EXCLUDING the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in investing activities. Such reporting would necessitate the entity to use the Net Cash provided by or used in Discontinued Operations, Total element provided in the taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-Footnote 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash from (used in) the entity's continuing operations. This element specifically EXCLUDES the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in operating activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-Footnote 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of net Income or Loss attributable to the noncontrolling interest (if any) deducted in order to derive the portion attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash outflow for acquisition of machinery and equipment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 17

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_PaymentsToAcquireMachineryAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15, 17

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Section Appendix C

-Paragraph 5

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_PaymentsToAcquireShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow from a borrowing supported by a written promise to pay an obligation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net cash inflow or outflow from noncontrolled interest to increase or decrease the number of shares they have in the entity. This does not include dividends paid to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ProceedsFromPaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15, 16

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Section Appendix C

-Paragraph 5

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3179-108585

+ Details

Name: us-gaap_ProceedsFromSaleOfShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26, 31

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfLongTermCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for a borrowing supported by a written promise to pay an obligation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 20

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

This item represents the gain (loss) realized during the period from the sale of trading securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27357-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 7

-Subparagraph c

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(c))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Trading Securities

-URI http://asc.fasb.org/extlink&oid=6526789

+ Details

Name: us-gaap_TradingSecuritiesRealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 38 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6

Investments In Available-For-Sale And Trading Securities
6 Months Ended

Feb. 29, 2012

Investments In Available-For-Sale And Trading Securities [Abstract]

Investments In Available-For-Sale And Trading Securities

Investments in Available-for-Sale and Trading Securities

The Company has invested in various bonds. These investments are classified as available-for-sale securities, and are carried at fair value as of February 29, 2012, based on the quoted market prices as of that date. These investments are subject to default risk. The Company intends to hold these for a minimum period of an additional 12 months. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss.

The Company also invests in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and are carried at fair value as of February 29, 2012. These investments are subject to fluctuations in the market price. During the six months ended February 29, 2012 and February 28, 2011, the Company had a net loss of $57,101 and $14,995 in trading of these securities, respectively.

X

- Details

Name: us-gaap_AvailableForSaleSecuritiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of investments in certain debt and equity securities (and certain other trading assets) which include all debt and equity securities (other than those equity securities accounted for under the equity or cost methods of accounting) with readily determinable fair values. Other trading assets include assets that are carried on the balance sheet at fair value and held for trading purposes. A debt security represents a creditor relationship with an enterprise that is in the form of a security. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities (and other trading assets).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27405-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6379141&loc=d3e15032-111544

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Equity Security

-URI http://asc.fasb.org/extlink&oid=6511694

-Topic 320

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27161-111563

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Debt Security

-URI http://asc.fasb.org/extlink&oid=6509901

-Topic 320

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 115

-Paragraph 3, 19, 20, 21, 22, 137

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27232-111563

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27357-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27290-111563

+ Details

Name: us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 9 135 1 false 0 0 false 3 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.dynacq.com/role/DocumentDocumentAndEntityInformation Document And Entity Information true false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.dynacq.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.dynacq.com/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 00200 - Statement - Consolidated Statements Of Operations Sheet http://www.dynacq.com/role/StatementConsolidatedStatementsOfOperations Consolidated Statements Of Operations false false R5.htm 00300 - Statement - Consolidated Statements Of Cash Flows Sheet http://www.dynacq.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements Of Cash Flows false false R6.htm 10101 - Disclosure - General Sheet http://www.dynacq.com/role/DisclosureGeneral General false false R7.htm 10201 - Disclosure - Basis Of Presentation Sheet http://www.dynacq.com/role/DisclosureBasisOfPresentation Basis Of Presentation false false R8.htm 10301 - Disclosure - Reorganization Of Segments And Reclassification Sheet http://www.dynacq.com/role/DisclosureReorganizationOfSegmentsAndReclassification Reorganization Of Segments And Reclassification false false R9.htm 10401 - Disclosure - Cash And Cash Equivalents Sheet http://www.dynacq.com/role/DisclosureCashAndCashEquivalents Cash And Cash Equivalents false false R10.htm 10501 - Disclosure - Investments In Available-For-Sale And Trading Securities Sheet http://www.dynacq.com/role/DisclosureInvestmentsInAvailableForSaleAndTradingSecurities Investments In Available-For-Sale And Trading Securities false false R11.htm 10601 - Disclosure - Investment In Real Estate And Notes Payable Notes http://www.dynacq.com/role/DisclosureInvestmentInRealEstateAndNotesPayable Investment In Real Estate And Notes Payable false false R12.htm 10701 - Disclosure - Inventories Sheet http://www.dynacq.com/role/DisclosureInventories Inventories false false R13.htm 10801 - Disclosure - Use Of Estimates Sheet http://www.dynacq.com/role/DisclosureUseOfEstimates Use Of Estimates false false R14.htm 10901 - Disclosure - Discontinued Operations Sheet http://www.dynacq.com/role/DisclosureDiscontinuedOperations Discontinued Operations false false R15.htm 11001 - Disclosure - Net Loss Per Share Sheet http://www.dynacq.com/role/DisclosureNetLossPerShare Net Loss Per Share false false R16.htm 11101 - Disclosure - Stock Based Compensation Sheet http://www.dynacq.com/role/DisclosureStockBasedCompensation Stock Based Compensation false false R17.htm 11201 - Disclosure - Fair Value Of Financial Instruments Sheet http://www.dynacq.com/role/DisclosureFairValueOfFinancialInstruments Fair Value Of Financial Instruments false false R18.htm 11301 - Disclosure - Foreign Currency Translation Sheet http://www.dynacq.com/role/DisclosureForeignCurrencyTranslation Foreign Currency Translation false false R19.htm 11401 - Disclosure - Revenue Recognition Sheet http://www.dynacq.com/role/DisclosureRevenueRecognition Revenue Recognition false false R20.htm 11501 - Disclosure - Noncontrolling Interest Sheet http://www.dynacq.com/role/DisclosureNoncontrollingInterest Noncontrolling Interest false false R21.htm 11601 - Disclosure - Comprehensive Loss And Accumulated Other Comprehensive Income Sheet http://www.dynacq.com/role/DisclosureComprehensiveLossAndAccumulatedOtherComprehensiveIncome Comprehensive Loss And Accumulated Other Comprehensive Income false false R22.htm 11701 - Disclosure - Contingencies Sheet http://www.dynacq.com/role/DisclosureContingencies Contingencies false false R23.htm 11801 - Disclosure - Industry Segments And Geographic Information Sheet http://www.dynacq.com/role/DisclosureIndustrySegmentsAndGeographicInformation Industry Segments And Geographic Information false false All Reports Book All Reports Process Flow-Through: 00100 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Feb. 28, 2011' Process Flow-Through: Removing column 'Aug. 31, 2010' Process Flow-Through: 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00200 - Statement - Consolidated Statements Of Operations Process Flow-Through: 00300 - Statement - Consolidated Statements Of Cash Flows dyii-20120229.xml dyii-20120229.xsd dyii-20120229_cal.xml dyii-20120229_lab.xml dyii-20120229_pre.xml true true XML 40 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6

Noncontrolling Interest
6 Months Ended

Feb. 29, 2012

Noncontrolling Interest [Abstract]

Noncontrolling Interest

Noncontrolling Interest

The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company's facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest ranged from 1.75% to 3.00% at February 29, 2012).

X

- Definition

Noncontrolling interest.

+ References

No definition available.

+ Details

Name: dyii_NoncontrollingInterestTextBlock

Namespace Prefix: dyii_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

Consolidated Balance Sheets (USD $)	Feb. 29, 2012	Aug. 31, 2011
Assets
Cash and cash equivalents	$ 15,842,467	$ 24,315,160
Accounts receivable, net of contractual allowances of approximately $187,059,000 and $188,513,000 at February 29, 2012 and August 31, 2011, respectively	500,824	1,192,279
Inventories	474,109	550,441
Trading securities	1,424,399	1,471,644
Interest receivable	178,874	192,366
Prepaid expenses	198,121	272,414
Income tax receivable	2,363,724	2,363,724
Assets of discontinued operations	6,651,726	6,909,527
Total current assets	27,634,244	37,267,555
Investments available-for-sale	18,281,129	18,722,274
Investment in real estate, net	1,915,218	1,941,041
Property and equipment, net	7,038,699	7,168,864
Income tax receivable	868,249	868,249
Deferred tax asset	612,216
Other assets	249,695	255,517
Total assets	56,599,450	66,223,500
Liabilities and stockholders' equity
Accounts payable	1,974,753	2,346,720
Accrued liabilities	13,691,664	18,430,553
Current portion of notes payable	121,543	97,918
Current portion of capital lease obligations	97,794	94,044
Liabilities of discontinued operations	615,598	604,302
Total current liabilities	16,501,352	21,573,537
Non-current liabilities:
Long-term portion of notes payable	1,125,903	1,093,961
Long-term portion of capital lease obligations	139,308	189,161
Total liabilities	17,766,563	22,856,659
Commitments and contingencies
Equity:
Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding
Common stock, $.001 par value; 100,000,000 shares authorized, 14,543,626 and 14,426,960 shares issued at February 29, 2012 and August 31, 2011	14,544	14,427
Additional paid-in capital	10,047,320	9,780,837
Accumulated other comprehensive income	6,326,320	7,453,676
Retained earnings	22,314,605	26,054,284
Total Dynacq stockholders' equity	38,702,789	43,303,224
Non-controlling interest	130,098	63,617
Total equity	38,832,887	43,366,841
Total liabilities and equity	$ 56,599,450	$ 66,223,500

General	6 Months Ended
General	Feb. 29, 2012
General [Abstract]
General	General Dynacq Healthcare, Inc., a Nevada corporation (the "Company"), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its subsidiaries in China and Hong Kong also (1) provided healthcare management services to a hospital in China until February 28, 2011; and (2) invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings. The Company through its United States subsidiaries (1) owns and operates one general acute care hospital in Pasadena, Texas, and (2) owns one general acute care hospital in Garland, Texas, which was closed on September 30, 2011, and accordingly this business is classified as "Discontinued Operations" for the six months ended February 29, 2012 and February 28, 2011 (see Note below on Discontinued Operations). The Company is currently composed of two divisions: U.S. and Corporate.

Contingencies	6 Months Ended
Contingencies	Feb. 29, 2012
Contingencies [Abstract]
Contingencies	Contingencies Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has recognized, in fiscal year 2011, an increase of $12.9 million in the contractual allowance and related interest expense at our Pasadena and Garland facilities. For a detailed discussion of this, see Revenue Recognition Policy under Notes to Consolidated Financial Statements. Motions filed seeking a refund in some cases in which the awards were voluntarily paid have been granted and the Company has been ordered to refund approximately $3.7 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. In September and October 2011, the Company deposited these amounts as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. We anticipate that similar motions requesting remand and a refund for awards voluntarily paid will be filed and will likely be granted by the 345th Judicial District Court of Travis County, Texas. If and when these additional motions are granted, the Company will be ordered to refund an additional $7.7 million, not including prejudgment interest. The Company has appealed the judgments requiring a refund to the carriers. The appeal of the refund judgments will progress simultaneously to the adjudication of those cases remanded for determinations of whether the services provided were unusually costly and unusually extensive. Voluntary payments made pursuant to the Decisions and Orders are premature payments by the carriers and will likely be ordered to be refunded. Once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in the underlying stop-loss fee disputes and that voluntary payments refunded to the carriers will be recaptured. The Company maintains various insurance policies that cover each of its U.S. facilities; including occurrence medical malpractice coverage. In addition, all physicians granted privileges at the Company's U.S. facilities are required to maintain medical malpractice insurance coverage. The Company also maintains general liability and property insurance coverage for each U.S. facility, including flood coverage. The Company does not currently maintain workers' compensation coverage in Texas. In regard to the Employee Health Insurance Plan, the Company is self-insured with specific and aggregate re-insurance with stop-loss levels appropriate for the Company's group size. Coverage is maintained in amounts management deems adequate. The management agreement for the Second People's Hospital required that 1% of the drug income, and drug income in excess of 40% of total sales, of the hospital be paid to the government. This requirement was designed to control the cost of drugs by discouraging the sale by the hospital of drugs purchased from other than approved drug vendors. However, the local government has not published a list of approved drug vendors and therefore has not enforced the payment provision since the inception of the original management agreement. The Company has been advised by a local attorney that enforcement of that provision is remote, so it has not accrued the amount that would be payable to the local government if this provision were enforced. If the government were to enforce this provision, Dynacq-Huai-Bei could potentially owe approximately $1.6 million to the government for the period of time since inception of the original management contract on the hospital to February 29, 2012. The Company is routinely involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our Texas facilities' fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure.

Basis Of Presentation	6 Months Ended
Basis Of Presentation	Feb. 29, 2012
Basis Of Presentation [Abstract]
Basis Of Presentation	Basis of Presentation The accompanying reviewed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $1.5 million and $1.3 million for the three months ended February 29, 2012 and February 28, 2011, respectively, and $2.8 million and $3.2 million for the six months ended February 29, 2012 and February 28, 2011, respectively. These reviewed financial statements should be read in conjunction with the audited financial statements at August 31, 2011. Operating results for the three and six months ended February 29, 2012 are not necessarily indicative of the results that may be expected for the year ending August 31, 2012.

Consolidated Balance Sheets (Parenthetical) (USD $)	Feb. 29, 2012	Aug. 31, 2011
Consolidated Balance Sheets [Abstract]
Contractual allowances for accounts receivable	$ 187,059,000	$ 188,513,000
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, issued	14,543,626	14,426,960

Document And Entity Information	6 Months Ended
Document And Entity Information	Feb. 29, 2012	Apr. 13, 2012
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Feb. 29, 2012
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2012
Entity Registrant Name	DYNACQ HEALTHCARE INC
Entity Central Index Key	0000890908
Current Fiscal Year End Date	--08-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		14,543,626

Foreign Currency Translation	6 Months Ended
Foreign Currency Translation	Feb. 29, 2012
Foreign Currency Translation [Abstract]
Foreign Currency Translation	Foreign Currency Translation The functional currency of the Company as a whole is the U.S. Dollar. The Company has designated the Chinese Yuan Renminbi as the functional currency for its subsidiaries in mainland China, and the U.S. Dollar for Sino Bond in Hong Kong. Assets and liabilities are translated into U.S. dollars using current exchange rates as of the balance sheet date. Income and expense are translated at average exchange rates prevailing during the period. The effects of foreign currency translation adjustments are included as a component of Accumulated Other Comprehensive Income within Stockholders' Equity.

Consolidated Statements Of Operations (USD $)	3 Months Ended		6 Months Ended
Consolidated Statements Of Operations (USD $)	Feb. 29, 2012	Feb. 28, 2011	Feb. 29, 2012	Feb. 28, 2011
Consolidated Statements Of Operations [Abstract]
Net patient service revenue	$ 966,716	$ 1,688,813	$ 2,811,689	$ 4,138,628
Costs and expenses:
Compensation and benefits	2,019,312	1,604,895	3,696,681	3,603,843
Medical services and supplies	343,508	365,464	566,626	784,020
Other operating expenses	1,349,336	1,550,251	2,672,125	3,354,188
Depreciation and amortization	160,287	44,109	310,098	90,954
Total costs and expenses	3,872,443	3,564,719	7,245,530	7,833,005
Operating loss	(2,905,727)	(1,875,906)	(4,433,841)	(3,694,377)
Other income (expense):
Rent and other income	1,257,844	196,608	1,260,442	977,266
Interest income	338,305	353,763	606,203	740,453
Interest expense	(143,265)	(9,750)	(294,589)	(20,300)
Total other income, net	1,452,884	540,621	1,572,056	1,697,419
Loss before income taxes from continuing operations	(1,452,843)	(1,335,285)	(2,861,785)	(1,996,958)
Benefit for income taxes		493,030		666,679
Loss from continuing operations	(1,452,843)	(842,255)	(2,861,785)	(1,330,279)
Discontinued operations, net of income taxes	(169,547)	(715,258)	(732,213)	(1,384,909)
Loss on disposal of discontinued operations, net of income taxes	(229,201)	(121,577)	(229,201)	(121,577)
Net loss	(1,851,591)	(1,679,090)	(3,823,199)	(2,836,765)
Less: Net loss attributable to noncontrolling interest	56,005	1,728	83,520	2,763
Net loss attributable to Dynacq Healthcare, Inc.	(1,795,586)	(1,677,362)	(3,739,679)	(2,834,002)
Basic and diluted loss per common share:
Loss from continuing operations attributable to Dynacq Healthcare, Inc.	$ (0.10)	$ (0.06)	$ (0.19)	$ (0.09)
Discontinued operations, net of income taxes	$ (0.01)	$ (0.05)	$ (0.05)	$ (0.10)
Loss on disposal of discontinued operations, net of income taxes	$ (0.02)	$ (0.01)	$ (0.02)	$ (0.01)
Net loss attributable to Dynacq Healthcare, Inc.	$ (0.13)	$ (0.12)	$ (0.26)	$ (0.20)
Basic and diluted average common shares outstanding	14,456,127	14,176,960	14,443,627	14,176,960
Amounts attributable to Dynacq Healthcare, Inc.:
Loss from continuing operations	(1,396,838)	(840,527)	(2,778,265)	(1,327,516)
Discontinued operations, net of income taxes	(169,547)	(715,258)	(732,213)	(1,384,909)
Loss on disposal of discontinued operations, net of income taxes	(229,201)	(121,577)	(229,201)	(121,577)
Net loss attributable to Dynacq Healthcare, Inc.	$ (1,795,586)	$ (1,677,362)	$ (3,739,679)	$ (2,834,002)

Inventories	6 Months Ended
Inventories	Feb. 29, 2012
Inventories [Abstract]
Inventories	Inventories Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.

Use Of Estimates	6 Months Ended
Use Of Estimates	Feb. 29, 2012
Use Of Estimates [Abstract]
Use Of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company's estimates is the determination of revenue to recognize for the services the Company provides and the determination of the contractual allowance. See "Revenue Recognition" below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.

Investments In Available-For-Sale And Trading Securities	6 Months Ended
	Feb. 29, 2012
Investments In Available-For-Sale And Trading Securities [Abstract]
Investments In Available-For-Sale And Trading Securities	Investments in Available-for-Sale and Trading Securities The Company has invested in various bonds. These investments are classified as available-for-sale securities, and are carried at fair value as of February 29, 2012, based on the quoted market prices as of that date. These investments are subject to default risk. The Company intends to hold these for a minimum period of an additional 12 months. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The Company also invests in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and are carried at fair value as of February 29, 2012. These investments are subject to fluctuations in the market price. During the six months ended February 29, 2012 and February 28, 2011, the Company had a net loss of $57,101 and $14,995 in trading of these securities, respectively.

Noncontrolling Interest	6 Months Ended
Noncontrolling Interest	Feb. 29, 2012
Noncontrolling Interest [Abstract]
Noncontrolling Interest	Noncontrolling Interest The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company's facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest ranged from 1.75% to 3.00% at February 29, 2012).